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  3Abstract 
 
Post-transcriptional gene regulation is a very powerful and evolutionary 
conserved mechanism which allows cells to finely modulate gene expression by acting at 
the level of their mRNAs. In this thesis the post-transcriptional regulation of the Brn-3b 
transcription factor was analyzed as a case study. This protein belongs to the POUIV 
family and to the homeobox super-family of transcription factors which are involved in 
neuronal differentiation and body patterning. 
The data presented in this thesis show that regulatory sequences contained in the 
3’UTR of Brn-3b mediate the degradation of its mRNA in some neuronal cell lines. 
Furthermore, the regions regulating this effect have been characterized and two different 
microRNAs, very short RNA molecules which are key players in the post-transcriptional 
regulation of mRNAs, have been found to be directly involved in regulating the levels of 
Brn-3b. 
As Brn-3b plays an essential role in the survival of retinal ganglion cells, it was 
also investigated whether its mRNA is similarly regulated in a retinal ganglion cell line 
(RGC-5) as it occurs in other neuronal cell lines. Intriguingly, possibly due to its pro-
survival role, Brn-3b is protected from degradation by microRNAs in RGC-5 cells in 
contrast to its fate in other cell types. Furthermore, one of the two microRNAs involved 
in its regulation is not expressed in the RGC-5 cell line, paralleling its expression profile 
in primary RGCs. 
Following a brief analysis concerning the possible regulation of Brn-3b in 
primary retinal ganglion cells, the possible general role of post transcriptional gene 
regulation was assessed by evaluating the role of Dicer in the differentiation of primary 
  4retinal ganglion cells. This showed that Dicer, one of the key enzymes in the production 
of microRNAs, might be involved in the modulation of neuronal differentiation markers 
and might thus have a direct role in retinal ganglion cell differentiation. 
Overall this thesis provides evidences that post-transcriptional gene regulation is a 
mechanism which might modulate the levels of mRNA molecules depending on whether 
the encoded protein has a pro-survival role. Furthermore, preliminary evidences suggest 
that Dicer, a key enzyme in the production of microRNAs, might have a role in the 
modulation of retinal ganglion cells differentiation markers. 
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1.1  Mechanisms involved in gene regulation 
Transcription is the biological process by which the genetic material is copied into 
RNA (Berg et al. 1964). This process, as many other biological phenomena, is subjected 
to a high and complex degree of regulation (Wolberger 1999; Li et al. 2010).  
Simple unicellular organisms such as E. coli, have found simple but efficient and 
elegant ways of controlling and regulating the expression of their genome (Grainger et al. 
2009). For example, via a system called the Lac operon (Jacob et al. 1961), E. coli 
synthesize the enzymes required to metabolize lactose only when lactose is present in the 
growing medium (Jacob et al. 1961). Multicellular organisms differentiate the expression 
pattern and levels of specific genes to best suit the needs of a specific group of cells 
(Goldberger 1974) .  
  Several mechanisms are involved in the control of the phenotypic expression of 
the genome of every biota. These can be schematically divided in 1) mechanisms 
controlling the transcription of the genomic material (Losick R. 1976; Platt 1986), 2) 
mechanisms controlling the translation of mRNA into protein (Platt 1986; Beyer et al. 
1988; Kruys et al. 1988) and 3) mechanisms involved in protein turnover and stability 
(Garlick et al. 1976; Schrader et al. 2009). All these mechanisms will be described and 
analyzed in the following paragraphs. 
 
 
1.1.1  Transcription and transcription factors 
Transcription is the first step in the expression of the genome and is a process 
controlled at different levels (Losick R. 1976; Platt 1986). Nuclear DNA, for instance, is 
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tightly bound to several classes of proteins which regulate its duplication, transcriptional 
state and protect it from degradation (Das et al. 1964; Falbo et al. 2010; Unnikrishnan et 
al. 2010). Depending on the staining properties which reflect the tightness of DNA 
packaging with proteins, chromatin (from the Greek for ‘colour’ (Flemming 1882) can be 
found in two forms which, according to the state of their condensation  were originally 
termed heterochromatin and euchromatin (Heitz 1929). The former is generally found at 
the periphery of the nucleus (Andrulis et al. 1998) and refers to a type of tightly packed 
chromatin, while the latter, euchromatin, is a form of “loose” DNA packaging (Richards 
et al. 2002; Richards 2008). The two forms have been historically associated with 
different transcriptional activity, whereby heterochromatin is transcriptionally inactive 
(Andrulis et al. 1998; Tham et al. 2001; Mondoux et al. 2007) and euchromatin active 
(Hsu 1962). This schematic scenario has been superseded by evidences which show that 
heterochromatin can play a very important role in chromosomal organization and 
inheritance (Gatti et al. 1992; Dernburg et al. 1996; Coulthard et al. 2003) and its 
remodelling has an important role during the early stages of mouse embryo development 
(Santos et al. 2002; Santos et al. 2010).  
In certain instances, same regions of DNA can be in either a heterochromatic or 
euchromatic state (Lyon 1962). This is exemplified by the phenomenon known as X-
chromosome inactivation (Lyon 1962) whereby of the two X-chromosomes contained in 
a cell of a female mammal, one of the two is rendered inactive by the acquisition of 
heterochromatic state while the other is transcribed (Ohno et al. 1959; Lyon 1961). A 
gene, Xist, which is expressed only by the chromosome which will be inactivated (Brown 
et al. 1991), is at the basis of this type of control (Brown et al. 1991). Following its 
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transcription, Xist RNA “covers” the X-chromosome from which it was transcribed and 
inactivates it (Penny et al. 1996; Panning et al. 1997). The mechanism that selects 
whether the maternal or paternal X-chromosome is to become inactive is currently 
considered to be random (Okamoto et al. 2004), but once this state is acquired it will be 
transmitted to daughter cells (Okamoto et al. 2004).  
A further level of transcriptional regulation is based on the assembly of the 
transcription complex, or pre-initiation complex, on the promoter of genes (Lee et al. 
2000; Latchman 2002). Amongst other proteins, TFs play an essential and highly 
regulated role in the assembly and function of the pre-initiation complex (Lee et al. 
2000). This is best exemplified by a description of some of the known events regulating 
the activity of TF’s.  
Monomeric inactive TFs, for instance, can become active upon their dimerization 
(Latchman 2002). The STAT1 transcription factor is inactive in its monomeric form but, 
upon the activation by the JAK pathway dimerizes (Chen et al. 1998) and, upon its 
binding to nucleolin, a cytoplasmic-nuclear shuttling protein, it relocates from the 
cytoplasm to the nucleus (Jerke et al. 2009).  
TFs can be post-translationally phosphorylated or glycosylated, a chemical 
modification  that can have a profound effect on their activity (Bohmann 1990; 
Papavassiliou et al. 1992). The phosphorylation of the cAMP-response-element-binding 
(CREB) transcription factor by protein kinase-A, for instance, alleviates the repressive 
activity exerted by CREB on the c-jun promoter thereby stimulating its expression 
(Lamph et al. 1990). The importance of correct phosphorylation of TFs in cellular   
physiology can be also exemplified by the observation that individuals harbouring a 
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mutation at threonine-58 of c-myc show an increased incidence in Burkitt lymphomas 
(Niklinski et al. 2000). Threonine-58 of c-myc is also subjected to glycosylation, a 
different post-translational modification which possibly affects the sub-cellular 
localization of this TF (Chou et al. 1995; Chou et al. 1995). Glycosylation can also play a 
direct role in the transactivation activity of a TF as exemplified by the 3-5 fold increase in 
activity of the SP1 transcription factor following its glycosylation (Jackson et al. 1988). 
Conversely, a reduced glycosylation state of this transcription factor is associated to its 
increased degradation (Han et al. 1997). 
The activity of TFs can be also modulated by their binding to specific ligands 
which can mediate their relocation from one sub-cellular compartment to another. This 
can be exemplified by the relocation from the cytoplasm into the nucleus of the estrogen 
receptor (ER) following its binding to estrogen (Hansen et al. 1986; Murdoch et al. 1991) 
or by the relocation of the vitamin D receptor (VDR) following its binding to Vitamin D 
(Luo et al. 1994). Many of the aforementioned mechanisms can combine in different 
ways to affect the modulation of a transcription factor (Orti et al. 1992) .  
Although TFs often exert their activity following their binding to specific DNA 
target sequences, this is not always the case. The COUP and S300-II, for instance, are 
two transcription factors which are both required for the activation of the ovoalbumin 
gene in Drosophila melanogaster (Tsai et al. 1987). While COUP binds a target sequence 
on the ovoalbumin promoter, S300-II exerts its function by stabilizing the COPU-
ovoalbumin promoter complex by interacting with COUP rather than to specific DNA 
sequences (Tsai et al. 1987). Alternatively, the binding of a transcription factor to 
multiple sites of the same promoter has a co-operative effect on its activation. This is the 
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case, for instance of the co-operative effect exerted by the binding of HSTF on three sites 
of the HSP70 promoter (Topol et al. 1985).  
The activity, function and localization of TFs and of other proteins associated 
with the transcription complex can be modulated by more events which, although will not 
be explored further in this thesis, play nonetheless an essential role in the regulation of 
gene expression at the transcriptional level (Jerke et al. 2009). 
The classification of transcription factors is mainly based on specific 
characteristics shared by its members such as the presence of conserved domains and the 
DNA consensus sequences they bind to (Stegmaier et al. 2004; Homsi et al. 2009). As an 
example, some of the most common TF families are reported in the table below (table 
1.0).  
 
 
A conserved 200 aa long domain found in TF that generates 
lineage diversity in the developing embryo.
T-box
A conserved domain of 128 aa that controls embryonic
development.
Paired Box
Hydrophobic dimerization structure characterized by the 
abundance of the aminoacid Leucine.
Basic Leucine zipper
Two alpha helices composed of 20 aa joined by a loop. Helix-loop-Helix
Common in TF involved in body patterning. Mutation in 
these TF cause the replacement of one body structure with 
another.
Homeodomain
Four Cysteines/Histidines binding a zinc atom. One or more 
of these “fingers” binds the major groove of DNA.
Zn-finger
A conserved 200 aa long domain found in TF that generates 
lineage diversity in the developing embryo.
T-box
A conserved domain of 128 aa that controls embryonic
development.
Paired Box
Hydrophobic dimerization structure characterized by the 
abundance of the aminoacid Leucine.
Basic Leucine zipper
Two alpha helices composed of 20 aa joined by a loop. Helix-loop-Helix
Common in TF involved in body patterning. Mutation in 
these TF cause the replacement of one body structure with 
another.
Homeodomain
Four Cysteines/Histidines binding a zinc atom. One or more 
of these “fingers” binds the major groove of DNA.
Zn-finger
TF class General characteristics   
 
 
 
 
 
 
 
 
Table 1.0: Common transcription factor families. 
------------- 
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Each family of TFs is made of several members and sub-groups thus providing a large 
numbers of similar yet unique variations in their ability to bind specific DNA sequences.  
 
 
1.1.2 Post-transcriptional  gene  regulation 
Another mechanism involved in the modulation of gene expression is based on 
the control of the splicing, intra-cellular localization, translation rate and turnover of 
mRNA molecules (Salditt-Georgieff et al. 1980; Beyer et al. 1988; Rasmussen et al. 
1993; Millevoi et al. 2009; Schoenberg et al. 2009; Pawlicki et al. 2010).  
The major steps in mRNA biogenesis, mRNA transcription, 5’ capping, splicing 
and polyadenylation occur all at the same time in the nucleus (Salditt-Georgieff et al. 
1980; Beyer et al. 1988; Rasmussen et al. 1993; Millevoi et al. 2009; Schoenberg et al. 
2009; Pawlicki et al. 2010). Nascent mRNA molecules are bound by a group of proteins 
called hnRNP (heterogeneous nuclear riboprotein) (Choi et al. 1984) which are involved 
in several of mRNA maturation events (Krecic et al. 1999; Shyu et al. 2000). As 
mentioned above, nascent mRNA molecules undergo a process named splicing (Berget et 
al. 1977; Beyer et al. 1988) which mediates the re-arrangement of the coding regions 
(exons) of the nascent mRNA molecule by the excision of specific non-coding parts 
(introns) (Berget et al. 1977; MacCumber et al. 1984; Blanchette et al. 2009).  The 
differential re-arrangement of  exons leads to the formation of mature mRNA molecules 
which encode for different proteins in a process called alternative splicing (Early et al. 
1980; Perlman et al. 1982). This was initially discovered following the finding that 
membrane bound and secreted antibodies, which have slightly different molecular weight 
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due to a difference in their μ heavy chain, are actually encoded by the same mRNA (Alt 
et al. 1980; Early et al. 1980). The alternative splicing of this mRNA produces two 
different antibodies (Alt et al. 1980; Early et al. 1980). It has been recently evaluated that 
circa 95% of nascent mRNAs with more than one exon can yield mRNAs which, by a 
process of alternative splicing will produce different polypeptides (Pan et al. 2008; Wang 
et al. 2008; Pan et al. 2009).  
Although splicing is generally regulated by the splicesome, a ribonucleo-protein 
complex involved in splicing (Grabowski et al. 1985), occasionally introns can self-splice 
from an mRNA molecule (Waring et al. 1984; van der Horst et al. 1985). This 
characteristic resembles that of rybozymes (Pace et al. 1985; Johnston et al. 2001), i.e. 
RNA molecules with enzymatic properties present in both eukaryotes and prokaryotes 
(Serganov et al. 2007). 
Translation of mRNA molecules can also be efficiently controlled by regulating 
their intra-cellular localization (St Johnston 1995; St Johnston 2005) as exemplified, for 
instance, by the sub-cellular localization of mRNAs in Drosophila melanogaster oocytes 
(Gillespie et al. 1995; Becalska et al. 2009) or in the denditres and axons of mammalian 
neurons (Aakalu et al. 2001; Eberwine et al. 2001; Brittis et al. 2002; Verma et al. 2005; 
Sotelo-Silveira et al. 2006; Yoon et al. 2009).  
RNA editing (Lewin 1983; Golden et al. 2008) is a yet another mechanism 
involved in regulating the message encoded by a mRNA molecule and which is based on 
the specific modification of some of its cytidine bases into uridine ones (or adenosine into 
inosine) by an enzymatic reaction (Chen et al. 1990; Davidson 2002). This mechanism 
leads to the modification of mRNA codon(s) and to the subsequent production of a 
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different protein from the one encoded by the gene as exemplified by the modification of 
the calcium permeability of a subunit of the AMPA receptor in the central nervous 
system of the rat following the editing of the its mRNA (Lomeli et al. 1994). 
The translation rate and turnover of mRNA(s) is a further mechanism to 
efficiently modulate gene expression (Lam et al. 2001; Serikawa et al. 2003; Brockmann 
R. 2007). Although the process is still being elucidated, it is known that in cis sequences 
contained within the 3’ untranslated region (3’UTR) of mRNAs, such as the AU-rich 
regions (AREs), are used as signals to regulate mRNA half-life (Kruys et al. 1988; 
Barreau et al. 2005). An actively translated mRNA is normally protected from 
degradation by mRNA-binding proteins such as the eukaryotic elongation factors elF-4E 
and elF-4G and poly-A proteins (Andrei et al. 2005). These act in concert to block the 
decapping and poly-A tail shortening that allow nucleases to degrade the mRNA 
molecule (Shaw et al. 1986; Kruys et al. 1988).  Furthermore, other RNA molecules such 
as siRNA or microRNAs can mediate the degradation of an mRNA by binding specific 
target sequences commonly localized on its 3’UTR (Elbashir et al. 2001; Lai 2002). 
These short RNA molecules provide the target specificity to a ribonucleoproteic complex 
named RISC (RNA Induced Silencing Complex) (Bernstein et al. 2001; Caudy et al. 
2002), which, via specific nucleases mediates the degradation or translation inhibition of 
a target mRNA. This last mechanism is part of the focus of this thesis and will be 
discussed in more detail from paragraph 1.2. 
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1.1.3  Protein turnover 
A further mechanism that is involved in the phenotypic expression of DNA is 
based on the modulation of protein stability and turnover (Garlick et al. 1976; Schrader et 
al. 2009). An intra-cellular quality control mechanism, for instance, ‘scans’ proteins from 
their synthesis to their folding into secondary and tertiary structures (Marquardt et al. 
1992; Roth et al. 2008). Misfolded and thus potentially dangerous proteins are removed 
from the cellular pool and directed towards degradation (Tanaka et al. 1988; Shimbara et 
al. 1992; Goldberg 2003). A misfolded protein not only might be impaired in its function 
but it might also act as dominant negative and inhibit the function of other proteins it 
might bind to (Thompson et al. 2002; Leandro et al. 2008). A mutated form of Hsc4P, for 
instance, interferes with the intra-cellular function of its wild type counterpart leading to 
an accumulation of misfolded proteins in the cytoplasm which in turn causes cell death in 
Drosophila melanogaster (Elefant et al. 1999; Thompson et al. 2002; Leandro et al. 
2008). In certain occasions, and by mechanisms which are still not fully understood, this 
event can cause tissue and organ specific diseases (Thompson et al. 2002). This scenario 
is especially important as it is at the basis of several diseases affecting the central nervous 
system including Alzheimer Disease, Prion related diseases, Tauopathies and Parkinson 
Disease (Pan et al. 1993; Aguzzi et al. 2009; Clavaguera et al. 2009; Frost et al. 2009; 
Ren et al. 2009). The aminoacid composition of proteins also plays a role in controlling 
their degradation (Schrader et al. 2009). Proteins rich in the aminoacids proline, glutamic 
acid, serine and threonine (PEST) are generally rapidly degraded (Rogers et al. 1986). 
Furthermore, protein turnover rate can be modified following changed intra-cellular 
circumstances. Due to its protective and anti-apoptotic function, for example, the half-life 
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of the protein p53 is increased 5-10 fold in mouse keratinocyte irradiated with UV-B 
compared to non-irradiated ones (Liu et al. 1994). 
 
 
1.2 Post-transcriptional  regulation  by small RNAs: an historical outline 
Post-transcriptional gene regulation was discovered in the early 1990’s while 
attempting to increase the amount of anthocyanin pigment produced by petunia flowers 
(Napoli et al. 1990). Napoli and his collaborators discovered that circa 40% of plants that 
expressed exogenously-transfected extra copies of the chalcone synthase (Chs) gene, a 
key enzyme in the production of the pigment, produced completely white flowers (Napoli 
et al. 1990). Other transgenic plants developed flowers with an intricate pattern of white 
interspersed with pigment (Napoli et al. 1990). The authors measured the levels of  Chs 
mRNA in the white flowers and found that both the exogenous and the endogenous Chs 
mRNAs were dramatically reduced, a phenomenon they named co-suppression (Napoli et 
al. 1990). It was also realized that the white phenotype co-segregated with the exogenous 
construct (Napoli et al. 1990), i.e. it reverted to wild-type phenotype as soon as the 
transgene was lost. This suggested that the expression of the exogenous construct 
triggered intra-cellular events leading to the suppression of Chs expression (Napoli et al. 
1990). The phenomenon was interpreted as due to the repression of the exogenous and 
endogenous CHS gene by methylation (Napoli et al. 1990). Beside the introduction of 
point mutations in duplicated genes in the fungus N. crassa (Selker et al. 1988) in a 
process called RIP (repeat induced point mutations), the study by Napoli and colluegues 
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was the first detailed observation that increased gene copy number in an organism could 
lead to the suppression of their expression rather than to their increase.  
Several years later it was discovered that, in the nematode C. elegans, the gene 
lin-4 produces two transcripts of 61 and 22 nt long, which, although being too short to 
encode for a protein, were nonetheless directly involved in negatively regulating the 
levels of Lin-14 protein (Lee et al. 1993). Lin-4, and a few years later Lin-7(Abbott et al. 
2005), were the first of a series of short RNA molecules eventually named microRNA or 
miRNA which are directly involved in gene regulation (Reinhart et al. 2000). 
Subsequently it was discovered that the injection of a dsRNA targeting a specific gene 
into C. elegans, resulted in a sustained and non-stoichiometric reduction of the levels of 
its mRNA (Fire et al. 1998). Although, once more, the phenomenon was interpreted as 
due to regulation at the genomic level (Fire et al. 1998), it was also suggested that it 
might occur at the RNA level and it might mimic a physiological phenomenon which was 
named RNAi, RNA inhibition (Fire et al. 1998). 
Meanwhile, the investigation of the phenomenon of co-suppression in plants led 
to the discovery that the degradation of the exogenous and endogenous mRNAs of the 
same gene was associated with the production of very short RNA molecules, roughly 25 
nucleotides long (Hamilton et al. 1999) which were then named siRNA few years later 
(Elbashir et al. 2001). Shortly afterwards it was eventually realized that co-suppresion in 
plants and RNAi in C. elegans were phenomena part of a similar mechanism and that 
microRNAs and siRNAs are its key-players (Hammond et al. 2000; Lagos-Quintana et al. 
2001; Lau et al. 2001; Lee et al. 2001). 
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The discovery of microRNAs has added a new level to our understanding of the 
mechanisms involved in post-transcriptional gene regulation. Since siRNA were initially 
discovered during transgene and virus mediated manipulation of gene copy number in 
plants (Waterhouse et al. 1998; Hamilton et al. 1999) it was initially assumed that these 
molecules played a role in the defence of the genome (Waterhouse et al. 1998). 
Intriguingly siRNA have now been found as also originating from centromeres, repeat 
RNA transcripts and transposons (Volpe et al. 2002; Aravin et al. 2003; Sijen et al. 
2003). SiRNAs do not thus seem confined to an exogenous origin and other are 
apparently the actual features that distinguish siRNA form microRNA. For instance, 
siRNA are generally slightly shorter than microRNA (circa 21 vs. 22-23 nucleotide long) 
(Hamilton et al. 1999; Caplen et al. 2001; Elbashir et al. 2001). Secondly, the microRNA 
pathway initiates in the nucleus (Lee et al. 2003). Thirdly, siRNAs are produced in the 
cytoplasm by Dicer-2, (a protein whose role will be described in detail in the next 
paragraphs) while microRNAs are processed by Dicer-1 (Lee et al. 2004; Okamura et al. 
2004). Further differences can be identified between siRNAs and microRNAs which, 
eluding the scope of this thesis, will not be further analyzed but have been extensively 
investigated and reviewed (Tang 2005; Golden et al. 2008; Shabalina et al. 2008; 
Carthew et al. 2009). 
Beside RNAi, long dsRNA can trigger an interferon-based response pathway 
which involves the activation of PKR, a protein kinase involved in RNA degradation 
(Thomis et al. 1993).  
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1.2.1  microRNAs: a general overview 
As mentioned before, microRNAs or miRNAs are 22-23 nucleotide long single 
stranded RNA molecules which are produced from long precursor transcripts (1-2 Kb) 
from within the genome of virtually every organism studied so far (Finnegan et al. 2003; 
Allen et al. 2004; Altuvia et al. 2005; Onishi et al. 2005; Smalheiser et al. 2005; Ying et 
al. 2005; Zhang 2005). MiRNA transcripts can derive from intergenic regions where they 
are synthesized from their own promoters by RNA-polymerase II (Lee et al. 2004; 
Corcoran et al. 2009; Reddy et al. 2009) or from within intronic sequences of genes, in 
which case they are transcribed following the gene’s own promoter (Ozsolak et al. 2008; 
Corcoran et al. 2009). According to currently available data, a slight majority of 
intergenic vs. intragenic miRNA transcripts are found in every biota studied so far and 
very little is known about the regulation of miRNA promoters (Griffiths-Jones 2006; 
Griffiths-Jones et al. 2006; Kim et al. 2007). MicroRNA transcripts are modified like any 
coding mRNA so that their 5’ end is ‘capped’ with methyl-guanosine and a poly(A)-tail 
added to it’s 3’ end (Cai et al. 2004).     
 
 
 
1.2.2  From pri-mirRNA to pre-miRNA 
Following their synthesis in the nucleus, pri-miRNA are incorporated in a 
structure named the microprocessor (Denli et al. 2004). This is mainly composed of two 
proteins: Drosha, an RNAse III enzyme and its cofactor DGCR8 (known as Pasha in D. 
melanogaster and C. elegans),  which has a double-stranded RNA binding domain (Lee 
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et al. 2003; Denli et al. 2004; Gregory et al. 2004; Han et al. 2004; Landthaler et al. 
2004). RNAseIII enzymes are proteins capable to bind and cleave double stranded RNA 
(Carmell et al. 2004) and are classified in three classes according to specific domains and 
functions. Drosha belongs to class II (Filippov et al. 2000), some prokaryotic and fungi 
RNAseIII to class I (Nicholson 1999) and Dicer, another RNAse involved in the 
maturation of microRNAs, belongs to class III (Bernstein et al. 2001). The selection 
mechanism(s) employed by the microprocessor to choose a specific RNA molecule as 
substrate is not fully known (Gaudin et al. 2006; Han et al. 2006). It has been shown (Han 
et al. 2006) that a ‘typical’ pri-miRNA molecule is characterized by one or more loops 
preceded by a stem of roughly three helical turns and which is surrounded at both ends by 
less essential segments (Han et al. 2006). Drosha cleaves the RNA circa two helices away 
from the loop leaving a 70 nucleotide long stem-and-loop structure, the pre-miRNA 
(Figure 1.0) (Han et al. 2006).  
Occasionally microRNAs can arise from spliced introns (Ruby et al. 2007) which 
are called mirtrons (Ruby et al. 2007) and access the microRNA biogenesis pathway 
bypassing the first maturation step mediated by Drosha (Berezikov et al. 2007; Okamura 
et al. 2007; Ruby et al. 2007). 
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Fig.1.0: Synthesis of pre-microRNA. Schematic representation of the role of Drosha/Dcgr8/Pasha in the 
production of pre-miRNA from the pri-miRNA precursor molecule. 
------------- 
 
 
1.2.3  From pre-miRNA to mature microRNAs 
Following its production, the pre-miRNA is bound by the nuclear transport 
protein Exportin 5 (Bohnsack et al. 2004; Zeng et al. 2004) in a non-sequence specific 
manner and exported into the cytoplasm via a Ran-GTP gradient (Gwizdek et al. 2003; 
Bohnsack et al. 2004). Following the relocation of the pre-miRNA molecule into the 
cytoplasm, GTP is hydrolyzed to GDP, the pre-miRNA released and exportin 5 shuttled 
back into the nucleus (Gwizdek et al. 2003; Bohnsack et al. 2004). The pre-miRNA is 
then subjected to another shortening process by Dicer, a class III RNAse III, in the 
cytoplasm (Bernstein et al. 2001; Macrae et al. 2006; MacRae et al. 2007). Dicer binds 
double stranded pre-miRNA via its helicase and PAZ domain (Cerutti et al. 2000; Zhang 
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et al. 2004; MacRae et al. 2007) which derives its name from the homology with three 
proteins named Piwi, Argo and Zwille (Cerutti et al. 2000) (Figure 1.1). 
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RNAse III
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Pre-miRNA
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RNAse III
RNAse III
3’
5’
Dicer
Pre-miRNA
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.1: Domains of Dicer. Schematic representation of Dicer. Refer to the text for the function of the 
various domains. dsRBD=double stranded RNA Binding Domain. 
-------------------- 
 
 
The catalytic domain of Dicer cuts the dsRNA in a non-sequence dependent manner 
(Basyuk et al. 2003; Lee et al. 2003) at a definite distance from its PAZ domain 
(Bernstein et al. 2001; Lee et al. 2002; Zhang et al. 2004) producing 22-23 nucleotide 
long dsRNA linear molecules with two or three nucleotide overhang at the 3’ end (Zhang 
et al. 2004; MacRae et al. 2007). By moving along the pre-miRNA precursor, Dicer 
produces 22-23 nucleotide long RNA molecules until all the molecule has been processed 
(Figure 1.2) (Zhang et al. 2004). 
 
  34 Chapter1: Introduction  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
22 nt
Mature miRNA
Pre-miRNA
Dicer
Stem and loop
22 nt
Mature miRNA
Pre-miRNA
Dicer
Stem and loop
 
 
 
Fig. 1.2: Dicer activity on pre-miRNA. The activity of Dicer on the pre-miRNA leads to the production of 
a mature 22 nucleotide long double stranded microRNAs. One of the two strands, the “passenger strand” 
(blue in this figure) is degraded, while the other (red) is the “guide strand” and is incorporated in the RISC 
where it confers specificity to the silencing complex. 
--------------- 
 
 
1.2.4 RISC 
Of the two RNA strands, one, the guide strand, is incorporated into a multiprotein 
complex called RISC (RNA Induced Silencing Complex) (Bernstein et al. 2001; Lee et 
al. 2003; Bartel 2004; Gregory et al. 2005) while the other, the passenger strand, is 
degraded. Although not yet fully understood, the mechanism that regulates which strand 
is chosen to become the ‘guide’ and which the ‘passenger’, lies in the thermodynamic 
differences in the 5’ ends of each strand (Tomari et al. 2004). The composition of RISC is 
still being investigated but several proteins have by now been identified (Song et al. 
2003; Liu et al. 2004; Forstemann et al. 2005; Gregory et al. 2005; Leuschner et al. 
2005). The core component of RISC is made of four Argonaute proteins in mammals 
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(Ago1-4) and two in Drosophila (Ago1-2). These proteins have conserved PAZ domain 
(which, as it has been previously described in this thesis, is also present in Dicer) and a 
PIWI domain which is homologous to RNAseH (Parker et al. 2004; Parker et al. 2005). 
Other proteins composing RISC include a small dsRBP (Double stranded RNA binding 
proteins) such as R2D2 (Robb et al. 2007; Kalidas et al. 2008), a ribonuclease termed 
C3PO which releasesd RISC from the degradation product of the passenger microRNA 
strand (Liu et al. 2009), proteins with RNA-helicase function (Robb et al. 2007) and the 
fragile-X mental retardation protein (Jin et al. 2004; Didiot et al. 2009), whose function is 
still unknown. The microRNA guide strand released by Dicer and incorporated by RISC 
mediates the specific binding to an mRNA target.  
 
 
1.2.5   MicroRNA-mediated mRNA degradation  
MicroRNAs generally exert their function by binding specific complementary 
sequences in the 3’UTR of their target mRNA (Rajewsky et al. 2004; Bagga et al. 2005), 
but it has been recently discovered that they can also bind the coding sequence of 
mRNAs (Duursma et al. 2008; Tay et al. 2008). The most important part of the 
microRNA molecules lies towards their 5’ end where a region of 5-7 nucleotides named 
the “seed” has been found to be essential for their function (Lewis et al. 2005; Saetrom et 
al. 2007). It is generally accepted (Lewis et al. 2003; Brennecke et al. 2005; Hall 2005; 
Lewis et al. 2005) that, in case of perfect match between the microRNA and mRNA, the 
latter is cleaved by the RNAseH activity of Ago proteins near the 11
th nucleotide from the 
5’ end of the miRNA (figure 1.3) (Lewis et al. 2003; Brennecke et al. 2005; Hall 2005; 
  36 Chapter1: Introduction  
 
Lewis et al. 2005). This is followed by the degradation of the truncated mRNA 
molecules. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1.3: Degradation of a target mRNA mediated by a specific microRNA. The target mRNA (green 
molecule) is bound by specific microRNA (red molecule) incorporated in the RISC and cut. 
(Hannon et al. 2004). 
---------------------- 
 
1.2.6 P-bodies 
In case of mismatch between the microRNAs and its target sequence, the mRNA 
is not degraded and it becomes part of a multiprotein complex known as P-body (Andrei 
et al. 2005; Liu et al. 2005; Rehwinkel et al. 2005; Parker et al. 2007; Takimoto et al. 
2009). This is composed by mRNA molecules and proteins with different functions such 
as proteins that constitute the decapping machinery which is involved in the removal of 
the methyl-guanosine found at the 5’ of mRNAs (Dcap-1, Dcap-2, Edc3-p) (van Dijk et 
al. 2002; Sakuno et al. 2004), poly(A)-tail removal proteins such as the Ccr4p/Pop2p/Not 
complex (Parker et al. 2007), RNA binding proteins, translation initiation factors such as 
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eIF4E-T etc (Andrei et al. 2005; Wilczynska et al. 2005), and exonucleases such as 
(Xrn1p) (Ingelfinger et al. 2002). Messenger RNAs can also exit their association with P-
bodies and re-enter translation (Brengues et al. 2005). For example, it has been shown 
that yeast cells in a stationary growth phase have increased numbers of P-bodies with 
associated mRNAs (Brengues et al. 2005). These molecules can then re-enter translation 
following growth stimuli (Brengues et al. 2005).  
Messenger RNAs can also be incorporated in P-bodies by a quality control 
process that degrades mRNAs with aberrant translation termination codons, a 
phenomenon called Nonsense-Mediated Decay (NMD) (van Dijk et al. 2002; Amrani et 
al. 2004). MicroRNAs with shortened 3’UTR or the stalling of a ribosome on a mRNA 
molecule during its translation are other mechanism which can lead these molecules to be 
incorporated into a P-body  (Amrani et al. 2004; Maquat 2004; Inada et al. 2005).  
As schematically represented in the figure below (figure 1.4), the equilibrium 
between mRNAs being translated and sequestered by P-bodies seems to be based on the 
competition between the assembly of the translation complex and the assembly of the P-
body (figure 1.4) (Parker et al. 2007) which is in turn affected by the mechanisms 
regulating intracellular mRNA fate described above. 
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Fig. 1.4: P-Bodies and their role in mRNA translation. An mRNA molecule can be shuttled from its 
inactive and hibernated state whilst contained in P-bodies (right of the figure) to being actively translated 
(left of the figure).  
(Parker et al. 2007). 
------------ 
 
 
1.2.7  MicroRNA production and activity: a summary  
 
The figure below (figure 1.5) summarizes the entire process which leads to the 
production of mature microRNAs form their synthesis as pri-miRNA, their initial 
shortening into pre-miRNA by Drosha, their active translocation into the cytoplasm, 
maturation to 22 nucleotide long microRNAs by Dicer, ending in their incorporation in 
RISC and in either the degradation of a target mRNA or the incorporation of the latter in 
P-bodies.  
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Fig. 1.5: MicroRNA production and effect on target mRNAs. Following the synthesis of pri-miRNA, 
their initial processing by Drosha in the nucleus and Dicer in the cytoplasm, a mature microRNA binds its 
target mRNA. In case of perfect match, the mRNA is degraded (left side) while in case of mismatches 
between the microRNA and its target mRNA, the latter is incorporated into a multiprotein complex (P-
bodies) and becomes translationally silent. MRNAs can be released from P-bodies and become 
translationally active.  
------------- 
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It has been estimated that 10-30% of mRNAs are targeted by microRNAs (Brennecke et 
al. 2003; Brennecke et al. 2005) and that every microRNA is on average potentially able 
to modulate the expression of circa 2000 different mRNAs (Brennecke et al. 2005; Lewis 
et al. 2005). More than 5000 unique microRNAs have been identified up to now and 
classified from more than 50 species (Griffiths-Jones et al. 2008). A recent analysis 
(Chiang et al. 2010) has confirmed the expression of at least 500 different microRNAs in 
mice but their number is constantly growing.  Human microRNAs alone have been 
predicted to target circa 30% of human genes and it appears that each microRNA can 
target circa 200 transcripts (Krek et al. 2005; Lewis et al. 2005; Xie et al. 2005).  
Intriguingly, a combination of available experimental data and in-silico analysis 
regarding microRNA and mRNA expression profiles in different human tissues is 
allowing the definition of cell-type-specific miRNA “signatures” (Sood et al. 2006). This 
implies that for any given microRNA expression profile, it would be theoretically 
possible to infer which mRNAs are possibly expressed in that same tissue (Sood et al. 
2006). Although more experimental data is needed in order to draw an accurate 
correlation between microRNAs and mRNAs expression in any given tissues and 
whether this has any physiological role, microRNAs can nonetheless be classified 
according to the tissue in which they are expressed or are expressed in higher proportion 
compared to other tissues. An example, concerning mammal microRNAs is summarized 
in the table below (table 1.1).  
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miR-16, miR-26a, miR-27a, miR-143a, miR-
21, let-7a, miR-7b, miR-30b, miR-30c
Ubiquitously expressed
miR-181, miR-223, miR-142 Enriched in haematopoetic tissues
miR-30b, miR-30c, miR-18, miR-20, miR-24, 
miR-32, miR-141, miR-193,
miR-200b
Enriched in kidney
miR-1b, miR-1d, miR-133, miR-206, miR-208, 
miR-143
Enriched in heart
miR-122a, miR-152, miR-194, miR-199, miR-
215
Enriched in liver
miR-99a, miR-127, miR-142a, miR-142s, 
miR-151, miR-189, miR-212
Enriched in spleen
miR-18, miR-19a, miR-24, miR-32, miR-130, 
miR-213, miR-20, miR-141, miR-193,
miR-200b
Enriched in lung
miR-12a, miR-125b, miR-128, miR-132, miR-
139, miR-7, miR-9, miR-124a,
miR-124b, miR-135, miR-153, miR-149, miR-
183, miR-190, miR-219
Enriched in brain
microRNA Expression pattern
 
miR-16, miR-26a, miR-27a, miR-143a, miR-
21, let-7a, miR-7b, miR-30b, miR-30c
Ubiquitously expressed
miR-181, miR-223, miR-142 Enriched in haematopoetic tissues
miR-30b, miR-30c, miR-18, miR-20, miR-24, 
miR-32, miR-141, miR-193,
miR-200b
Enriched in kidney
miR-1b, miR-1d, miR-133, miR-206, miR-208, 
miR-143
Enriched in heart
miR-122a, miR-152, miR-194, miR-199, miR-
215
Enriched in liver
miR-99a, miR-127, miR-142a, miR-142s, 
miR-151, miR-189, miR-212
Enriched in spleen
miR-18, miR-19a, miR-24, miR-32, miR-130, 
miR-213, miR-20, miR-141, miR-193,
miR-200b
Enriched in lung
miR-12a, miR-125b, miR-128, miR-132, miR-
139, miR-7, miR-9, miR-124a,
miR-124b, miR-135, miR-153, miR-149, miR-
183, miR-190, miR-219
Enriched in brain
microRNA Expression pattern
 
Table 1.1: Example of the expression profile of microRNAs in different human tissues.  
(He et al. 2004) 
-------------- 
 
 
1.3  General role of microRNAs 
Besides being an extremely powerful tool in the hands of scientists whishing to 
knock-down the expression of specific genes, microRNAs actually play an essential role 
in several aspects of cellular physio-pathology.  
In order to understand the overall role played by the RNAi pathway during 
development, Dicer and Dgcr8 have been experimentally knocked-out in mice (Bernstein 
et al. 2003; Wang et al. 2007; Ma et al. 2010; Suh et al. 2010). As further discussed in the 
following paragraph (1.4), the genetic ablation of Dicer in mice leads to embryonic death 
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(Bernstein et al. 2003) and it is essential for mice oocyte maturation (Murchison et al. 
2007) whilst the elimination of Dgcr8, although not lethal, is associated to mice 
embryonic arrested development (Wang et al. 2007) but has no effect on oocyte 
maturation (Suh et al. 2010). Furthermore, while the deletion of Dicer is associated with 
mRNAs mis-regulation (Suh et al. 2010), Dgcr8 knock out and wild type mRNA profiles 
are virtually identical (Suh et al. 2010). Due to the essential role played by Drosha in the 
biosynthesis of microRNAs (Lee et al. 2003; Denli et al. 2004; Gregory et al. 2004; Han 
et al. 2004; Landthaler et al. 2004), these data suggest that endogenous siRNAs, rather 
than microRNAs, are at the basis of the Dicer knock-out phenotype (Suh et al. 2010). 
Intriguingly, miRNA-mediated mRNA degradation is reduced during oocyte 
development in  mice, a phenomenon which might be linked to increased mRNA stability 
in growing oocytes (Ma et al. 2010). 
In regard of other possible role played by Dicer in cellular physiology it has also 
to be mentioned its functions in the formation of heterochromatin (Pal-Bhadra et al. 
2004) and centromeres (White et al. 2004) via mechanisms which are still being 
investigated (Halic et al. 2010).  
Several groups have been analyzing the role of microRNAs in different aspects of 
development and disease and some of these will be discussed in the following 
paragraphs. 
 
1.3.1 Stem  cells   
The existence of cells with the capability of differentiating in many different cell 
types was firstly demonstrated following the injection of hematopoietic tissues in 
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irradiated mice (Becker et al. 1963). The implanted cells gave rise to macroscopic 
colonies which started differentiating along the erythrocytic, granulocytic and 
megacaryocitc lines (Becker et al. 1963). The term ‘stem’ cell derives from “meristem” 
which means “to divide” in ancient greek and was first coined  by the botanist Karl 
Wilhelm von Nägeli (Nägeli 1858) and describes cells with the potential of 
differentiating in several cell types. The term stem cell is applied to both embryonic stem 
cells and adult stem cells (Haskill et al. 1970; Micklem et al. 1972; Stent 1985). The 
former are cells of the blastocyst which will give rise to all the different specialized adult 
cell types and organs that compose an adult organism (Evans et al. 1981), while the latter 
are found in several organs and tissues and provide a source of cells which replace the 
ones lost through normal wear and tear (Ito et al.; Harrison 1979; Simon et al. 1995; 
Bazan et al. 2004; Simon-Assmann et al. 2007).   
As mentioned above, the experimental deletion of Dicer in mice, leads to 
embryonic death which seems to be due to the depletion of stem cells (Bernstein et al. 
2003; Wang et al. 2007) while Dgcr8 knock-out mice embryos have an arrested 
development, due to the inability to silence embryonic stem cells self-renewal capability 
when exposed to differentiation stimuli (Wang et al. 2007; Melton et al. 2010). The latter 
phenotype can be rescued by the re-introdcution of Dgcr8 (Wang et al. 2007) or by the 
introduction of stem-cells specific microRNAs belonging to the mir-290 family (Wang et 
al. 2008). Interestingly, the Lin-7 microRNA family has an opposite role to the mir-290 
cluster in embryonic stem cells in mice (Melton et al. 2010) whereby let-7 inhibits and 
mir-290 indirectly activates a number of genes involved in self-renewal (Melton et al. 
2010). Intriguingly, the mir-290 cluster is amongst the most abundantly expressed 
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miRNA in mouse embryonic stem cells (Judson et al. 2009) and has a similar function to 
the mir-302 cluster in human embryonic stem cells (Lin et al. 2008; Wang et al. 2008). 
Intriguingly Dicer has also been found to play an indirect role in the methylation 
state of Xist promoter (Brown et al. 1991; Nesterova et al. 2008) in embryonic stem cells 
by regulating the levels of methyltransferase in these cells (Nesterova et al. 2008). 
 
 
1.3.2 Cancer 
As mentioned in section 1.2, Lin-4 and Lin-7 were the first microRNAs to be 
identified and they are both involved in the developmental timing and overall cell growth 
of the nematode C. elegans (Lee et al. 1993; Reinhart et al. 2000). Because of these 
features, several studies (Calin et al. 2006; Calin et al. 2006; Gaur et al. 2007) have 
investigated the potential role played by microRNAs in cell-cycle and cell-growth 
impairment which are often disrupted in cancer and have evidenced that microRNAs 
profiles are often very different between normal tissues and their cancerous counterparts 
(Calin et al. 2006; Calin et al. 2006; Gaur et al. 2007). Furthermore, it has been observed 
that several genes encoding for microRNAs are located in known fragile chromosomal 
regions often associated with different forms of cancer (Calin et al. 2004).  
Both the up-regulation and down-regulation of microRNAs have been found 
associated with cancer. For instance, chronic lymphocytic leukemia (CLL) is often 
associated with a deletion on chromosome 13 in humans (Pekarsky et al. 2005). Although 
this region does not contain any evident gene(s) causally involved in this form of CLL, it 
was found that it encodes for two miRNAs, mir-15a and mir-16a, whose expression is 
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frequently down-regulated in patients with B cell chronic lymphocytic leukemia (Calin et 
al. 2004; Pekarsky et al. 2005). Further examples concern the reduction of miR-143 and 
miR-145 expression which is directly associated to colorectal neoplasia in humans 
(Michael et al. 2003) or the expression levels of mir-22 which are often reduced in some 
human breast cancers (Xiong et al. 2010). Conversely, it has been described that mir-155 
is  up-regulated 100-fold in patients with Burkitt's lymphoma (Metzler et al. 2004). 
Increased levels of the mir-17-92 cluster are found instead in patients with B cell 
lymphoma (He et al. 2005). Interestingly, the artificial manipulation of the expression 
levels of this microRNA cluster in mice is associated to increased incidence of 
lymphomas (He et al. 2005). Because if its pro-tumorigenic capacity, the mir-17-92 
cluster has been named oncomir-1, the first microRNA with oncogenic properties (He et 
al. 2005). Another oncomir, mir-21, has been shown to have a causative role in the 
development and progression of hepatocellular carcinomas by regulating cell 
proliferation, apoptosis and tumor invasiveness (Liu C 2010). 
Beside their role as oncogenes, microRNAs can also have a tumor-suppressor 
activity. The reduction of let-7 microRNA levels, for instance, is associated to an increase 
of RAS protein levels in several forms of lung cancer (Johnson et al. 2005) and the 
artificial over-expression of this microRNA induces a down-regulation of RAS levels 
which results in reduced cellular growth (Johnson et al. 2005). Another example concerns 
the role of mir-519 in the suppression of tumor growth (Abdelmohsen et al. 2010). This 
microRNA targets the mRNA encoding for HuR (Calaluce et al. 2010), an RNA binding 
protein which has been shown to bind AU-rich elements (ARE) of proto-oncogenes, thus 
protecting them from degradation (Calaluce et al. 2010). Furthermore, increased levels of 
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the mir-103/107 are found in breast cancer with metastasis and unfavourable outcome 
(Martello 2010). The experimental inhibition of this microRNA reduces metastatic 
capability of malignant cells. Intriguingly, the mir-103/107 miRNA targets Dicer mRNA 
and this leads to a global reduction of miRNA biosynthesis (Martello 2010). 
The recent identification of microRNAs in human plasma (Mitchell et al. 2008), 
offers also an intriguing diagnostic possibilities regarding the identification of microRNA 
signatures associated to specific cancers (Mitchell et al. 2008) as exemplified, for 
instance, by the detection of mir-141 in the serum of patients with prostate cancer 
(Mitchell et al. 2008). 
 
 
1.3.3 Neuronal  cells 
The role played by microRNAs in the development of the nervous system was 
initially established in zebrafish mutants in which the RNAse III and RNA-binding 
domain of Dicer had been disrupted (Giraldez et al. 2005). This resulted in abnormal 
somitogenesis, heart development and brain formation (Giraldez et al. 2005). The specific 
role played by microRNAs in brain development in zebrafish Dicer mutants, was 
established by the rescue of the brain defects following the injection of mir-430 (Giraldez 
et al. 2005; Giraldez et al. 2006). A microarray approach and in vivo validation has 
shown that mir-430 can target several hundred mRNAs (Giraldez et al. 2006) and that it 
is involved in the elimination of maternal mRNAs during embryogenesis (Giraldez et al. 
2006). 
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The first neuronal disease to be identified as being associated with the 
microRNAs pathway is the Fragile X syndrome (FXS), an inherited disease causing 
learning disabilities and delayed speech and language development (Caudy et al. 2002; 
Jin et al. 2004). The disease is linked to the Fmr1 gene which, as mentioned before, 
encodes for a protein (Caudy et al. 2002) part of RISC, the multiprotein complex 
involved in the production of microRNAs (Caudy et al. 2002; Song et al. 2003; Liu et al. 
2004; Forstemann et al. 2005; Gregory et al. 2005; Leuschner et al. 2005). Other 
examples include mir-106 and mir-520c which, for instance, can modulate the expression 
of the amyloid precursor protein (APP), implicated in Alzheimer’s disease (AD) (Patel et 
al. 2008). Another neurodegenerative disease, Parkinson’s disease (PD) (Parkinson 
1817), has been found to be associated in some patients to a mutation in the 3’UTR of the 
fibroblast growth factor 20 (Fgf20) (Wang et al. 2008) which might impair the binding of 
mir-433 (Wang et al. 2008). Fgf20 activates the expression of α-synuclein (Forloni et al. 
2000) which is associated to a form of Parkinson’s disease (Forloni et al. 2000; Wang et 
al. 2008). The mutations on the 3’UTR of Fgf-20 mRNA thus results in elevated levels of 
Fgf20 which induces an increase of the levels of α-synuclein (Wang et al. 2008) . 
The identification of Dicer, mRNAs and ribosomes at synaptic terminals (Steward 
et al. 1982; Lugli et al. 2005; Schuman et al. 2006), has triggered an interest  in 
understanding the mechanisms regulating translation at distant locations from the nucleus 
(Steward et al. 1982; Lugli et al. 2005; Schratt et al. 2006). It has been established, for 
instance, that mir-134 plays a direct role in synaptic plasticity by regulating dendritic 
spine size via the down-regulation of Limk1 mRNA, a protein kinase involved in 
synaptic development (Schratt et al. 2006). So far, more than 80 different microRNAs 
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have been found at synaptic terminals (Kim et al. 2004) and most importantly Dicer is 
enriched at postsynaptic densities suggesting that microRNAs might be produced in situ 
(Lugli et al. 2005). Furthermore, microRNAs have been found to be expressed in 
dendrites of explanted rat dorsal root ganglion neurons stimulated with trophic factors 
such as NGF or NT3 (Hengst et al. 2006). 
It has also been recently discovered that mRNAs, microRNAs and proteins can be 
transferred across synapses inside exosomes (Faure et al. 2006; Gibbings et al. 2009), 
small lipid vesicles derived from multivesicular bodies (MVBs) of the endocytic pathway 
(Faure et al. 2006). This opens a new possibility of inter-cellular communication and 
post-transcriptional gene regulation  
 
 
1.3.4 Cardiogenensis 
Cardiovascular development provides another example of the direct role played 
by microRNAs in organogenesis. For instance, mir-1/2, mir-133 and mir-206 are 
expressed and have a role in cardiac and skeletal muscles (Kwon et al. 2005; Zhao et al. 
2005; Chen et al. 2006). In particular, the mir-1/2 cluster is expressed from E8.5 in the 
mouse and increases throughout development (Zhao et al. 2007). The experimental 
deletion of this cluster in mice, results in ventricular septal heart defects and occasional 
heart oedema (Zhao et al. 2007) which is likely to be caused by an impaired regulation of 
Hand2, an essential basic helix-loop-helix transcription factor involved in the growth of 
ventricular myocyte (Zhao et al. 2005; Zhao et al. 2007). A precise dosage of Hand2 is 
required for normal cardiomyocyte development and morphogenesis (Srivastava et al. 
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1995; Yelon et al. 2000; McFadden et al. 2005) and the control of its expression levels by 
mir-1/2 is thus essential for normal cardiac development (Zhao et al. 2007). Intriguingly, 
mir-1/2 plays an antagonistic role to mir-133 (Chen et al. 2006). Whereas mir-1/2 
promotes myogenesis by targeting histone deacetylase 4 mRNA, miR-133 instead 
enhances myoblast proliferation by repressing serum response factor (SRF) (Chen et al. 
2006).  
Beside its role in cardiogenesis, microRNAs have been shown to be involved in 
development of the vascular system (Fish et al. 2008; Suarez et al. 2008; Nicoli et al. 
2010). The lack of mir-126, for example, leads to collapsed blood vessels and cranial 
haemorrhages in zebrafish (Fish et al. 2008). This microRNA is the most abundantly 
expressed microRNA in zebrafish endothelial cells and exerts its activity by targeting 
Spred1 and PIK3R2 mRNAs which are both involved in the response of endothelial cells 
to vascular endothelial growth factor (VEGF) (Fish et al. 2008). In contrast, miR-92a 
represses the growth of new blood vessels by targeting mRNAs encoding for pro-
angiogenic proteins such as the integrin subunit alpha5. (Bonauer et al. 2009). These 
results have suggested the possibility of suppressing or inducing the expression of 
specific microRNAs as a way to control neo-angiogenesis in tumours or viceversa to 
stimulate blood vessels growth in ischemic tissues (Dews et al. 2006; Hua et al. 2006; 
Poliseno et al. 2006; Kuehbacher et al. 2007; Bonauer et al. 2009).  
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1.3.5  MicroRNA and transcription factors 
MicroRNAs have also been found to be involved in the regulation of mRNAs 
encoding for many kinds of proteins including transcription factors (Wan et al.; Hobert 
2004; Szulwach KE 2010). For instance, the expression of the E2F3a transcription factor, 
which along with other members of the E2F family regulates cell proliferation and 
apoptosis (Paulson et al. 2006; Chong et al. 2009), is tightly regulated by mir-128 (Zhang 
et al. 2009). The down-regulation of this microRNA leads to increased levels of E2F3a 
which in turn causes oncogenic transformation of glia cells (Zhang et al. 2009).  
An even more interesting example concerns the regulation of the Hox network by 
microRNAs. Hox genes are a group of highly related and conserved genes which regulate 
the formation of the embryonic anterior-posterior axis (Colberg-Poley et al. 1985; 
Manley et al. 1985; Fienberg et al. 1987; Holland et al. 1988; Schughart et al. 1988; 
Krumlauf 1994; Matsuo et al. 1995). Mammals have four HOX clusters (A to D) which 
contain
 39 genes (Krumlauf 1994). They encode for transcription factors which share a 
conserved domain named homeobox (Schneuwly et al. 1986; Gehring 1987; Kessel et al. 
1987). Their expression is time and space regulated, i.e. each hox gene is activated after 
the one preceding it in the same cluster (Deschamps et al. 1993; Tschopp et al. 2009). 
Interestingly, the mir-196 family, which is encoded by genes interspersed within the 
HoxA, B and C clusters (Yekta et al. 2004), targets the 3’UTR of Hox genes representing
 
each cluster: HoxB8, HoxC8, HoxD8 and HoxA7 (Mansfield et al. 2004; Yekta et al. 
2004). Members of the mir-10 family, instead, are expressed from within Hox-4 
paralogues and target HoxB1a and HoxB3a (Mansfield et al. 2004; Woltering et al. 
2008).  
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The Brn-3 transcription factors, composed of Brn-3a, Brn-3b and Brn-3c, share 
some characteristics with the Hox family, mainly a DNA binding homeodomain in their 
C-terminus (Gruber et al. 1997; Morris et al. 1997) and are involved in several aspects of 
neuronal survival and differentiation (Collum et al. 1992; Gerrero et al. 1993; Turner et 
al. 1994; Gan et al. 1996; Xiang et al. 1998).  
Surprisingly, in contrast with the lack of any conservation in the 3’ untranslated 
region of Brn-3a and Brn-3c, the 3’UTR of Brn-3b is remarkably conserved across 
different species (Calissano et al. 2007). This suggests that this region might have a role 
in the regulation of Brn-3b expression in specific cell types. The analysis of this region 
and its role in the regulation of Brn-3b constitutes the other focus of this thesis but firstly 
the Brn-3 family of transcription factors will be analysed and their function described.   
 
 
1.4  POU IV transcription factors  
  As reported in the previous paragraph, Hox proteins are critical in the anterior-
posterior body axis formation (Fienberg et al. 1987; Schughart et al. 1988) and 
characterized by the presence of a 60 aminoacid conserved homeodomain which binds 
DNA (Colberg-Poley et al. 1985; Manley et al. 1985; Fienberg et al. 1987; Holland et al. 
1988; Schughart et al. 1988; Krumlauf 1994; Matsuo et al. 1995). This domain is 
characteristic of other families of transcription factors such as the Brn-3a, Brn-3b and 
Brn-3c proteins (Collum et al. 1992; Gerrero et al. 1993; Ninkina et al. 1993; Xiang et al. 
1993; Turner et al. 1994). These are members of the POUIV class of transcription factors 
and are expressed in different parts of the central and peripheral nervous system (Sturm et 
  52 Chapter1: Introduction  
 
al. 1988; Collum et al. 1992; Gerrero et al. 1993; Turner et al. 1994; Gan et al. 1996; 
Xiang et al. 1998). Members of the POUIV family, beside a typical homeodomain shared 
with other homeobox proteins (Sturm et al. 1988), are characterized by the presence of 
another DNA binding domain (DBD), the POU specific domain, which was initially 
defined after its identification in the Pit1, Oct-1/2 and Unc-86 transcription factors 
(Sturm et al. 1988; Sturm et al. 1988) (figure 1.8 and 1.9). As shown in the figure below 
(figure 1.6), POUIV members are a sub-group within the POU family of transcription 
factors.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.6: POU family of transcription factors. Evolutionary tree representing the POU family of 
transcription factors. The mouse and chicken Brn-3a, Brn-3b and Brn-3c POUIV members are highlighted 
by an orange box.  From: (Candiani et al. 2005) 
----------------- 
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Members of the POUIV class, besides the C-terminal POU domain also share a short 
conserved region in their N-terminus, the POUIV box (figure 1.7) (Theil et al. 1993). The 
highest homology between the Brn-3 transcription factors is in their C-terminal DBD 
while their N-terminus shares a moderate conservation amongst family members (figure 
1.8 and 1.9) (Collum et al. 1992; Ring et al. 1993). Due to the focus of this thesis on Brn-
3b and Brn-3a TFs and due to the lower degree of homology shared by Brn-3c with the 
other two members of the POUIV family, Brn-3c will not be analyzed or discussed 
further in this thesis. 
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Fig.1.7:  Homology of Brn-3a (POU4F1) and Brn-3b (POU4F2) proteins. The green shaded box 
indicates the POU IV box, the purple the POU domain and the yellow the homeodomain. The arrow 
indicates the position of the essential wild type Val and Ile (in Brn-3a and Brn-3b respectively) in the 
homeodomain. The artificial substitution of this aminoacid transforms Brn-3a-Val/Ile into a repressor and 
Brn-3b-Ile/Val into an activator  (Morris et al. 1997).  
---------------- 
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1.4.1  Structure of POU IV proteins  
 
As shown in figure 1.7 and schematically in figure 1.8, the C-terminal of Brn-3 
proteins is composed of an 80 aminoacid long POU domain (which is present only in the 
members of this class) (Sturm et al. 1988; Collum et al. 1992) and of a 60 aminoacid long 
homeodomain (which is shared among other homeodomain proteins) (Gruber et al. 1997; 
Morris et al. 1997). The two domains bind DNA in a synergistic way (Gruber et al. 1997) 
although the POU domain has a higher affinity for DNA than the homeodomain (Gruber 
et al. 1997).  
The N-terminus activation domain (AD) of Brn-3a, which contains a highly 
conserved region, the POUIV box (Gerrero et al. 1993), is able to transform fibroblasts 
(Theil et al. 1993). Intriguingly, this region is conserved and has been shown to play an 
essential part in the oncogenic activity of c-myc (Niklinski et al. 2000). As discussed in 
more detail in the following paragraphs, beside its pro-oncogenic role, the AD plays a 
very important part in the modulation of transcriptional regulation of Brn-3a. 
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NH2 COOH
Brn-3 schematic structure
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Fig. 1.8: Schematic structure of the Brn-3 proteins. Schematic (not to scale) representation of the Brn-3 
protein conserved domains. AD=activation domain, DBD= DNA binding domain. The length, in 
aminoacids, is indicated below each DBD.  
----------- 
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1.4.2  Antagonistic role of Brn-3a and Brn-3b  
Both Brn-3a and Brn-3b can be found in two different isoforms,  long and  short 
(Theil et al. 1995; Liu et al. 1996; Latchman 1998), which derive from alternatively 
transcribed mRNAs with the long one having an extra N-terminus domain (figure 1.9) 
(Liu et al. 1996). It has also been demonstrated that Brn-3a long and short isoform can 
originate from transcripts produced from two distinct promoters, the short one being in 
the intron that separates the two exons (Thomas et al. 2004). The long form of Brn-3a 
(Brn-3aL) is characterized by an extra 84 aminoacids which contain the POU IV box (Liu 
et al. 1996; Smith et al. 1998) while the long form of Brn-3b (Brn-3bL) has 57 more 
aminoacids at its N-terminal (Theil et al. 1995). Furthermore, due to an alternative 
translational start site, the short form of Brn-3b (Brn-3bS) has nine extra amino-terminal 
residues that are not found in the longer form (Theil et al. 1993; Theil et al. 1995).  
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Fig. 1.9: Long and short isoforms of Brn-3 proteins. Schematic representation of the long (L) and short 
(S) Brn-3a and Brn-3b transcription factors isoforms. Transcription start sites are indicated by arrows. The 
dotted line in the N-terminal of Brn-3aL indicates a cryptic promoter within its intron which is used for the 
production of its short isoform. 
---------------- 
 
 
The two forms differ in their ability to activate the expression of overlapping but different 
subset of genes. Although both forms of Brn-3a can transactivate neuronal differentiation 
genes (Lakin et al. 1995; Liu et al. 1996; Latchman 1998; Ma et al. 2003), only the extra  
84 amino acids contained at the N-terminus of its long form mediate the transactivation 
of anti-apoptotic genes such as Bcl-2 and Bcl-x (Lakin et al. 1995; Smith et al. 1997; 
Smith et al. 1998; Smith et al. 2001).  
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Several studies have focused on the antagonistic yet complementary role of Brn-
3a and Brn-3b in neuronal cells (Morris et al. 1994; Budhram-Mahadeo et al. 1995; Smith 
et al. 1996). When the ND7 neuroblastoma cell line is induced to differentiate via serum 
removal, Brn-3b levels decrease while Brn-3a levels increase (Budhram-Mahadeo et al. 
1995). This phenomenon is strictly coupled  to the differential expression of a subset of 
genes involved in the cellular routing towards differentiation (Brn-3a) (Lakin et al. 1995; 
Smith et al. 1998; Smith et al. 1999; Smith et al. 2001; Calissano et al. 2003), or 
proliferation (Brn-3b)  (Budhram-Mahadeo et al. 1998; Dennis et al. 2001; Samady et al. 
2004; Lee et al. 2005). Via their POU domain, both transcription factors bind the same 
octamer target core sequence, AT(A/T)A(T/A)T(A/T)AT with the initial AT generally 
preceded by a GC dinucleotide (Gruber et al. 1997). The repressive activity of Brn-3b on 
Brn-3* target promoters lies in the valine at position 378 (figure 1.8) and might be due to 
the recruitment of a binding partner or to a modification of the POU domain structure that 
alters its ability to bind DNA (Morris et al. 1997). As mentioned above, Brn-3 proteins 
can also homo- or heterodimerize (Theil et al. 1995).  In Brn-3a and Brn-3b co-
transfection experiments in neuronal cells, Brn-3b has a dominant negative effect on the 
activity of Brn-3a on its target promoters (Morris et al. 1994; Theil et al. 1995). 
 
 
 
1.4.3  Promoter activation by Brn-3 proteins  
While both long and short forms of Brn-3a and Brn-3b exert their transcriptional 
activity via their DBD, their N-terminal is essential for the activation of a specific subset 
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of genes (Latchman 1998; Smith et al. 1998; Calissano et al. 2003; Berwick et al. 2009). 
So, for instance, the Bcl-2, Bcl-x and α-internexin promoter are activated only by the 
long form of Brn-3a (Budhram-Mahadeo et al. 1995; Smith et al. 1998; Ensor et al. 
2001). This phenomenon can be abolished by the co-expression of the isolated N-
terminal of Brn-3a (Smith et al. 1998) suggesting that the activation of the long-form 
specific promoters require an extra co-factor (Smith et al. 1998). As also mentioned 
before, the N-terminal of Brn-3a has oncogenic properties as demonstrated by its ability 
to transform primary fibroblasts (Theil et al. 1993), a phenomenon which is intriguingly 
abolished upon its co-transfection with Brn-3bS (Theil et al. 1993). This is due to the 
direct interaction of Brn-3bS and Brn-3aL which leads to the formation of an inactive 
heterodimer (Theil et al. 1995). Thus Brn-3b, which is also found in breast cancers 
(Budhram-Mahadeo et al. 1999; Budhram-Mahadeo et al. 2006), can have a cancer 
suppressive activity when inactivating Brn-3a (Theil et al. 1993).  
The Brn-3a and Brn-3b long and short isoforms are expressed in vivo at different 
ratios which plausibly reflect their requirement at the transcriptional level (Ninkina et al. 
1993; Xiang et al. 1993; Liu et al. 1996; Fedtsova et al. 1997; Xiang et al. 1997; Xiang et 
al. 1997; DeCarvalho et al. 2004; Ichikawa et al. 2005). So, for instance, Brn-3aL is 
found more expressed in the rat brain and spinal cord (Ninkina et al. 1993; Fedtsova et al. 
1997), whereas its short form is more abundant in DRG (Ninkina et al. 1993; Ichikawa et 
al. 2005). Brn-3bS, instead, is more abundantly expressed in retinal ganglion cells and 
DRG (Xiang et al. 1993; Xiang et al. 1997; DeCarvalho et al. 2004) and the long form in 
the spinal cord (Liu et al. 1996). 
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As reported in the table below (table 1.2), Brn-3a is an overall stronger promoter 
activator than Brn-3b and in some instances (α-internexin, SNAP-25, herpes simplex 
promoters) plays an antagonistic role (Budhram-Mahadeo et al. 1995; Budhram-Mahadeo 
et al. 1995; Lakin et al. 1995; Lillycrop et al. 1995). Furthermore, Brn-3a target genes are 
generally involved in cellular differentiation, scaffolding and cell survival (Budhram-
Mahadeo et al. 1995; Morris et al. 1996; Smith et al. 1996; Smith et al. 1997; Smith et al. 
1998; Smith et al. 1999; Sugars et al. 2001; Calissano et al. 2003; Farooqui-Kabir et al. 
2004; Berwick et al. 2009) while Brn-3b regulates cell cycle and proliferation (Smith et 
al. 1996; Budhram-Mahadeo et al. 1998; Budhram-Mahadeo et al. 1999; Samady et al. 
2006). For simplification purposes the table below (table 1.2) does not report distinction 
in the activity exerted by the long and short isoforms of each transcription factor. 
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HSP27
P53
Bcl-x
Bcl-2
Egr-1
Papilloma virus
INos
NF-L, NF-M, NF-H
SNAP-25
Herpes Simplex Virus
Doppel
α-internexin
NaV 1.7
Nicotinic acetylcholine receptor 2
HSP27
CDK4
INos
Doppel
Estrogen Receptor Element
Estrogen Receptor Element
Plakoglobin
Brca1
Herpes simplex virus
SNAP-25
α-internexin
Promoter Activation Promoter Repression
Brn-3a
Brn-3b
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.2:  Promoter activation and repression by Brn-3* transcription factors. Schematic 
representation of genes activated and repressed by Brn-3a and Brn-3b see (Lillycrop et al. 1995; Milton et 
al. 1995; Smith et al. 1997; Gay et al. 1998; Smith et al. 1998; Budhram-Mahadeo et al. 1999; Ndisang et 
al. 1999; Smith et al. 2001; Budhram-Mahadeo et al. 2002; Calissano et al. 2004; Farooqui-Kabir et al. 
2004; Samady et al. 2006; Diss et al. 2008).  
------------------- 
 
 
1.4.4  Modulation of Brn-3a activity  
The activity of Brn-3a can be modulated by post-translational modification and 
interactions with specific co-factors (Theil et al. 1995; Budhram-Mahadeo et al. 1998; 
Dennis et al. 2002; Thomas et al. 2002; Calissano et al. 2003). It has been previously 
demonstrated that while the C-terminal of Brn-3a can functionally bind the EWS 
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transcription factor leading to a reduction in the transactivation of the Bcl-x promoter 
(Thomas et al. 2002) via its N-terminus,  Brn-3a can functionally interact with Rin, a 
member of the RAS super-family (Calissano et al. 2003). This interaction enhances the 
ability of Brn-3a to transactivate the egr-1 promoter, a Nerve Growth Factor (NGF) early 
responsive gene (Calissano et al. 2003). Furthermore, the N-terminus of Brn-3a contains 
a domain, the POUIV box, which is only found in POU IV proteins (Gerrero et al. 1993) 
(see figure 1.10). This region, which is highly homologous to a domain of the c-myc 
family, contains a threonine in position 39 which has been previously shown to be 
phosphorylated in neuronal cells (Gerrero et al. 1993; Theil et al. 1993; Calissano et al. 
2005; Berwick et al. 2009). Un-published data from our laboratory suggest that the 
phosphorylation of threonine-39 influences the binding between Rin and Brn-3a and 
might, in turn, affect the transactivation of Brn-3a target promoters. The phosphorylation 
of Brn-3a on serine 121 and 122, which is promoted by neuronal differentiation stimuli, 
has the effect of increasing the transactivation of Bcl-2 and Bcl-x, two related anti-
apoptotic genes (Calissano et al. 2005). 
Furthermore, as mentioned above, one of the key elements at the basis of Brn-3a 
and Brn-3b different activity is in the valine/isoleucine difference between Brn-3a and 
Brn-3b at position 378 of their POU homeodomain (figure 1.8, page 48). The change of 
valine into isoleucine can transform Brn-3a from an activator into a repressor and 
viceversa Brn-3b from a repressor into an activator (Dawson et al. 1996).  
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1.4.5  Role of Brn-3 proteins in neuronal survival 
All Brn-3* transcription factors play an essential role in the survival and 
differentiation of a specific subset of neuronal cells (McEvilly et al. 1996; Xiang et al. 
1998; Gan et al. 1999). Brn-3a plays an essential role in the survival of sensory neurons 
of dorsal root ganglia (McEvilly et al. 1996; Huang et al. 1999), while Brn-3b has an 
analogous role in the retinal ganglion cells of the developing eye (Gan et al. 1999; Mu et 
al. 2004) and Brn-3c in the ear (Xiang et al. 1993; Xiang et al. 1996; Xiang et al. 1997; 
Xiang et al. 1998; Clough et al. 2004). Brn-3a knock-out mice die a few days after birth 
(Xiang et al. 1996), while mice lacking Brn-3b, although viable, exhibit a specific and 
dramatic loss of up to 70% of retinal ganglion cells (RGC) (Gan et al. 1996; Eng et al. 
2001; Wang et al. 2002). Brn-3a is predominantly expressed in sensory neurons of dorsal 
root ganglia, trigeminal ganglion and in the red nucleus where it plays a pro-survival and 
anti-apoptotic activity (Collum et al. 1992; Fedtsova et al. 1995; McEvilly et al. 1996). 
Brn-3b instead is predominantly expressed in developing and adult RGCs (Theil et al. 
1993; Xiang et al. 1993). In mice, Brn-3b can normally be detected as early as E11.5 with 
its expression steadily increasing until E16.5 (Gan et al. 1996; Xiang 1998). In 30% of 
RGCs, Brn-3a and Brn-3b are co-expressed although Brn-3a expression starts two days 
later, at E13.5 (Budhram-Mahadeo et al. 1995; Quina et al. 2005).  
 
 
1.4.6  Role of the Brn-3b transcription factor in retinal ganglion cells 
Brn-3b was initially identified following a specific search of POU domain 
transcription factors in mouse retina which led to the identification of a highly expressed 
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POUIV protein in the E16 embryonic retina (He et al. 1989; Xiang et al. 1993). Further 
studies revealed that this protein, Brn-3b or POU4F2, is expressed in retinal ganglion 
cells (RGCs) (Gan et al. 1996; Xiang 1998) and shares a high homology with the Brn-3a 
transcription factor (Ring et al. 1993). As shown in the figure below (figure 1.11), RGCs 
are born in mouse at embryonic stage E12.5 and continue to be produced until P0 when 
natural neuronal selection eliminates neurons which did not establish any synaptic 
connection with their targets (Erkman et al. 2000).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.10: Role of Brn-3b on the development of RGCs. Wild type or Brn-3b knock-out mice have been 
analysed for the number of axons produced by their respective retinal ganglion cells during their 
development. (Erkman et al. 2000) 
-------------- 
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As indirectly measured by the number of remaining axons, very few RGC survive 
in Brn-3b knock out mice (figure 1.10). Experimental evidence has shown that up to 70% 
of RGC are lost in Brn-3b knockout mice (Erkman et al. 2000). Since Brn-3b is 
expressed in circa 70% of RGCs (Erkman et al. 2000), this suggests that this transcription 
factor plays an essential role in all RGCs in which it is expressed. While the vast majority 
of RGC co-express Brn-3a, Brn-3b and Brn-3c (Pan et al. 2005; Badea et al. 2009), the 
lack of Brn-3b causes per se the death of RGCs (Erkman et al. 2000; Qiu et al. 2008). 
The remaining 30% of RGCs express Brn-3a and/or Brn-3c which partially compensate 
for the lack of Brn-3b (Xiang 1998). The experimental replacement of Brn-3b with 
exogenously transfected Brn-3a copies is associated with reduced RGC death levels (Pan 
et al. 2005). Once more this evidence suggests that Brn-3a is able to transactivate Brn-3b 
target genes which are involved in RGC survival (Pan et al. 2005). Furthermore, although 
with a much more severe effect, conditional Brn-3a knock-out mice show an impairment 
in dendritic stratification in the retina (Badea et al. 2009) suggesting that all Brn-3 
transcription factors can have a functional role in RGC survival (Badea et al. 2009). RGC 
death in Brn-3a expressing cells, though, might be due to a temporal expression 
difference, whereas Brn-3a is expressed two days later and this might not be sufficient to 
rescue Brn-3b deficient cells from their death. (Qiu et al. 2008).  
Brn-3b is also expressed in the superior colliculus (tectum in avian brain), the 
periaqueductal gray matter and in a small region of the brain stem (Xiang et al. 1993). 
The co-expression of the three Brn-3 transcription factors in these regions could also 
explain why trigeminal and dorsal root ganglia, where Brn-3b is also expressed, don’t 
show any sign of neuronal loss in Brn-3b knockout mice (Ninkina et al. 1993). Although 
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the cause of RGC loss in mice lacking Brn-3b is not fully understood (Gan et al. 1996; 
Wang et al. 2000), anatomical evidence shows that these mice have a thinner retina and a 
reduction of the optic nerve diameter due to a dramatic loss of RGC axonal projection 
(Gan et al. 1996; Wang et al. 2000). Some of the remaining axons do not cross the optic 
chiasm and remain ipsilateral (Erkman et al. 2000). Mice lacking Brn-3b show a total 
abolishment of vertically moving stimuli, a reduction of the horizontally moving stimuli 
and a defect in pupil constriction in response to light stimuli (Badea et al. 2009). The 
death of Brn-3b knock-out RGCs is likely to be due to several causes including improper 
cell specification, differentiation and defects in RGC axonal pathfinding which results in 
their failure to enter the optic nerve (Erkman et al. 2000; Qiu et al. 2008). Furthermore, 
the forced over-expression of Brn-3b in non RGC-cells of the retina has the effect of 
repressing their growth  (Qiu et al. 2008).  
Several studies have partially unfolded the molecular events involved in RGC 
death (Wang et al. 2000; Wang et al. 2001; Weishaupt et al. 2005; Qiu et al. 2008). It has 
been established, for instance, that Brn-3b regulates the expression of other transcription 
factors such as Olf1, Brn-3a and Irx2 which are involved in neuronal differentiation (Mu 
et al. 2004). Other factors regulated by Brn-3b include proteins related to neuronal 
integrity such as gamma-synuclein, neurofilament light and middle chain (Mu et al. 
2004). Overall though, the exact mechanisms leading to RGC death in Brn-3b knock-out 
mice are still being investigated. 
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1.5  Aim of the thesis    
Given the importance of the Brn-3b transcription factor in the development of the 
retina (Turner et al. 1994; Xiang 1998; Gan et al. 1999; Erkman et al. 2000; Wang et al. 
2000; DeCarvalho et al. 2004; Badea et al. 2009) and the potentially important role 
played by post-transcriptional gene regulation in neurons (Kim et al. 2004; Nelson et al. 
2004; Rogelj et al. 2004; Sempere et al. 2004; Lai et al. 2005; Rogaev 2005; Smirnova et 
al. 2005), I wanted to analyse whether Brn-3b mRNA is subjected to post-transcriptional 
regulation in neuronal cells. As reported above, the 3’UTR of mRNAs plays a significant 
part in the regulation of mRNA stability, translation rate and turnover (Canete-Soler et al. 
1998; Kenealy et al. 2000; Thames et al. 2000; Giles et al. 2003; Pontrelli et al. 2004; 
Andreassi et al. 2009; Ji et al. 2009). Intriguingly, not only the coding sequence, but also 
the 3’UTR of Brn-3b is highly evolutionary conserved (data presented in paragraph 3.0 of 
this thesis). This region exhibits between 99% and 97% nucleotide identity between 
human and mouse and mouse and rhesus monkey respectively (paragraph 3.0, figure 3.0), 
suggesting a possible important role due to its conservation. The same region of Brn-3a 
in contrast shows a 40% homology and the lack of any evident conserved regions (data 
not shown). 
The first chapter of the results (chapter 3) will report the data obtained whilst 
investigating whether the 3’UTR of Brn-3b is subjected to post-transcriptional gene 
regulation in neuronal cells. For this purpose the 3’UTR of Brn-3b was sub-cloned in a 
reporter construct and the levels of the reporter mRNA and protein measured in ND7 
cells subjected to differentiation. This has led to the identification of specific regions 
contained in its 3’UTR which are essential for its post-transcriptional regulation and 
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found that they are targeted by specific microRNAs, mir-23 and mir-214.  The 
mutagenesis of their binding sites on the 3’UTR of Brn-3b has shown that these 
microRNAs play a direct role in the regulation of Brn-3b in neuronal cells. Furthermore 
these microRNAs and Dicer are up-regulated in ND7 cells induced to differentiate.  
In the second results chapter of this thesis (chapter 4) it will be demonstrated that 
Brn-3b is differentially regulated by mir-23 and mir-214 in an immortalized retinal 
ganglion cell line (RGC-5). Contrary to what occurs in ND7 cells, Brn-3b levels are not 
affected by treatments aimed at inducing the differentiation of RGC-5 cells and one of the 
microRNAs involved in the regulation of Brn-3b (mir-214), is not expressed in the RGC-
5 cell line. Intriguingly, mir-214 is not expressed in primary retinal ganglion cells. The 
co-transfection of mir-23 and mir-214 in RGC-5 cells is able to induce the reduction in 
the levels of both an exogenous construct containing the 3’UTR of Brn-3b and of the 
endogenous Brn-3b. The data presented in this chapter suggest that a pro-survival factor 
such as Brn-3b might be protected from microRNA-mediated regulation in RGC-5 in 
which it plays an essential role. This hypothesis is also supported by data in which the 
experimental knock-down of Brn-3b leads to increased RGC-5 cell death, thus paralleling 
a similar phenotype in primary RGCs.  
In parallel to the analysis of the regulation of Brn-3b in immortalized neuronal 
cell lines, the role of Dicer in the differentiation of primary RGCs will be investigated.   
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2.1  Cell lines and transfection 
The neuroblastoma ND7, the breast cancer MCF-7 and the RGC-5 retinal ganglion 
cell lines were routinely cultured in DMEM supplemented with 10% Fetal Calf Serum 
(FCS) at 37°C, 95% humidity and 5% CO2. SH-SY5Y cells were cultured in 50% MEM, 
50% Hams F12 supplemented with 15% FCS. All cell lines, apart from RGC-5 which 
was a kind gift of Professor Neeraj Agarwal (UNT Health Science Center, Fort Worth, 
TX, USA), are part of the laboratory stock. ND7 cells were produced by fusing primary 
rat dorsal root ganglion neurons with mouse C1300 neuroblastoma cells (Wood et al. 
1990). All cells were grown to ~80% confluency prior to trypsinization which was 
performed by removing the old medium and gently washing the adherent cells with 
phosphate buffered saline (PBS) (Invitrogen) before adding enough trypsin (Invitrogen) 
to cover the cell monolayer. The flask was incubated at room temperature for 20-30 
seconds, trypsin decanted and cells incubated for a further 40 seconds before being 
detached from the surface of the flask by pipetting with 5 ml of serum-containing 
medium (10% FCS) added to stop digestion by trypsin. Normally 1/10
th of the original 
culture was passed into a new flask.  
Apart from RGC-5 cells, all cell lines were transfected with GeneJuice (Novagen) 
according to the manufacturer’s instruction. RGC-5 cells were transfected with 
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. For all the 
serum starvation experiments on the ND7 cell line, cells were transfected with the 
indicated constructs and the following day (day 0) incubated in full medium with or 
without FCS in order to induce differentiation for the indicated days. Staurosporine 
(Sigma) was diluted in dymethyl-sulfoxide (DMSO) and used at a final concentration of 
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20  μM. Actinomycin D (Sigma), which inhibits transcription by binding to the 
transcription initiation complex, was used at a final concentration of 7.5 μg/ml for 0, 4 
and 8 hours (Giles et al. 2003). KCl was used at a final concentration of 50mM. 
 
2.2  Cell storage and recovery 
Cells were frozen by the following method. After trypsinization, cells were 
detached by repeatedly pipetting with Hanks Balanced Salt Solution (HBSS) and 
transferred to a 50 ml tube. Cells were then spun at 1000 RPM for 5 minutes, the 
supernatant decanted and the cell pellet was resuspended in 90% FCS plus 10% v/v 
dimethyl sulfoxide (DMSO, Sigma). Aliquots containing 1x10
6  cells per ml were 
transferred to cryovials (NUNC, Roskilde, Denmark), placed into a freezing pot at -70
oC 
for 24 hours and then transferred to a permanent storage in liquid nitrogen. When needed 
cells were rapidly thawed at 37°C in a waterbath and transferred drop-wise to an 
appropriate flask with the appropriate pre-warmed growth medium. The following day 
the medium was replaced to eliminate any DMSO residue. 
 
2.3  E.coli strains and transformation. 
In this thesis the DH5α (F-, endA,1 glnV4,4 thi-1, relA1, gyrA96, deoR, nupG, 
lacZdeltaM15, hsdR17) and HM101 (F-, mcrB, mrr, hsdS20(rB-mB-), recA13, leuB6, 
ara-14, proA2, lacY1, galK2, xyl-5, mtl-1, rpsL20, glnV44)  E.coli strains were used 
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(Stratagene). Cells were transformed according to the manufacturer’s instructions. 
Briefly, 50μl of cells were transferred to a pre-chilled tube, mixed with the DNA to be 
transformed and incubated on ice for 30 minutes. Cells were then heat-shocked at 42°C 
for 42 seconds and quickly transferred back on ice for few minutes after which 750μl of 
LB medium (10g Tryptone, 5g yeast extract, 10g NaCl in a liter of dH2O) was added and 
cells transferred into an orbital incubator for an hour at 37°C. After incubation, 250μl of 
cells were plated onto LB-agar plates containing the appropriate antibiotic, spread with a 
glass rod and incubated overnight at 37°C. Colonies were then individually picked with 
the end of a yellow tip, transferred into a 15ml tube containing LB supplemented with the 
appropriate antibiotic and incubated overnight at 37°C. The following day an aliquot of 
cells was subjected to a small scale extraction of DNA with the aid of a kit (Qiagen). In 
this protocol, an aliquot of the overnight bacterial growth is transferred to a 1.5ml tube 
and bacteria spun at 10.000rpm for 40 seconds. The supernatant is discarded and bacteria 
are resuspended in 100μl of solution 1 (50 mM glucose, 25 mM Tris-Cl, pH 8.0, 10 mM 
EDTA, pH 8.0) then incubated for few minutes in 100μl of solution 2 (0.2 N NaOH, 1% 
SDS) and then in 250μl of solution 3 (3 M potassium acetate, 11.5% acetic acid). 
Following a spin at 13.000rpm for 10 minutes, the supernatant containing the DNA is 
bound to a silica-based column, washed with 750μl of solution QF and eluted with 50μl 
of ddH2O. DNA is then quantified via the Nanodrop spectrophotometer (Thermo 
Scientific). A larger scale of the above mentioned protocol (maxiprep) was routinely used 
when larger amount of plasmid DNA were needed.  
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2.4 Site-directed  mutagensis 
Mutation of the microRNA target sequence on the 3’UTR of Brn-3b was achieved via the 
QuickChange site directed mutagenesis (Stratagene) following the manufacturer’s 
instructions with the following primers: 
 
 
 
 
Fw5′ AGAGTTGATGCTTCAGGTGCTATGATAGAG 3’
Rw 5′ GTCTCTATCATAGCACCTGAAGCATCAACT 3’ Mir-323
Fw5′ CCGTGTAGACCAGATGCGCTGGCGGAAGTC 3’
Rw 5′ CAAGACTTCCGCCAGCGCATCTG GTCTACA 3’ Mir128
Fw5′ GGAAGTTGCGACGGTTGCGTTCACTG 3’
Rw 5′CAGTGAACGCAACCGTCGCAACTTCC 3’ Mir 214
FW-5′ GAGTTGATGCTTAACGGGCTATGATAGAGACATCTC 3′
RW-5′ GAGATGTCTCTATCATAGCCCGTTAAGCATCAACTC 3’ Mir 23 
downstream
Fw-5′ AACAATTCCGGTAAACGGGCACCCAGACCAAGCCAG 3’
Rw 5′ CTGGCTTGGTCTGGGTGCCCGTTTACCGGAATTGTT  3’ Mir-23 
upstream
 
Fw5′ AGAGTTGATGCTTCAGGTGCTATGATAGAG 3’
Rw 5′ GTCTCTATCATAGCACCTGAAGCATCAACT 3’ Mir-323
Fw5′ CCGTGTAGACCAGATGCGCTGGCGGAAGTC 3’
Rw 5′ CAAGACTTCCGCCAGCGCATCTG GTCTACA 3’ Mir128
Fw5′ GGAAGTTGCGACGGTTGCGTTCACTG 3’
Rw 5′CAGTGAACGCAACCGTCGCAACTTCC 3’ Mir 214
FW-5′ GAGTTGATGCTTAACGGGCTATGATAGAGACATCTC 3′
RW-5′ GAGATGTCTCTATCATAGCCCGTTAAGCATCAACTC 3’ Mir 23 
downstream
Fw-5′ AACAATTCCGGTAAACGGGCACCCAGACCAAGCCAG 3’
Rw 5′ CTGGCTTGGTCTGGGTGCCCGTTTACCGGAATTGTT  3’ Mir-23 
upstream
Table 2.0: Primers used for mutagenesis. Primers used for the sited directed mutagenesis of the reported 
microRNA binding sites on the 3’UTR of Brn-3b. 
------------ 
 
2.5  Deletion of the GFP::3b-3’UTR with Bal-31 
The sequential deletion of Brn-3b was performed with the Bal-31 nuclease (New 
England Biolabs). Firstly 10μg of GFP::3b-3’UTR construct were linearized by digesting 
with the PsiI restriction enzyme (Promega). The linearized DNA was then added to a 
master mix containing the Bal-31 buffer and Bal-31 enzyme. Aliquots were then 
transferred to eight 1.5ml tubes kept on ice. At time zero the tubes were transferred to a 
30°C water bath and the reaction stopped at different time points by adding EDTA to a 
0.05M final concentration and by heating at 75°C. 
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2.6  Coverslip preparation  
Glass coverslips (13mm, VWR International) were etched for 30 minutes in nitric 
acid in a 50ml tube at room temperature, rinsed several times with ddH2O and incubated 
in absolute methanol for 15’. Coverslips were then spread on a piece of 3MM paper and 
allowed to dry in an oven (or room temperature) after which they can be used 
immediately or stored at room temperature indefinitely. On the day of use, coverslips 
were spread on a square piece of 3MM paper and 100μl of Poly L-Lysine (PLL) 
(200ng/μl) was added on one side and incubated for 30 minutes after which PLL was 
eliminated and coverslips briefly rinsed in ddH2O. 100μl of Laminin (50 ng/μl) were 
subsequently added to the PLL-treated side, incubated for 30 minutes, rinsed with ddH2O 
and allowed to dry at room temperature. 
 
2.7  Chick retina isolation and culture: 
Fertilized Bovans Goldline eggs were obtained from Henry Stewart & Co.Ltd and 
incubated at 37.5°C in 90% humidity. Embryos were staged according to Hamburger and 
Hamilton (Hamburger 1951; Hamburger et al. 1992). At the desired developmental stage 
(E6, E7 and E8) eggs were removed from incubator, a circular aperture opened on top of 
the shell with scissors and the chick embryo isolated and sacrificed. The head, separated 
from the body, was transferred into a 10 ml petri dish containing HBSS or PBS. Under a 
microscope (STEMI SV11+Zeiss Schott light, KL1500 electronics), the eyes were 
carefully isolated from the rest of the tissue. The connective tissue and then the 
pigmented epithelium were carefully removed paying attention to avoid the piercing of 
the retina, and then the iris and the corpus vitreum were removed. The isolated retina of 
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circa 0.5 cm
2  was then flat-mounted, retinal ganglion cell side-up, on a piece of 
nitrocellulose filter (Sartorius AG) pre-wet in HBSS or PBS as shown in figure 2.0.  
 
Optic nerve exit
Preparation of retinal strips
Eye
Isolated retina
Retina flat-mounted on
nitrocellulose membrane
Iris
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.0: Preparation of retinal strip. See section 2.7 for explanation. 
------------------ 
 
The filter with the attached retina was then transferred to the “chopping” board of a tissue 
chopper (Mc Ilwain) and cut in strips of the desired width (normally between 100 and 
200  μm) while keeping the tissue moist with full medium (DMEM, 10% FCS, 2% 
Chicken serum, 100U/ml Penicillin/100g/ml Streptomycin (Invitrogen). Following the 
cut, strips were individually picked with the aid of tweezers and rapidly transferred, 
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(retina facing down) onto pre-wet PLL/Laminin coated coverslips, each set in the well of 
a six-well culture dish. Normally two strips were laid on coverslips in parallel 5-6 mm 
one from the other and a light stainless steel bar was set transversally on top of the strips 
to stop them from moving (figure 2.1). One or two drops of full medium were then added 
on top of the coverslips and then incubated for ten minutes at 37°C before 4ml of full 
medium were added and incubated at 37
oC and 5% CO2 in a humidified incubator 
(Jencons-PLS). 
 
 
 
 
 
 
 
 
 
 
 
Tissue chopper blade
set at 100-200 microns
PLL/Laminin coated coverslip
Weight
Retinal strips
Retina flat-mounted on
nitrocellulose membrane
 
Fig. 2.0: Preparation of retinal strips and assembly on PLL/Laminin coated coverslips. 
-------------- 
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2.8  Immunofluorescence of primary RGCs 
For the analysis of the expression of Dicer in primary chick retinal ganglion cell 
neurites, retinal strips were grown on coverslips as described above and after 4 days 
processed for immunofluorescence analysis. Paraformaldheyde (PFA) at 4% in PBS 
(w/v) or -20
o C cold methanol, were used to fix/permeabilize RGCs the detection of actin 
(PFA) and Dicer (methanol). PFA was dissolved in 60-70°C hot water in the presence of 
alkali. The solution was then filtered and either used immediately or aliquoted and stored 
at  
-20°C. Methanol was stored at -20°C for at least 2 hours before use. Coverslips were 
transferred to individual wells of a 24-well plate with the retinal strips facing up and 
immediately incubated with 500μl of the fixative of choice for five minutes. After 
methanol or PFA were removed, coverslips were submerged in 1X PBS until further use. 
Coverslips fixed with PFA were subsequently permeabilized with 0.1% Triton-X100/PBS 
for 5 minutes at room temperature. Methanol has both fixative and permeabilization 
properties and thus the treatment with Triton-X100 is not necessary. 
Following the fixative-permeabilization step, anti-Dicer (Santa Cruz, SC30226) or 
anti-Actin (Abcam Ab40864) antibodies were diluted 1:25 or 1:200 respectively in 
1%BSA in PBS and 50μl were spotted in the well of a six-well plate. Coverslips were 
then lowered on the drop containing the antibody dilution, retina facing down, the plate 
sealed and incubated overnight at 4°C in a humidified chamber to avoid evaporation. The 
following day coverslips were rinsed three times with PBS and then incubated with a 
1:500 dilution of anti-Rabbit-FITC conjugated (DAKO) in 1%BSA/PBS for 1 hour at 
room temperature followed by two brief washes with PBS and briefly rinsed with ddH2O 
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to remove salts. The coverslips were then lowered, retina-side facing down, on a drop of 
mounting medium containing DAPI (DAKO) on the surface of a microscope slide. When 
DAPI is bound to DNA and is excited with ultra-violet light it emits a violet light which 
is used to localize cell nuclei. Coverslips were then sealed with nail-varnish which was 
allowed to dry in the dark for twenty minutes before analyzing them under fluorescent 
and/or light microscope. 
 
2.9 RNA  extraction 
Growth medium was removed and cells were washed twice with PBS before 
between 500μl and 1000μl of Trizol (Invitrogen) solution was added to each individual 
well according to its size. Cells were incubated in this solution for 2-3 minutes at room 
temperature. A syringe plunger was used to scrape the resultant cell lysate from the plate 
surface and then pipetted into a 1.5ml tube and 200l of chloroform added. The lysate was 
shaken vigorously for 30 seconds, incubated at room temperature for 5 minutes and spun 
at 12,000g in a refrigerated centrifuge at 4
oC for 15 minutes. The aqueous supernatant was 
transferred to a new 1.5ml tube and 500l of isopropanol added. The lysate was then 
incubated for 10 minutes at room temperature before the mixture was spun at 12,000g in a 
refrigerated centrifuge at 4
oC for 15 minutes. All liquid was removed from the tube and 
the resultant RNA pellet washed once with 70% ethanol before being spun at 12,000g (at 
4
oC) for 5 minutes. All liquid was again removed from the tube by pipetting and the RNA 
pellet dried at 60
oC for few minutes. The RNA was then resuspended in an appropriate 
volume of sterile distilled water and stored at -20
oC until use. 
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Following extraction, the quality of the total RNA was evaluated via 
spectrophotometric analysis. Good quality RNA has an A260/A280 ratio close to 2.0 
(Sambrook et al., 1989). RNA was also visually inspected by running an aliquot on a 1.0 
% agarose gel in a Tris-Acetate-EDTA medium (40 mM Tris base, 40 mM Acetic acid, 1 
mM EDTA) containing 0.8 g/ml ethidium bromide. Intact RNA shows a 28S ribosomal 
RNA band of circa double the intensity of the 18S ribosomal RNA band when viewed 
under ultraviolet radiation. 
 
 
2.10   Synthesis of single-stranded copy DNA (cDNA) 
RT-PCR is performed on a DNA template, so extracted RNA is reverse-
transcribed to complementary DNA, (cDNA) prior to PCR amplification. This was 
performed using a commercial reverse-transcriptase enzyme, Superscript II (Invitrogen). 
The reaction was primed random hexamers (GE Healthcare, UK). Reactions were 
performed according to the manufacturer’s general instructions. Generally, 1g of total 
RNA was incubated with 250ng of random hexamers, and the total volume made up to 
11l with sterile distilled water. This was then placed in a 70
oC water-bath for 10 minutes 
to denature any RNA secondary structure and subsequently transferred on ice. After few 
minutes, an 8 l mix, containing 2l 0.1M DTT (Invitrogen), 4l 5x Superscript II First 
Strand Buffer (Invitrogen), 1l 10mM dNTP mix (Promega), 1l (24.5 units) RNaseOUT 
(an RNase inhibitor; Invitrogen) and 1l (200 units) of Superscript II RT enzyme were 
added to the denatured RNA and incubated at 42
oC for 1 hour. Following the reaction, 
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80l sterile distilled water were then added to bring the final volume to 100l. cDNA 
samples were subsequently stored at -20
oC until use. 
 
2.11   Real time RT-PCR primer design 
RT-PCR primers were designed according to available sequences. They were 
tested for an optimal annealing temperature of at least 60
oC, the lack of any evident 
hairpin formation, self-annealing and formation of primer-dimers. A list of the primers 
used in this thesis is reported in the table below (table 2.1). 
 
 
get
 
ct
 
  T
 P
 
 
 
 
 
 
 
 
 
270 60 5’ AGAGGGCGCCTTGCTTCCCC 3’
5’ TGCCAGGGCTGTGCTGCTGT 3’
MAP2C F
MAP2C R
MAP2C
(Chick)
280 60 5'-TGGCGTCCATCTGCGACTC-3’
5'- CTCAGGCTTGTTCATTTTCTC- 3'
Brn-3a F
Brn-3b R
Brn-3a
455 59 5’-AGCCGGCTCCCCCTTTCA-3
5’-GACGGCCCATATCTTCTTC-3
Brn-3b F
Brn-3b R
Brn-3b
472 60 5'  GTGCGAACGGATTTGGACG 3’
5’ CCAGTAGACTCCACGACACA 3’
GAPDH F
GAPDH R
GAPDH
492 60 5’- GGGGCGCATAGTAGGTTCTGCTCACGCC 3’
5’ CCTTCGAGAACCATCGGACCCCGCTCCG -3’
Dcr F
Dcr R
Dicer
353 60 5’-CACAAGGATCAGCCTGCAGCTCG  3’
5’-TTC TGG CTC CTC CTC AGTCA 3’
MAP2C F
MAP2C R
MA 2C
1750 60 5’GAGCTCTAGGGACCCTTCTCCAGGGATGGCCC T-3’
5’GGAACCCGGGTGCCAGTAAAACATTAAAA 
TCATCTC3’
3b-Sac F
3b-Bam R
3b-
3’U R
187 60 5’-AGA TGA CCC AGA TCA TGT TTG AG-3’
5’-AGG TCC AGA CGC AGG ATG-3’
Actin F
Actin R
a in
Amplicon size 
(nt)
Annea-
ling 
T (oC)
Primer sequences 5’-3’ Primer 
names
Tar
270 60 5’ AGAGGGCGCCTTGCTTCCCC 3’
5’ TGCCAGGGCTGTGCTGCTGT 3’
MAP2C F
MAP2C R
MAP2C
(Chick)
280 60 5'-TGGCGTCCATCTGCGACTC-3’
5'- CTCAGGCTTGTTCATTTTCTC- 3'
Brn-3a F
Brn-3b R
Brn-3a
455 59 5’-AGCCGGCTCCCCCTTTCA-3
5’-GACGGCCCATATCTTCTTC-3
Brn-3b F
Brn-3b R
Brn-3b
472 60 5'  GTGCGAACGGATTTGGACG 3’
5’ CCAGTAGACTCCACGACACA 3’
GAPDH F
GAPDH R
GAPDH
492 60 5’- GGGGCGCATAGTAGGTTCTGCTCACGCC 3’
5’ CCTTCGAGAACCATCGGACCCCGCTCCG -3’
Dcr F
Dcr R
Dicer
353 60 5’-CACAAGGATCAGCCTGCAGCTCG  3’
5’-TTC TGG CTC CTC CTC AGTCA 3’
MAP2C F
MAP2C R
MAP2C
1750 60 5’GAGCTCTAGGGACCCTTCTCCAGGGATGGCCC T-3’
5’GGAACCCGGGTGCCAGTAAAACATTAAAA 
TCATCTC3’
3b-Sac F
3b-Bam R
3b-
3’UTR
187 60 5’-AGA TGA CCC AGA TCA TGT TTG AG-3’
5’-AGG TCC AGA CGC AGG ATG-3’
Actin F
Actin R
actin
Amplicon size 
(nt)
Annea-
ling 
T (oC)
Primer sequences 5’-3’ Primer 
names
Target
 
Table 2.0: List of primers used in this thesis 
----------- 
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2.12   Real time RT-PCR    
In this thesis, changes in gene expression on target cells were measured by 
quantitative real-time reverse-transcription polymerase chain reaction (qRT-PCR). Real-
time qRT-PCR is a technique for quantifying the amount of mRNA expression of a 
particular gene at a particular time or in a particular cell or tissue type. It relies on the fact 
that PCR amplifies a target in an almost exponential manner until the reaction reaches a 
plateau phase due to limiting conditions, such as primer availability. By monitoring the 
accumulation of product in real-time after each amplification cycle (using fluorescent 
dyes), the exponential/non-exponential status of the reaction can be determined and the 
amount of starting template in two samples relative to each other can be calculated by a 
variety of analyses (in this thesis, the 2
-Ct method was used). Subsequently, some of the 
mRNA expression differences observed were also investigated at the level of protein 
expression. 
Quantitative RT-PCR (qRT-PCR) was performed using the DNA Engine Opticon 
system (MJ Research). Briefly, PCR reactions were performed in duplicate in white-
coloured plastic 8-well strips or in white-coloured 96-well plates (both from BioRad) in a 
final volume of 20l, containing 5l of cDNA, 500 nM (0.5M) of each specific primer 
and 1x Platinum SYBR Green qPCR mix (Invitrogen), according to the manufacturer’s 
instructions. Amplification was via an initial denaturation step at 95
oC for 3 minutes to 
activate the Platinum hot-start Taq, followed by cycling of 95
oC for 30 seconds, 57-62
oC 
(depending on the primer pair) for 30 seconds and 72
oC for 30 seconds. A final melt curve 
analysis was carried out routinely from 65
oC to 95
oC with 0.3
oC steps. When the melting 
temperature of a specific amplicon is reached the two strands separate, the SYBR I Green 
  82 Chapter2: Material and Methods  
 
dye is released and therefore no longer fluoresces. Thus melt curves are used to verify 
product composition. In addition, an aliquot of the reaction was run on agarose gel 
containing ethidium bromide in order to visualise the products and verify their size. As a 
negative control, a minus reverse-transcriptase and a minus cDNA samples were added 
for every PCR reaction. The first negative control monitors the exclusion of any DNA 
carry-over during the extraction of RNA. The second controls for the exclusion of any 
DNA contamination from pipettes, water, buffers etc.  
In order to evaluate the amount of a specific amplicon, the 2
-Ct
 method (Livak 
& Schmittgen, 2001) was used. This relies on the “normalization” of the amplified 
product versus a control gene whose expression does not vary in those specific 
experimental conditions. This allows for the exclusion of variables including sample-to-
sample differences in RNA input, RNA quality and reverse-transcription efficiency that 
might contribute to apparent inter-sample target gene expression differences. Expression 
of these normalizing genes could then be used in analyses to ‘equilibrate’ differences due 
to non-biological variables. After some tests, the actin, and glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) normalizing genes were chosen. Following the RT-PCR with 
the Opticon system, raw data were processed via the 2
-Ct
 to evaluate the expression 
levels of the mRNAs.   
 
2.13  Polymerase Chain Reaction 
Polymerase chain reaction (PCR) is a technique which allows the exponential 
amplification of a specific stretch of DNA by using a thermostable DNA polymerase and 
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DNA oligonucleotides as primers. A non-quantitative PCR was used to amplify the 
3’UTR of Brn-3b (paragraph 3.1 of this thesis) by using 50 ng of mouse chromosomal 
DNA, 50 μM dNTPS, 3 mM MgCl2, and 20 pmoles of each oligos. A denaturation step at 
94°C for 30” was followed by the annealing step at 55°C for 30”, followed by an 
extension step at 72°C 1’30”. The cycles were repeated 30 times and an aliquot of the 
PCR run on an agarose gel to be analyzed before being processed for its subclonin as 
described in paragraph 2.17.  
 
2.14  Precautions in manipulating nucleic acids 
RT-PCR is a powerful technique, capable of amplifying millions of amplicons 
from just a few template molecules. Consequently, small levels of DNA contamination 
(for example, from previous PCR amplifications and samples with high DNA levels) can 
easily result in product formation even in the absence of added cDNA template. All RT-
PCRs in this project were performed simultaneously with “no template control” reactions 
(in which sterile distilled water rather than a cDNA template was added) in order to verify 
that positive results were not caused by contamination of the reaction by an external DNA 
source. However, in order to minimise the possibility of contamination, a number of 
precautions were taken at all steps prior to (RNA extraction and cDNA synthesis), and 
including, the PCR: 
1.    Use of dedicated equipment and consumables for RNA extractions, cDNA 
synthesis and RT-PCRs only (pipettes, tubes, tube racks, solutions). 
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2.    Use of sterile filtered tips to prevent contamination of dispensing pipettes by 
aerosols. 
3.   Use of gloves and frequent glove changes. 
4.    Aliquoting of solutions (dNTPs, primers, Taq DNA polymerase buffer) using 
dedicated pipettes to prevent contamination of original stocks. 
5.   Use of ultraviolet radiation (UV)-treated sterile distilled water aliquots. 
6.   Physical separation of pre- and post-PCR manipulations. 
 
2.15 Northern  blot  
For northern blot analysis of microRNAs, total RNA was extracted as described 
above and its concentration evaluated via Nanodrop (Thermo Scientific). 
Thirty  micrograms of total RNA were resuspended in an equal amount of 2X RNA 
sample buffer (720µl of 37% formaldehyde (12.3M), 2ml of 100% glycerol, 3084µl of 
formamide), heated at 70°C for 10 minutes, cooled on ice and then loaded onto a 15% 
polyacrylamide, 7M Urea, 1X TBE gel which had been pre-run for 10 minutes at 
200volts. Samples were then run at 200volts in 1X TBE until the bromophenol blue dye 
had reached the bottom of the gel. The gel apparatus was then dismantled and the nucleic 
acids transferred to a Hybond N+ (Hybond) membrane via a semi-dry apparatus at 
10volts for 20 minutes in 0.5X TBE buffer. The nucleic acids were subsequently 
immobilized onto the membrane in a UV-crosslinker set at 1.200 joules (BDH). The 
membrane was then pre-incubated in a 50ml falcon tube with 5ml of Ultra-Hyb oligo 
hybridization buffer (Ambion) at 42°C for two hours. The pre-hybridized membrane was 
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then incubated overnight in 5ml of pre-heated Ultra-Hyb oligo hybridization buffer 
containing the appropriate probes at 42°C.  
Probes:  
U6:   gcaggggccatgctaatcttctctgtatcg   
mir-214: ctgcctgtctgtgcctgctgt 
mir-128: aaaagagaccggttcactgtga 
mir-23: ggaaatccctggcaatgtgat,   
were end labeled for an hour at 37°C  with T4 polynucleotide Kinase (Promega) in the 
presence of 5μl of γ
32P-ATP (50uCi or 1.85MBq). The following day the membrane was 
washed three times for 1 minute each at room temperature in 2×SSC, 0.1%SDS. 
Membranes were sealed in a plastic bag and then exposed to a phosphor-imager screen 
(Biorad). Following exposure for the desired amount of time the screens were scanned 
via a phosphor-imager machine (Biorad) and bands quantified with the QuantityOne 
software (Biorad). 
 
2.16 Western  blot 
For western blot analysis, cells were normally grown in a six-well plate.  On the 
day of the experiment, cells were washed twice with PBS and lysed with 100μl of RIPA 
buffer (10mM TRIS pH 7.5, 150mM NaCl, 0.2% NP-40) supplemented with protease 
inhibitors (mini-cocktail, Roche). The cell lysate was collected, transferred to a 1.5ml 
tube and spun at 13.000 rpm for 5 minutes to remove cell membranes. An aliquot of the 
cell lysate was transferred into a new 1.5 ml tube and mixed with the appropriate amount 
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of 4X Laemmli sample buffer (0.25M Tris, pH 6.8, 6 % SDS, 40 % glycerol, 0.04 % 
Bromophenol Blue, 0.04% xylene cyanol, 20% -mercaptoethanol (ME). 
Samples were then incubated at 95°C for 3-5 minutes to denature proteins and 
subsequently loaded on polyacrylamide gel for proteins. This gel is composed of two 
parts which are polymerized sequentially one on top of the other. The lower gel or 
resolving gel is composed in accordance to the desired acrylamide concentration as 
exemplified in the table below (table 2.2): 
 
 
% Total Acrylamide:     8 %  10 %  12 %  15 % 
2O    (ml)  12.1 10.5 8.75 6.25   H
4X Tris Buffer Ph 8.8*  (ml)  6.25  6.25  6.25  6.25 
29:1 Acrylamide:Bis  (ml)  6.67  8.35  10  12.5 
 10 % APS  ()  130 130 130 130 
TEMED  ()  14 14 14 14 
                 
  Total Vol:     25 ml  25 ml  25 ml  25 ml 
 
 
Table 2.2: Lower (resolving) gel composition *4X Tris Lower Buffer: Tris-base 1.5M, Sodium Dodecyl 
Sulfate (SDS) 0.4%, pH to 8.8 with HCl 
---------------- 
  An increase in acrylamide concentration allows a better separation of low 
molecular weight protein and vice versa. After pouring the gel, a layer of butanol or 
isopropanol was slowly layered on top to reduce the contact with air (which reduces the 
polymerization rate) and to level the surface. When the gel was polymerized, butanol was 
removed, the surface gently washed with ddH2O, air-dried and the upper gel (or stacking 
gel) added on top with a comb to create the wells (table 2.3). 
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10 ml Total Vol:
20 () TEMED
40 () 10 % APS
1.7 (ml) 29:1 Acrylamide:Bis
2.5 (ml) 4X Upper Tris Buffer*
5.8 (ml) H2O 
5 % % Total Acrylamide:
10 ml Total Vol:
20 () TEMED
40 () 10 % APS
1.7 (ml) 29:1 Acrylamide:Bis
2.5 (ml) 4X Upper Tris Buffer*
5.8 (ml) H2O 
5 % % Total Acrylamide:
 
Table 2.3: Upper (stacking) gel composition.*4X Tris Upper Buffer: Tris base 0.5M, SDS 0.4%, pH to 
6.8 with HCl 
.-------------- 
Following polymerization the gel was submerged in running buffer (25mM Tris-
Cl, 190mM Glycine, 0.1%SDS), the comb carefully removed, the wells flushed once or 
twice with running buffer to eliminate any non polymerized acrylamide and samples 
loaded in the wells. A current of 25mA was applied and samples run until the 
bromophenol blue reached the lower end of the gel. Proteins were then transferred onto 
Hybond-C nitrocellulose membrane via a semidry apparatus (Biorad) at 10V for 30 
minutes. The transfer occurred in the presence of 1X transfer buffer (3.03gr Tris, 14.4gr 
Glycine, 20ml Methanol brought to a liter with ddH2O). After the transfer, the membrane 
was visually inspected to assess the transfer of the protein marker and then incubated in 
5% non-fat milk, 0.1% Tween-20 in PBS for an hour or more. This step blocks any non 
specific sites on the membrane. Subsequently the membrane was incubated for an hour 
with the appropriate primary antibody, washed twice with milk-tween20, incubated with 
the secondary antibody conjugated to horseradish peroxidase (HRP), washed twice with 
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PBS-tween-20 and incubated for 1 minute with a 50-50 mix of chemiluminescence 
solution A and B (Pierce). The solution was then eliminated and the membrane exposed 
to autoradiography films (Kodak) for the necessary time. Films were then developed 
using an automated developer (Xograph Compact X4). Antibodies used: anti-GFP 1:5000 
(Sigma G-1544), anti-Neomycin 1:1000 (Upstate), anti-P85 1:1000 (Upstate), anti-Dicer 
1:250 (Santa Cruz, SC30226). 
 
2.17 Constructs  and  vectors 
The 3′UTR of Brn-3b (NM_138944) was amplified via polymerase chain reaction 
(PCR) from 500ng of mouse genomic DNA with the following primers:  
3bUTR-SacI: 5′gagctctagggacccttctccagggatggccc3′ and  
3bUTR-BamHI: 5′ggaacccgggtgccagtaaaacattaaaatcatctc3′.  
The resulting product of circa 1.7Kb was sub-cloned in the SacI and BamHI multiple 
cloning site of the pEGFP-C1 vector, downstream of GFP. Following the ligation, the 
product was transformed in DH5α competent cells as described in section 2.3, page 64 of 
this thesis. The mCherry vector (Clontech) encoding for red fluorescent protein was part 
of the lab stock  
The Brn-3b shRNAmir-pGIPZ clones (V2LHS_47689, V2LHS_47684, 
V2LHS_47687) were purchased from Open Biosystems. The vector used for the over-
expression of Dicer in primary RGC (pUHD10-3) is a kind gift of Professor Tatsuo 
Fukagawa Department of Molecular Genetics, National Institute of Genetics, Japan. 
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2.18  Measurement of cell death via flow cytometry analysis 
RGC-5 and ND7 cells were transfected with shRNAmir as described in section 
2.1, their medium changed after four hours and then incubated in full medium for two 
days. The supernatant and trypsinized cells of each sample were incubated with 
propidium iodide and run according to standard operating procedures on a LSRII analyser 
(BD bioscience) using FACSdiva
® software. Cells were gated according to their light 
scattering properties. For analysis of GFP-labelled cells, live cells were plotted showing 
staining on GFP-A channel and PI-A (propidium Iodide). Typically 20,000 events were 
collected in each FACS experiment which was repeated at least four times. Error bars 
indicate standard deviation.     
 
 
2.19   MicroRNAs and siRNA 
MicroRNAs (mir-23 and mir-214) were ordered from Applied biosystem and had 
the following sequence: 
Mir-23: AUCACAUUGCCAGGGAUUUCC 
Mir-214: ACAGCAGGCACAGACAGGCAGU 
These were transfected in RGC-5 cells, ND7 cells and in primary retinal cells with 
Lipofectamine 2000 (RGC-5 and primary RGCs) and Genejuice (ND7) at a 50μM final 
concentration as described previously. The siRNA specific for Dicer was ordered from 
Applied biosystems (s23755) and transfected with Lipofectamine 2000. 
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2.20  Measurement of protein concentration  
  The BCA assay (Smith et al., 1985) measures the formation of Cu
+ from Cu
2+ by 
the biuret complex in alkaline solutions of protein using bicinchoninic acid. The BCA 
reagent forms a complex with Cu
+, which has a strong absorbance at 562 nm. Protein for 
the standard curve used was BSA (Sigma) 1mg/ml, concentrations for the standard curve 
range from 0 (blank) to 50g.  5l of buffer (RPMI) was added to the standard curve 
samples to account for any changes in absorbance caused by RPMI. 5l of samples were 
added to 45l of water. 1ml of BCA (sigma) was added to each sample (including 
standard curve samples) and mixed. The mixture was incubated in water bath at 37
oC for 
10 minutes following which 20l of copper sulphate solution were added to each sample. 
All samples were incubated at 37
oC for at least 20 minutes. Following incubation, 
samples were cooled at room temperature and their absorbances measured at 562 nm 
versus a blank. The concentration of unknowns were then determined from a plot of 
concentration vs. absorbances obtained for the standard protein solutions.  
 
 
2.21 Statistical  analysis 
  Paired T tests were used to analyse the data. Real time RT-PCR data were 
analysed using one-way Anova followed by Dunnett’s multiple comparison test (if 
compared to control sample) or Bonferroni’s post hoc test (if compared to one another). P 
values of < 0.05 were considered statistically significant.  
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3.0  Evolutionary conservation of the 3’UTR of Brn-3b  
Members of the POUIV family of transcription factors show some intriguing 
aspects at the level of their evolutionary conservation. As one would expect from 
members of the same class, the coding sequence of Brn-3a and Brn-3b is more than 95% 
homologous (data not shown).  
Differences are found instead at the level of their 3’ untranslated region (3’UTR) 
whereby this region between Brn-3a and Brn-3b is only 35% homologous (data not 
shown). Similarly the 3’UTR of Brn-3a, with a 35% homology,  is poorly conserved 
amongst different species (data not shown) while, in contrast, the 3’UTR of Brn-3b in 
mouse, rat and human is more than 60% homologous (figure 3.0). 
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Rat              GACCCTT-----CTCCAGGGATGGCCCTTTCCCTTCGCCCTCTCTTTT-CTAACC 53 
Mouse            GACCCTT-----CTCCAGGGATGGCCCTTTCCCTTCGCCCTCTTTTTTTCTAACC 54 
Homo             AGACTCTTGGCCTCTCCAGAGACGCCCCTTTCC--TCGTCCGCTCTTTT------- 51 
                ***  *** ***     ****** ** * ********  *** ** ** ****        
 
Rat             CCCCTCTTGTCTCTCCTGCCTCTTTTCTTTCTACTTTGGCTATCAGAAA-CAATTCCGGT 112 
Mouse           CCCTTCTTGTCTCTTCTGCCTCTTTCCTTTCTACTTTGGCTATCAGAAAACAATTCCGGT 114 
Homo            ---CTCTCCTCTCTTCTGCCTCTTTTCACT----TTTGGCGACTAGAAA-CAATTCCAGT 103 
                    ***  ***** ********** *  *    ****** *  ***** ******* ** 
 
Rat             A CCCAGACCAAGTCAGGAGCAAAGA-----------AACAAGCAGCTGAGCC 161 
Mouse           A CCCAGACCAAGCCAGGAGCAAAGA-----------AGCAAGCAGCTGAGCC 163 
Homo            A TCTCGACAAATCGAGGACTGAAGAGGGAGCGAACGAGCGAACAACTGAGCC 163 
                ********* *  *** **   ****   ****           * * * ** ******* 
 
Rat             CAAATCAGAAAGATTGTGAATTGATTTCGCAAAGTGAAGAAAAAACAAAATCACAAACA- 220 
Mouse           CAAATCAGAGAGATTGTGAACCGGTTTCGCA--GTGAAGAAAAACCAAAACCACAAACAA 221 
Homo            CAAGCCGGTGAGAATGTGAAACAGTTTCTCA-----AAGGAAAG----AATAACAAAAG- 213 
                ***  * *  *** ******    **** **     *** ***     **  *****    
 
Rat             CACCACA---AAAGGAATTTGTCACGTTGTAACAGAGCTGTCCCTTTTAAGCGCACCTCG 277 
Mouse           CACAACACGAAAAGGAATTTGTCAAGTTGTAGCAGAGCTGTCCCCTTTAACTGCACCTGG 281 
Homo            -----------ATGGTATTTGTC-TGTTGTAGCAAAGTTGTCCCTTTGAACCCCACCT-- 259 
                           * ** *******  ****** ** ** ****** ** **   *****   
 
Rat             ACTGCTCAGCTTCATCAGAGGAAGTGTGGAGCTGGTTGTCAACAGGAAGACAGAGGGACA 337 
Mouse           GCTGCTCGGCTTCATCAGAGAAAGCGAGGAGCTGACTGTCAACAGGAAGGTAGAGGGACA 341 
Homo            ------CGGCTTCTTCAGAGGAAGTGTGGAGATGGCTGTTTGCAGGAAGGCAGACGAGAC 313 
                      * ***** ****** *** * **** **  ***   *******  *** *     
 
Rat             AGCTTCTGAAAACCCCGCAAGAATGAGCAAGTAAGATTTGTTTTTATTCTTACAGACGTC 397 
Mouse           AGCTTTTGAAAACCCTGCAAGAATGAGCAAGTAAGATTTGTTTTTGTTCTTACAGACGTC 401 
Homo            AGTGTTTAAAAAGTCCACAAGAATGATCAAGTAAGATTTGTTTTTATTCTTACAGACATC 373 
                **  * * ****  *  ********* ****************** *********** ** 
 
Rat             ACCT-TGTTCACGTTTAAAAGTACACTTTGCAGCTATTTTTCAGAAATAGAAATTGATTC 456 
Mouse           ACCT-TGTTCATGTTTAAAAGTACACTTTGCAGCTATTTTTCAGAAATAGAAATTGATTC 460 
Homo            ACCCGTGTTCAAGTTTAAAAGTACACTTTGCAACTATTTTTCAGAAATAGAAATTGATTC 433 
                ***  ****** ******************** *************************** 
 
Rat             AGGACTGAAACTCGAAGCTAGAGTTGATGCTT ACGATAGAGACGCCTCTAAA 516 
Mouse           AGGACTGAAACTCGAAGCTAGAGTTGATGCTT ATGATAGAGACATCTCTAAA 520 
Homo            AGGACTAAAACTTTAAACTAGAGTTGATGCTTAATGTGA-----TAGAGACATCTCTAAA 488 
                ****** *****  ** **********************     *******  ******* 
 
Rat             GTATTTTGAATT--AAAAAAAGATGGCAGATTTTCTGCATTTACACTGTATATTATATAT 574 
Mouse           GTATTTTGAATT--AAAAAAAGATGGCAGATTTTCTGCATTTACACTGTATATTATATAT 578 
Homo            GTATTTTGAATTTTAAAAAAAGATGGCAGATTTTCTGCATTTACACTGTATATTATATAT 548 
                ************  ********************************************** 
 
Rat             ATATTTTTATTGTGGTTCTTATCGCTTTCTTCCTTCTCTAAAGTGTTAATACTTACG-AA 633 
Mouse           ATATTTTTACTGTGGTTCTTATCGCTTTCTTCCTTCTCTGAAGTGTTAACACTTATGGAA 638 
Homo            ATATTTTTATTGTGGTTCTTACC-CCCTTTTCCTTCTCTGAAGTGTTAATGCTTAAGAAA 607 
                ********* *********** * *  * ********** *********  **** * ** 
 
Rat             GGAGTTGCG TGTTCACTGATCTTGACAACTATTATTAGATTATTGCCGTACAA 693 
Mouse           GGAGTTGCG TGTTCACTGATCTTGACAGCTATTATTAGATTATTGCCGTACAA 698 
Homo            AGAGTTGCGCCTGCTGTGTTCACTGATCTTGAAAGCTATTATTAGATTATTGCAGAACAA 667 
                 ******************************* * ****************** * **** 
 
Rat             CCTTCTGTAAATTATTAATTTATCTCTCTGGCAACTTAATTTTGTGCACATCCTAACTAA 753 
Mouse           CCCTCTGTAAATTATTAATTTATCTCTCTGGCAACTTAATTTTGTGCACATCCTAATTAA 758 
Homo            CCCTCTGTAAATTATTAATTTATCTCTCTAGCAACTTAATTTTGTGCACATTCTAATTAA 727 
                ** ************************** ********************* **** *** 
  TAGG-
TAGG-
TAGA
AATGTGAA
AATGTGAA
AATGTGAA
AATGTGAC
AATGTGAT
CCTGCTG
CCTGCTG
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.0: Alignment of the 3’UTR of Rat, Mouse and Human Brn-3b. The 3’UTR of rat, mouse and 
human Brn-3b (XM_001074669 NM_138944, NM_004575.2 respectively) were aligned via bioinformatic 
tool. Red boxes indicate the binding sites of the following microRNAs, from top to bottom: mir-23 
(upstream), mir-23 (downstream), mir-214,  respectively. The TAG at position 1 indicates the stop codon. 
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GACCCTT-----CTCCAGGGATGGCCCTTTCCCTTCGCCCTCTCTTTT-CTAACC 53 
Mouse            GACCCTT-----CTCCAGGGATGGCCCTTTCCCTTCGCCCTCTTTTTTTCTAACC 54 
Homo             AGACTCTTGGCCTCTCCAGAGACGCCCCTTTCC--TCGTCCGCTCTTTT------- 51 
                ***  *** ***     ****** ** * ********  *** ** ** ****        
 
Rat             CCCCTCTTGTCTCTCCTGCCTCTTTTCTTTCTACTTTGGCTATCAGAAA-CAATTCCGGT 112 
Mouse           CCCTTCTTGTCTCTTCTGCCTCTTTCCTTTCTACTTTGGCTATCAGAAAACAATTCCGGT 114 
Homo            ---CTCTCCTCTCTTCTGCCTCTTTTCACT----TTTGGCGACTAGAAA-CAATTCCAGT 103 
                    ***  ***** ********** *  *    ****** *  ***** ******* ** 
 
Rat             A CCCAGACCAAGTCAGGAGCAAAGA-----------AACAAGCAGCTGAGCC 161 
Mouse           A CCCAGACCAAGCCAGGAGCAAAGA-----------AGCAAGCAGCTGAGCC 163 
Homo            A TCTCGACAAATCGAGGACTGAAGAGGGAGCGAACGAGCGAACAACTGAGCC 163 
                ********* *  *** **   ****   ****           * * * ** ******* 
 
Rat             CAAATCAGAAAGATTGTGAATTGATTTCGCAAAGTGAAGAAAAAACAAAATCACAAACA- 220 
Mouse           CAAATCAGAGAGATTGTGAACCGGTTTCGCA--GTGAAGAAAAACCAAAACCACAAACAA 221 
Homo            CAAGCCGGTGAGAATGTGAAACAGTTTCTCA-----AAGGAAAG----AATAACAAAAG- 213 
                ***  * *  *** ******    **** **     *** ***     **  *****    
 
Rat             CACCACA---AAAGGAATTTGTCACGTTGTAACAGAGCTGTCCCTTTTAAGCGCACCTCG 277 
Mouse           CACAACACGAAAAGGAATTTGTCAAGTTGTAGCAGAGCTGTCCCCTTTAACTGCACCTGG 281 
Homo            -----------ATGGTATTTGTC-TGTTGTAGCAAAGTTGTCCCTTTGAACCCCACCT-- 259 
                           * ** *******  ****** ** ** ****** ** **   *****   
 
Rat             ACTGCTCAGCTTCATCAGAGGAAGTGTGGAGCTGGTTGTCAACAGGAAGACAGAGGGACA 337 
Mouse           GCTGCTCGGCTTCATCAGAGAAAGCGAGGAGCTGACTGTCAACAGGAAGGTAGAGGGACA 341 
Homo            ------CGGCTTCTTCAGAGGAAGTGTGGAGATGGCTGTTTGCAGGAAGGCAGACGAGAC 313 
                      * ***** ****** *** * **** **  ***   *******  *** *     
 
Rat             AGCTTCTGAAAACCCCGCAAGAATGAGCAAGTAAGATTTGTTTTTATTCTTACAGACGTC 397 
Mouse           AGCTTTTGAAAACCCTGCAAGAATGAGCAAGTAAGATTTGTTTTTGTTCTTACAGACGTC 401 
Homo            AGTGTTTAAAAAGTCCACAAGAATGATCAAGTAAGATTTGTTTTTATTCTTACAGACATC 373 
                **  * * ****  *  ********* ****************** *********** ** 
 
Rat             ACCT-TGTTCACGTTTAAAAGTACACTTTGCAGCTATTTTTCAGAAATAGAAATTGATTC 456 
Mouse           ACCT-TGTTCATGTTTAAAAGTACACTTTGCAGCTATTTTTCAGAAATAGAAATTGATTC 460 
Homo            ACCCGTGTTCAAGTTTAAAAGTACACTTTGCAACTATTTTTCAGAAATAGAAATTGATTC 433 
                ***  ****** ******************** *************************** 
 
Rat             AGGACTGAAACTCGAAGCTAGAGTTGATGCTT ACGATAGAGACGCCTCTAAA 516 
Mouse           AGGACTGAAACTCGAAGCTAGAGTTGATGCTT ATGATAGAGACATCTCTAAA 520 
Homo            AGGACTAAAACTTTAAACTAGAGTTGATGCTTAATGTGA-----TAGAGACATCTCTAAA 488 
                ****** *****  ** **********************     *******  ******* 
 
Rat             GTATTTTGAATT--AAAAAAAGATGGCAGATTTTCTGCATTTACACTGTATATTATATAT 574 
Mouse           GTATTTTGAATT--AAAAAAAGATGGCAGATTTTCTGCATTTACACTGTATATTATATAT 578 
Homo            GTATTTTGAATTTTAAAAAAAGATGGCAGATTTTCTGCATTTACACTGTATATTATATAT 548 
                ************  ********************************************** 
 
Rat             ATATTTTTATTGTGGTTCTTATCGCTTTCTTCCTTCTCTAAAGTGTTAATACTTACG-AA 633 
Mouse           ATATTTTTACTGTGGTTCTTATCGCTTTCTTCCTTCTCTGAAGTGTTAACACTTATGGAA 638 
Homo            ATATTTTTATTGTGGTTCTTACC-CCCTTTTCCTTCTCTGAAGTGTTAATGCTTAAGAAA 607 
                ********* *********** * *  * ********** *********  **** * ** 
 
Rat             GGAGTTGCG TGTTCACTGATCTTGACAACTATTATTAGATTATTGCCGTACAA 693 
Mouse           GGAGTTGCG TGTTCACTGATCTTGACAGCTATTATTAGATTATTGCCGTACAA 698 
Homo            AGAGTTGCGCCTGCTGTGTTCACTGATCTTGAAAGCTATTATTAGATTATTGCAGAACAA 667 
                 ******************************* * ****************** * **** 
 
Rat             CCTTCTGTAAATTATTAATTTATCTCTCTGGCAACTTAATTTTGTGCACATCCTAACTAA 753 
Mouse           CCCTCTGTAAATTATTAATTTATCTCTCTGGCAACTTAATTTTGTGCACATCCTAATTAA 758 
Homo            CCCTCTGTAAATTATTAATTTATCTCTCTAGCAACTTAATTTTGTGCACATTCTAATTAA 727 
                ** ************************** ********************* **** *** 
-------------------- 
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ACTGTCCGA
ACTGTCCGA
ACTGTCTGA
GCTTTGT
GCTTTGT
Rat             CTAAACTTCTTTAGTCTGAAAAATAAAACCGGCGGATACATATAGGTAGTGATGCTCAAA 813 
Mouse           TTAAACTTCTTTAGTCTGAAAAATAAAACCGGCGGATACGTATAGCTAGTGATGCTCAAA 818 
Homo            TTAAACTTCTTCCGTCTAAAAAA----AGTGGGGGAAATGTATAGCTAGTAACGTTCAAA 783 
                 **********  **** *****    *  ** *** *  ***** **** * * ***** 
 
Rat             TGTTCTTTTTTCTTTTTCCGTCTGATGAGTTCCCTGGAGTTTCACAGCTTTCCCGCTTAG 873 
Mouse           -ACATTTTTCTTTTTTTCTTTTTGGT------CCTGGATTTTTACAGCTT-CCCACTTAG 870 
Homo            ---AAATTTTGTTTGATGAGTTTACC---------GAATTTTTACAGCTT-TCCTCCTAT 830 
                      ***   **  *   * *            * * *** *******  ** * **  
 
Rat             ACTGTGTTCTCTTCGGCCTAGTTGTATATTCTCACTTTGAATGAAGATTGTTTCCTCCCT 933 
Mouse           ACTGTGTTCGCTTTGGCCTAGTTGTATATTCTCACTTTGAATGAAGATTGTTTCTTCCCT 930 
Homo            ACTGTGTTCCTTTTGACCCATTTGTATATTCTCACTT-GAATGAAGATTGTTT-TTTTCT 888 
                *********  ** * ** * **************** ***************  *  ** 
 
Rat             TTGTTTTTAACTGGTAGCGTTCTAATTTGTGAGCTGACACTTGATAATGGATGTCTTAAT 993 
Mouse           TTGTTTTTGACTGGTAGTGATCTAATTTGTGAGCTGACACTTTATAATTGATGTCTTAAC 990 
Homo            TTGTTTTT-ACTGGTAGTGTTCTGATTTGTGAGTCGACACTCAGTAATGGATGTCTTAAT 947 
                ******** ******** * *** *********  ******   **** **********  
 
Rat             CGTGTAGATCTGATTC AGTCTTGTTTACTTCCTTCCATATTTAATGGGGAT 1053 
Mouse           CGTGTAGACCAGATTC AGTCTTGTTTACTTCCTTACATATTTAATGGGGAT 1050 
Homo            CGTGTAGACCTGATTC AGTATTGTTTACTTCGTTACATATTTAATGGGGAT 1007 
                ******** * *********** ***** *********** ** **************** 
 
Rat             TCCCACATTGTCCCCCGCAGCACACGTGCTCTCTCACTCACTTTACAAGCCTACACACAG 1113 
Mouse           TCCCATATTGTCCCC-GCGGCACACGTGCTCTCTCACTCACCTTACATGCCTACACACAA 1109 
Homo            TCCCACATTGTCCCC-ATGACACATGAGCGCTCTCACTTACCCT---TACACACACACAC 1063 
                ***** *********     **** * ** ******** **  *     *  *******  
 
Rat             ACACACAGTACACGTCTCTAACAGAAGAGAAGGGGCAGTTGGAGGTACGACTGATAACCA 1173 
Mouse           ACACACA-TACACATCTCTAACAGAAGAGAAGAAGCAGCTGGAGGTACCAACGATGAGCA 1168 
Homo            ACACACA-CACACACCTCTAACAGAAGGGAAGAAGCAGTTGGAAGCATGACCGAT----- 1117 
                *******  ****  ************ ****  **** **** * *  *  ***      
 
Rat             GTGTATCCTTTTCCAGCCT-AGGTGCGTTCTCCACTTGGTGCTTACTCTGCTGGACTCAA 1232 
Mouse           GTGTATACTTTCCCAGCCTTAGGTGCAGTCTCCACTTGGTGCTTACTCTGCTGGATTCTA 1228 
Homo            --GCACCATTTTCTAGTTTTAGGTGCATTTGCCACTTGGTGTTTGCCCTTCAGATTTT-- 1173 
                  * *   *** * **  * ******  *  ********** ** * ** * *   *    
 
Rat             AGATTTCACCCAGGTATTTCAATCTCCCAGCTTTTAGTT -GGCTACATTT-GA 1290 
Mouse           AGATTTCACCAAGGTATTTCCATCTCCCAGTTTTCGATT -TGCTACATTTTGA 1287 
Homo            AGATTTCACCAAGGTATTTCAGTCTTCCAGTTTTCAATTGCTTTGTTGGCTACATGTTAA 1233 
                ********** *********  *** **** ***   *********  ******* *  * 
 
Rat             CCTTTATAGGA-TCCTTCAGTTTTTCCTTTTAGGATGTTTGTTTGTAGGGG-AAAATTTT 1348 
Mouse           CCTTTATAGGGGTCCTTCATTTTTTCCTTTTAGGAGGTTTGTTTGTAGGGGGAAAAATTT 1347 
Homo            TATTTATAGGAATACTTCAGTTTTTCCTTTT-GGAGGTTTGTTTGTAGAAAAACTAATTT 1292 
                  ********  * ***** *********** *** ************    *  * *** 
 
Rat             GGAACTATAAGAAAGACAGTGCACTGCCTGTAAATTCACAGTGTTTGGTAGAATCCTTTT 1408 
Mouse           GGAACTATAAGAAAGACAGTGCACTGCTTGTAAATTCACAGTGTTTGGTAGAATCCTTTT 1407 
Homo            G-AACTATAAGAAAGACAGTGCACTGCTTGTAAATTCACATTGTTTGGAAAAATTCTTTT 1351 
                * ************************* ************ ******* * *** ***** 
 
Rat             GGAGCACACACACAAGAATAGGTACACAGCGACTGGTACCTTCTCTATTGTAAATATTTC 1468 
Mouse           GGAGCACACACACA--AATAGGTACAAAGTGACTGGTACCTTATCTATTGTAAATATTTC 1465 
Homo            GGAACAAAAA------ATTAGGTACATGATAACTGGTACCTTATCTACTGTAAATATTTC 1405 
                *** ** * *      * ********     *********** **** ************ 
 
Rat             ATTCAAAATGATGCACATATAAATATATTCTTACAGAATTTGCTGTAATTGTTGATCCAT 1528 
Mouse           ATTCAAAATGATGCACATATGAATATATTCTTACAGAATTTGCTGTAATTGCTGATCCAT 1525 
Homo            ATTAAAAATGATGCACACATAGATATATTCTTACAAATTTTGCTGTA-TTGCTGTTCTCT 1464 
                *** ************* **  ************* * ********* *** ** **  * 
 
Rat             TTGAGGCTCTCCAAAGTTCTGAGTTCTGTATATGACCTCGTTCCTTGTTTTTGTTAATGA 1588 
Mouse           TTGAGGCTCTCCAAAGTTCTGAGTTCTGTATATGACCTCGTTTCTTGTTTTTGTTAATGG 1585 
Homo            TTGAGGCTCTCCAAAGTCTTGAGTTCTGTATATGGCCTGGTTTCTTGTTTTTATTAATAG 1524 
                *****************  *************** *** *** ********* *****   
Rat             CTAAACTTCTTTAGTCTGAAAAATAAAACCGGCGGATACATATAGGTAGTGATGCTCAAA 813 
Mouse           TTAAACTTCTTTAGTCTGAAAAATAAAACCGGCGGATACGTATAGCTAGTGATGCTCAAA 818 
Homo            TTAAACTTCTTCCGTCTAAAAAA----AGTGGGGGAAATGTATAGCTAGTAACGTTCAAA 783 
                 **********  **** *****    *  ** *** *  ***** **** * * ***** 
 
Rat             TGTTCTTTTTTCTTTTTCCGTCTGATGAGTTCCCTGGAGTTTCACAGCTTTCCCGCTTAG 873 
Mouse           -ACATTTTTCTTTTTTTCTTTTTGGT------CCTGGATTTTTACAGCTT-CCCACTTAG 870 
Homo            ---AAATTTTGTTTGATGAGTTTACC---------GAATTTTTACAGCTT-TCCTCCTAT 830 
                      ***   **  *   * *            * * *** *******  ** * **  
 
Rat             ACTGTGTTCTCTTCGGCCTAGTTGTATATTCTCACTTTGAATGAAGATTGTTTCCTCCCT 933 
Mouse           ACTGTGTTCGCTTTGGCCTAGTTGTATATTCTCACTTTGAATGAAGATTGTTTCTTCCCT 930 
Homo            ACTGTGTTCCTTTTGACCCATTTGTATATTCTCACTT-GAATGAAGATTGTTT-TTTTCT 888 
                *********  ** * ** * **************** ***************  *  ** 
 
Rat             TTGTTTTTAACTGGTAGCGTTCTAATTTGTGAGCTGACACTTGATAATGGATGTCTTAAT 993 
Mouse           TTGTTTTTGACTGGTAGTGATCTAATTTGTGAGCTGACACTTTATAATTGATGTCTTAAC 990 
Homo            TTGTTTTT-ACTGGTAGTGTTCTGATTTGTGAGTCGACACTCAGTAATGGATGTCTTAAT 947 
                ******** ******** * *** *********  ******   **** **********  
 
Rat             CGTGTAGATCTGATTC
 
  ACTGTCCGA
ACTGTCCGA
ACTGTCTGA
GCTTTGT
GCTTTGT
AGTCTTGTTTACTTCCTTCCATATTTAATGGGGAT 1053 
Mouse           CGTGTAGACCAGATTC AGTCTTGTTTACTTCCTTACATATTTAATGGGGAT 1050 
Homo            CGTGTAGACCTGATTC AGTATTGTTTACTTCGTTACATATTTAATGGGGAT 1007 
                ******** * *********** ***** *********** ** **************** 
 
Rat             TCCCACATTGTCCCCCGCAGCACACGTGCTCTCTCACTCACTTTACAAGCCTACACACAG 1113 
Mouse           TCCCATATTGTCCCC-GCGGCACACGTGCTCTCTCACTCACCTTACATGCCTACACACAA 1109 
Homo            TCCCACATTGTCCCC-ATGACACATGAGCGCTCTCACTTACCCT---TACACACACACAC 1063 
                ***** *********     **** * ** ******** **  *     *  *******  
 
Rat             ACACACAGTACACGTCTCTAACAGAAGAGAAGGGGCAGTTGGAGGTACGACTGATAACCA 1173 
Mouse           ACACACA-TACACATCTCTAACAGAAGAGAAGAAGCAGCTGGAGGTACCAACGATGAGCA 1168 
Homo            ACACACA-CACACACCTCTAACAGAAGGGAAGAAGCAGTTGGAAGCATGACCGAT----- 1117 
                *******  ****  ************ ****  **** **** * *  *  ***      
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                ********** *********  *** **** ***   *********  ******* *  * 
 
Rat             CCTTTATAGGA-TCCTTCAGTTTTTCCTTTTAGGATGTTTGTTTGTAGGGG-AAAATTTT 1348 
Mouse           CCTTTATAGGGGTCCTTCATTTTTTCCTTTTAGGAGGTTTGTTTGTAGGGGGAAAAATTT 1347 
Homo            TATTTATAGGAATACTTCAGTTTTTCCTTTT-GGAGGTTTGTTTGTAGAAAAACTAATTT 1292 
                  ********  * ***** *********** *** ************    *  * *** 
 
Rat             GGAACTATAAGAAAGACAGTGCACTGCCTGTAAATTCACAGTGTTTGGTAGAATCCTTTT 1408 
Mouse           GGAACTATAAGAAAGACAGTGCACTGCTTGTAAATTCACAGTGTTTGGTAGAATCCTTTT 1407 
Homo            G-AACTATAAGAAAGACAGTGCACTGCTTGTAAATTCACATTGTTTGGAAAAATTCTTTT 1351 
                * ************************* ************ ******* * *** ***** 
 
Rat             GGAGCACACACACAAGAATAGGTACACAGCGACTGGTACCTTCTCTATTGTAAATATTTC 1468 
Mouse           GGAGCACACACACA--AATAGGTACAAAGTGACTGGTACCTTATCTATTGTAAATATTTC 1465 
Homo            GGAACAAAAA------ATTAGGTACATGATAACTGGTACCTTATCTACTGTAAATATTTC 1405 
                *** ** * *      * ********     *********** **** ************ 
 
Rat             ATTCAAAATGATGCACATATAAATATATTCTTACAGAATTTGCTGTAATTGTTGATCCAT 1528 
Mouse           ATTCAAAATGATGCACATATGAATATATTCTTACAGAATTTGCTGTAATTGCTGATCCAT 1525 
Homo            ATTAAAAATGATGCACACATAGATATATTCTTACAAATTTTGCTGTA-TTGCTGTTCTCT 1464 
                *** ************* **  ************* * ********* *** ** **  * 
 
Rat             TTGAGGCTCTCCAAAGTTCTGAGTTCTGTATATGACCTCGTTCCTTGTTTTTGTTAATGA 1588 
Mouse           TTGAGGCTCTCCAAAGTTCTGAGTTCTGTATATGACCTCGTTTCTTGTTTTTGTTAATGG 1585 
Homo            TTGAGGCTCTCCAAAGTCTTGAGTTCTGTATATGGCCTGGTTTCTTGTTTTTATTAATAG 1524 
                *****************  *************** *** *** ********* *****   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.0: Alignment of the 3’UTR of Rat, Mouse and Human Brn-3b (Continued from previous page) 
The red boxes indicate the mir-128 and mir-330 binding sites respectively. 
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Rat             AT----TATTTACTATAGTAATGTATTAAGTTATTTTGGGTGTTGTTTCATTGTCTTTCA 1644 
Mouse           GT----TATTTACTATAGTAATGTATTAAGTTATTTTGAGTGTTGTTTCATTGTCTTTCA 1641 
Homo            ATGGTTTATTTACTATGGTAATGTATTAATTTATTTTTGGTGTTGTTCGATTGTCTTTCA 1584 
                 *    ********** ************ *******  ********  *********** 
 
Rat             TCGAAGAGATGATTTTAATGTTTTATTGGCAAAGTATGCTACTTTTTTCATTAAAATATG 1704 
Mouse           TTGAAGAGATGATTTTAATGTTTTACTGGCAAAGTATGCTGCTTTTTTCATTAAAATATG 1701 
Homo            TTGAAGAGATAATTTTAATGTTTTATTGGCAACGTATGCTGCTTTTT-CATTAAAATATG 1643 
                * ******** ************** ****** ******* ****** ************ 
 
Rat             CTATTAATATTAAATGACTTTTAAAACGTG 1734 
Mouse           CTATTAATATTAAATGACTTTTAAAACGTG 1731 
Homo            CTATTAAAATTAAATGGCTTTTA------- 1666 
                ******* ******** ******        
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Fig. 3.0: Alignment of the 3’UTR of Rat, Mouse and Human Brn-3b (Continued from previous page) 
-------------- 
 
The level of conservation of the 3’UTR of Brn-3b in different species suggests 
that this region could play an as yet unidentified role in its regulation. As reported in the 
introduction, post-transcriptional gene regulation can operate at the level of the 3’UTR of 
an mRNA (Fire et al. 1998; Kenealy et al. 2000; Pontrelli et al. 2004; Yang et al. 2005). 
The analysis of the 3’UTR of Brn-3b via bio-informatic tools (Targetscan.org and 
mirnaviewer at http://cbio.mskcc.org/mirnaviewer) showed the presence of putative 
microRNA binding sites which are evolutionary conserved (figure 3.0, red boxes). In 
order to understand whether these or other in-cis sequences contained in the 3’UTR of 
Brn-3b are involved in its regulation, this region was subcloned downstream of GFP in a 
reporter construct that would allow the detection and evaluation of this phenomenon. 
 
 
3.1  Regulation of a reporter mRNA containing the 3’UTR of Brn-3b.  
 
As reported in the introduction, Brn-3a and Brn-3b are oppositely regulated in 
ND7 cells induced to differentiate via serum removal (Smith et al. 1996). While Brn-3a 
  96Chapter3: Brn-3b regulation by microRNAs in neuronal cell lines 
 
levels increase, Brn-3b levels are reduced (Smith et al. 1996). This phenomenon raised 
the question of whether serum removal in ND7 cells could induce the degradation of Brn-
3b via mechanisms acting on its 3’UTR.  
This region was thus sub-cloned downstream of GFP to obtain the 
peGFP::3bUTR construct as reported in section 2.17 of this thesis. The peGFP::3bUTR 
and the empty peGFP control constructs were transfected into ND7 neuroblastoma cells. 
After 24 hours, cells were induced to differentiate via serum removal and after 1, 3 or 5 
days, the levels of GFP were assessed via western blot analysis (fig. 3.1). The levels of 
neomycin, expressed in the same vector, were used for normalization purposes. 
As shown in figure 3.1 the levels of GFP are reduced in the GFP reporter 
construct containing the 3’UTR of Brn-3b compared to the vector expressing GFP alone.  
 
 
 
 
 
 
 
 
 
 
 
 
  97Chapter3: Brn-3b regulation by microRNAs in neuronal cell lines 
 
GFP levels in ND7 cells
0
20
40
60
80
100
120
Day0 Day1 Day3 Day5
R
e
l
a
t
i
v
e
 
v
a
l
u
e
s
UTR
GFP
GFP::3b-3’UTR                     GFP
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.1: Modulation of GFP levels following serum removal in ND7 cells. Downregulation of a reporter 
construct containing the 3’UTR of Brn-3b in ND7 cells induced to differentiate via serum removal. The 
graph represents the average of three experiments. The lower panel represents a typical western blot 
analysis (days=days without FCS). Bars indicate standard deviation. 
----------------- 
 
 
In order to exclude that the reduction of GFP levels in cells transfected with the 
peGFP::3b-3’UTR construct could be due to increased cell death, the experiment shown 
in fig 3.1 was repeated by co-transfecting GFP::3b-3’UTR or GFP control vectors with a 
mCherry vector which expresses red fluorescent protein (RFP). If the reduced levels of 
GFP as seen when expressed in fusion with the 3’UTR of Brn-3b had toxic effect, the 
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levels of red fluorescence would have been reduced alongside the levels of green 
fluorescence compared to the control vector. As shown in fig 3.2 while the levels of 
green fluorescence are reduced in cells transfected with the GFP::3b-3’UTR and induced 
to differentiate via serum removal (panel D, GFP column), the amount of red 
fluorescence is the same in both the GFP::3b-3’UTR and GFP transfected cells and it is 
independent on serum removal (panel B, D, RFP column). The number of “green” and 
“red” cells were counted blind by another member of the laboratory and reported in a 
graph (fig 3.3) which shows that the loss of “green signal” is not associated to a reduction 
in the “red signal” when the 3’UTR of Brn-3b is expressed alongside GFP.  
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Fig. 3.2: Example of GFP and RFP expression in ND7 cells. (A-B): ND7 cells transfected with GFP and 
mCherry vectors and then incubated respectively with (A) or without serum (B) for two days. 
(C-D): ND7 cells transfected with the peGFP::3b-3’UTR and mCherry and incubate respectively with (C) 
or without serum (D) for two days. GFP=green fluorescent protein, RFP=red fluorescence protein 
---------------- 
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Fig. 3.3: Quantification of GFP and RFP expression in ND7 cells. Graphical representation of the 
average of three independent experiments measuring the number of fluorescent green and red cells in five 
different fields counted blind. The error bars indicate standard error. 
---------------- 
 
 
This result suggests that the reduction of GFP levels in the presence of the 3’UTR 
of Brn-3b is likely to be due to a specific reduction of GFP-3b’3’UTR mRNA levels 
rather than increased cell death as mediated by the chimaeric construct.  
 
In order to expand the result, the experiment reported in fig 3.1 was repeated in 
the SHSY-5Y human neuroblastoma and in the MCF-7 human breast cancer cell line, 
both of which express Brn-3b (Lee et al. 2005; Budhram-Mahadeo et al. 2008). This 
experiment was performed in order to investigate whether the down-regulation of Brn-3b 
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could be a neuronal-only phenomenon or whether it is independent of the origin of the 
cell type. As shown in figure 3.4, the levels of the chimaeric mRNA were reduced in the 
SH-SY5Y cell line but not in the MCF-7 cell line following serum removal. This 
suggests that the reporter mRNA containing the 3’UTR of Brn-3b is not intrinsically 
unstable. Although the experiment was performed in two neuronal cell lines and one 
breast cancer line only, this result prompted speculation on whether the degradation of 
the 3’UTR of Brn-3b occurred in neuronal cells only.  
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Fig. 3.4: Modulation of GFP levels in different cell lines. The SH-SY5Y and MCF-7 cell line have been 
transfected and treated as reported above and the levels of GFP evaluated by western blot. The graphs 
represent the average of at least three experiments and the error bar represents standard error.  
------------------ 
 
 
3.2   Degradation of the mRNA containing the 3’UTR of Brn-3b 
Since the GFP:3b-3’UTR and GFP vector differ only by the presence of the 
3’UTR of Brn-3b in the former construct, it is unlikely that the observed reduction in 
  102Chapter3: Brn-3b regulation by microRNAs in neuronal cell lines 
 
GFP protein levels is due to differential protein stability and suggested that the observed 
phenomenon occurred at the post-transcriptional level.  In order to clarify this aspect, 
ND7 cells were transfected as reported above, serum starved and treated with 
Actinomycin-D. By inhibiting transcription, this compound allows the evaluation of 
mRNA turnover. Total RNA was extracted from ND7 cells treated with actinomycin-D 
and, following cDNA synthesis, subjected to realtime RT-PCR analysis with primers for 
GFP. As shown in figure 3.5, the levels of the mRNA containing the 3’UTR of Brn-3b 
are strongly and rapidly reduced compared to the control GFP mRNA. This indicates that 
the observed reduction of GFP at the protein level is due, at least in part, to the 
degradation of its mRNA when the 3’UTR of Brn-3b is present. Since both constructs are 
under the control of the CMV constitutive promoter, no differential transcriptional 
regulation is likely to occur, and post-transcriptional regulation acting on sequences 
contained within the 3’UTR of Brn-3b is therefore likely to be responsible for reduced 
GFP levels. 
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Fig. 3.5: GFP mRNA turnover analysis. ND7 cells were transfected with the indicated constructs and 
subsequently treated with Actinomycin D for the indicated hours. Total RNA was then extracted and its 
cDNA used as a template in a realtime qRT-PCR reaction with primers specific for GFP. Values were 
normalized versus the levels of neomycin which is expressed from the same construct. Error bars indicate 
standard error. 
------------------ 
 
 
3.3  Sequential deletion of the 3’UTR of Brn-3b with Bal-31 
In order to map the region of the 3’UTR of Brn-3b responsible for this effect, a 
series of deletion constructs were made in this region with the Bal-31 exonuclease and 
subsequently assessed for their sensitivity to differentiation-induced degradation using 
the assay described above. Bal-31 (as reported in figure 3.6) is an exonuclease enzyme 
which degrades both 3’ and 5’ ends of duplex linear DNA without causing any internal 
excision.  
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Fig. 3.6: Mechanism of Bal-31 activity. Bal-31 digests duplex linear DNA from both its 3’ and 5’ termini 
allowing a time-controlled shortening of DNA. The figure schematically represents the strategy adopted in 
order to reduce the length of the 3’UTR of Brn-3b. 
-------------- 
 
 
The digestion rate and hence the resulting length of the DNA fragment can be regulated 
by controlling the incubation time of Bal-31 (figure 3.6). In order to evaluate the nuclease 
activity of Bal-31  in this system, a test deletion was initially performed on the 
peGFP::3bUTR, linearized with the PsiI restriction enzyme. This enzyme cuts the 3’UTR 
of mouse Brn-3b in the middle and the linearized vector has thus half of this region at 
  105Chapter3: Brn-3b regulation by microRNAs in neuronal cell lines 
 
each end. Digested products were run on an agarose gel for visualization and evaluation 
purposes. The distance of the DNA bands from the well in which they were loaded was 
plotted on a semi-logarithmic scale versus the marker represented at the left, as shown in 
the inset in figure 3.7. This test digestion allowed to evaluate the relationship between 
Bal-31 activity versus time on the peGFP::3b-3’UTR construct and to calculate that the 
digestion rate is approximately 75 base pairs (bp) of DNA per minute.  
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Fig.3.7: Time-dependent activity of Bal-31. The peGFP::3b-3’UTR construct was linearized with the PsiI 
restriction enzyme, incubated with Bal-31 for the times indicated and run on an agarose gel (inset). 
--------------- 
 
 
Subsequently a reaction was set up consisting of a linearized peGFP::3b’3UTR construct 
and Bal-31 in the appropriate buffer and aliquoted in several tubes kept on ice. All tubes 
  106Chapter3: Brn-3b regulation by microRNAs in neuronal cell lines 
 
were then transferred to Bal-31 operating temperature. At different time points the 
reaction was stopped, the construct re-ligated and transformed into competent bacteria. 
Minipreparations of DNA were subjected to a restriction enzyme digest to release the 
insert and to measure its length as shown in figure 3.8. 
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Fig 3.8: 3b-3’UTR insert release from Bal-31 treated peGFP::3b-3’UTR construct. The peGFP::3b-
3’UTR construct was linearized with PsiI, incubated with Bal-31 for the time reported in figure 3.6, re-
ligated and transformed in competent DH5α E.coli cells. A DNA minipreparation from bacterial colonies 
was subjected to a digestion with SacI and BamHI restriction enzymes to release the insert. 
---------------- 
 
 
With this approach several Bal-31 deletion mutants ranging from ~1.6 Kb (Bal1) to 
~500bp (Bal7) were obtained. From Bal8 onwards, no insert was left and the constructs 
were thus not used for any subsequent experiment. Due to the fact that Bal1 and Bal2 as 
well as Bal 3 and Bal4 are similar to one another, only the Bal1, Bal4, Bal6 and Bal7 
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deletion mutants were subsequently used in GFP assay to evaluate their responsiveness to 
serum removal (Fig.3.9). The reaction in lane 5 seems not to have been digested by Bal-
31 and the insert released following digestion with SacI and BamHI is the size of wild 
type 3b::3’UTR. 
 
 
3.4   Analysis of Bal-31 deletion mutants. 
The four Bal-31 deletion mutants were then transfected in ND7 cells in order to 
assess whether the responsiveness to serum removal had been diminished. As shown in 
the figure below (figure 3.9), while the Bal1 deletion mutant still responds to serum 
removal like the wild type (3b-3’UTR), the Bal4, Bal6 and Bal7 mutants have lost this 
responsiveness, suggesting that the in–cis sequences responsible for the down-regulation 
of the chimaeric mRNA harbouring the 3’UTR of Brn-3b have been removed.  
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Fig. 3.9:  Analysis of GFP levels of the peGFP3b::3’UTR deletion mutants.  The Bal-31 deletion 
mutants described in figure 3.7 were transfected in ND7 cells alongside their wild type counterpart and a 
GFP vector in an assay directed to measure their responsiveness to serum removal. 
----------------- 
 
 
All the Bal-31 deletion mutants were sequenced and analysed using 
bioinformatics tools for known sequences that might influence mRNA stability at the 
post-transcriptional level (Jacobs et al. 2006) but, apart from microRNA binding sites as 
shown in figure 3.0, no AU-rich or other known sequences were found.  
The Bal1 mutant responds to serum removal as the wild type and it is likely 
therefore that the deleted region containing the mir-128a/b binding site is not involved in 
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the serum deprival mediated degradation of the reporter construct. In contrary, Bal4, Bal6 
and Bal7 mutants, have lost the responsiveness to serum removal and their deleted region 
is putatively targeted by three different microRNAs: mir-23, mir-128, and mir-214, one 
of which, mir-23, has two target sites on the 3’UTR of Brn-3b (figure 3.10). 
 
  mir-34c
mir-152
mir-449
mir-148a/b  
 
 
 
 
 
 
 
Fig. 3.10: MicroRNA target site localization on the 3’UTR of Brn-3b. Schematic representation of the 
indicated microRNA putative binding sites on the wild type 3’UTR of Brn-3b and on its Bal-31 deletion 
mutants. The PsiI restriction site is in red typeface. 
---------------- 
 
These microRNAs putatively bind to highly conserved (90-100%) sites in the 3’UTRs of 
mouse and human Brn-3b and this evolutionary conservation further supports a possible 
regulatory role (figure 3.10 and table 3.0). Furthermore none of these putative 
microRNAs have any matching binding sites on the 3’UTR of the closely related Brn-3a 
transcription factor which is up-regulated doing ND7 cell differentiation suggesting 
specificity for Brn-3b (data not shown).  
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3b-3’ UTR
Bal1
Bal4
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mir-214 mir-23 GFP
mir-23b
mir-323
mir-128a/b
mir-30a-5p
mir-330
mir-34c
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mir-449
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Bal6
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3b-3’ UTR
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100 (7/7) 65 (13/20) 90 (18/20) Mir-214
71 (5/7) 70 (14/20) 90 (18/20) Mir-128
100 (7/7) 80 (16/20) 100 (20/20) Mir-23 (downstream)
100 (7/7) 65 (13/20) 95 (19/20) Mir-23 (upstream)
microRNA “seed” homology 
on mouse Brn-3b 3‘UTR.
microRNA overall homology 
on mouse Brn-3b 3’UTR.
Mouse/human   
conservation
100 (7/7) 65 (13/20) 90 (18/20) Mir-214
71 (5/7) 70 (14/20) 90 (18/20) Mir-128
100 (7/7) 80 (16/20) 100 (20/20) Mir-23 (downstream)
100 (7/7) 65 (13/20) 95 (19/20) Mir-23 (upstream)
microRNA “seed” homology 
on mouse Brn-3b 3‘UTR.
microRNA overall homology 
on mouse Brn-3b 3’UTR.
Mouse/human   
conservation
 
 
 
 
Table 3.0: Putative microRNA target sites in the 3’UTR of Brn-3band their conservation. 
------------------ 
 
 
3.5  Mutation of the microRNA binding sites on the 3’UTR of Brn-3b 
In order to determine whether these microRNAs play a specific role in the 
degradation of the GFP::3b-3’UTR reporter construct, their putative target sequences on 
the 3’UTR of Brn-3b were individually mutagenised by changing three out of the seven 
nucleotides, known as the “seed” (shown in red in table 3.1) which is essential for the 
binding of the microRNA to its target sequence. 
 
 
  Mir-23 (upstream) 
  Seed conservation: 100% 
  Overall mouse/human transcript homolgy: 98% 
 
      
 
     3' CCUUUAGGGACCGU  5'  Human miRNA 
           *** ** *  *******        
     5' AACAAUUCCAGUAA  3'  Human Brn-3b 
    ||||||||| ||||||||||          
     5' AACAAUUCCGGUAA  3'  Mouse Brn-3b 
           *** ** *  *******        
     3' CCUUUAGGGACCGU  5'  Mouse miRNA 
 
 
 
 
  UACACU
AUGUGA
AUGUGA
UACACU
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Mir-23 (downstream) 
Seed conservation: 100% 
Overall mouse-human transcript homology: 100% 
 
      
      
     3' UCUCCAGCUGGCACA  5'  Human miRNA 
        ****** *** *  ********           
     5' AGA-GUUGA-UGCUU  3'  Human Brn-3b              
    ||| ||||| ||||||||||||                       
     5' AGA-GUUGA-UGCUU  3'  Mouse Brn-3b  
        *** ** **  *  ********         
     3' UCUCCAGCUGGCACA  5'  Mouse miRNA 
 
 
 
 
 
 
 
 
 
  UUACACU
AAUGUGA
AAUGUGA
UUACACU
 
 
 
 
 
 
 
 
 
 
 
Mir-214 
Seed conservation: 100% 
Overall mouse/human transcript homology: 95% 
 
        
 
     3' GACGGACAGACACG  5'  Human miRNA 
              ** ** *********       
     5' AAAAGAGU-UGCGC  3'  Human Brn-3b            
     || |||| ||||||||||||                       
     5' GAAGGAGU-UGCGC  3'  Mouse Brn-3b  
              ** ** *********       
     3' GACGGACAGACACG  5'  Mouse miRNA 
 
 
 
 
 
 
 
 
 
GACGACA
CUGCUGU
CUGCUGU
GACGACA
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Mir-128 
Seed conservation: 71% 
Overall mouse/human transcript homology: 95% 
 
      
 
     3' UUUUCUCUGG-CCAAG  5'  Human miRNA 
             ***** * ********       
     5' CGUGUAGACCUGAUUC  3'  Human Brn-3b 
        |||||||||| |||||||||||                       
     5' CGUGUAGACCAGAUUC  3'  Mouse Brn-3b  
             ***** * ********         
     3' UUUUCUCUGG-CCAAG  5'  Mouse miRNA 
 
 
 
 
 
 
 
 
UGACACU
ACUGUCU
ACUGUCC
UGACACU
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.1: Putative microRNA binding sites on the 3’UTR of Brn-3b.  Each box represents the 
evolutionary conservation of the microRNA binding sites and related microRNA in the 3’UTR of murine 
and human Brn-3b. The identities between miRNA and 3’UTR are indicated by asterisks. The seven 
nucleotide region known as the “seed” is highlighted in red letters. 
------------------- 
 
 
 
The GFP levels resulting from the mutated constructs were assessed by western blot. As 
shown in figure 3.11, the mutagenesis of the sites targeted by mir-23 (A, B), or mir-214 
(C) but not by mir-128 (D) seems sufficient to avoid the reduction of GFP following 
serum removal. This result is consistent with the observation reported in section 3.4 (and 
also figure 3.9 and 3.10) that the Bal1 mutant, which lacks the mir-128 binding site, still 
responds to serum removal, while Bal4 and Bal7 mutants, lacking the mir-23 and mir-214 
binding sites no longer have this response.  
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Fig. 3.11: Effect of mutations of microRNA binding sites. The indicated microRNA binding sites on the 
3’UTR of Brn-3b were individually mutagenised and their role measured as the amount of GFP protein 
produced by each construct with or without serum as measured via western blots. The scale is the same for 
all graphs and it has been normalized to 3b-3’UTR WT plus FCS=100. 
--------------- 
 
 
The ‘downstream’ mir-23 target site (B) seems more important than the ‘upstream’ one 
(A) as the mutagenesis of this binding site produces a stronger reduced response to serum 
removal. This is also reflected by the level of homology of this region in mouse and 
human since the ‘downstream’ mir-23 binding site on the 3’UTR of Brn-3b is more 
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conserved than the ‘upstream’ one. In contrast, mir-128, which in this assay does not 
seem to have any role in the regulation of the chimaeric construct, has a very low 
homology with its target site on the Brn-3b 3’UTR, especially at the critical 5’ “seed” end 
of the microRNA (table 3.1, last panel). 
Intriguingly, the introduction of mutations in the microRNA binding sites seems 
to trigger a reduced production of GFP in the presence of serum. This is particularly 
evident in the mir23/mir23 double mutant (E), in which both mir-23 sites have been 
mutagenised and in the mir23/mir23/mir214 (F) triple mutant in which the mir-214 site 
has also been mutagenised. In both instances the overall levels of GFP are considerably 
lower than mutants harbouring mutations only in one microRNA binding site. The 
analysis of this phenomenon is outside the scope of this thesis but it is possible that cells 
are able to identify heavily mutated and thus potentially “dangerous” mRNAs and 
dispose of them accordingly.  
 
 
3.6   Effect of the chimaeric constructs on the expression of endogenous Brn-3a 
and Brn-3b. 
The analysis of the regulation of the reporter construct containing the 3’UTR of 
Brn-3b triggered questions regarding the fate of the endogenous Brn-3b in similar 
experimental circumstances. The next step was thus to understand whether a similar 
phenomenon occurs to the endogenous Brn-3b mRNA. 
ND7 cells were transfected with the peGFP::3bUTR or GFP control vector and 
the levels of the endogenous Brn-3a and Brn-3b mRNA evaluated following serum 
removal as described previously. If specific microRNAs are directly involved in the 
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downregulation of Brn-3b, then the transfection of a reporter construct containing the 
3’UTR of Brn-3b should “titrate” all the available microRNAs and reduce or block 
endogenous Brn-3b degradation. Given the lack of any significant homology between the 
3’UTR of Brn-3a and Brn-3b, the same treatment should have no effect on the levels of 
Brn-3a. As shown in figure 3.12, the endogenous Brn-3b mRNA levels are not reduced 
following serum removal in ND7 cells transfected with the peGFP::3bUTR, but are 
reduced as normal in the presence of the ‘empty’ GFP vector. In the same experimental 
conditions, the levels of the endogenous Brn-3a mRNA increase during serum removal as 
expected. 
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Fig 3.12: Expression levels of the Brn-3a and Brn-3b endogenous mRNA. ND7 cells were transfected 
with the peGFP::3b-3’UTR or empty GFP vector and induced to differentiate via serum removal. Total 
RNA was extracted and used for a qPCR using specific primers. The graph represents the average of at 
least three experiments. 
----------------- 
 
 
3.7  Expression of microRNAs and Dicer in ND7 cells 
Following the identification of specific microRNAs as possibly involved in the 
modulation of Brn-3b, it became important to evaluate their expression levels in ND7 
cells grown in full medium or without serum. A realtime RT-PCR approach was initially 
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used to evaluate the levels of specific pri-miRNA. Unfortunately, a high level of non-
specific products and high variability in the obtained results (data not shown) led to 
discard this technique in favour of a northern blot analysis. Contrary to a PCR-based 
system in which small variations of the amount of the original template can result in big 
differences at the end of the exponential amplification reaction, a northern blot technique 
offers the advantage of giving a linear representation of the amount of specific 
microRNAs (or mRNAs) and giving thus a potentially more realistic result than a PCR-
based approach.  
Total RNA extracted from ND7 cells grown with or without FCS, was thus 
subjected to northern blot analysis with mir-23, mir-214, mir-128, mir-96 and mir-152 
probes. The first three microRNAs have been chosen because they have a putative target 
site on the 3’UTR of Brn-3b, with mir-23 and mir-214 putatively having a role in its 
degradation while mir-128 apparently without any role in the modulation of Brn-3b. Mir-
96 and mir-152, instead, although expressed in mouse, do not have a putative target site 
on the 3’UTR of Brn-3b and are thus used as controls to establish whether the potential 
modulation of microRNA expression is a general or specific for some microRNAs. Mir-
96 is predominantly expressed in the olfactory epithelium (Bak et al. 2008) and mir-152 
predominantly expressed in the pituitary gland (Bak et al. 2008) of mice. Both control 
microRNAs are thus expressed in mouse nervous system (Hohjoh et al. 2007; Bak et al. 
2008). As shown in figure 3.13, mir-23 and mir-214, are detectable and their levels are 
increased in ND7 cells subjected to serum removal. Mir-128 is barely detectable and its 
expression is not changed by serum removal. Mir-96 and mir-152 are detectable in ND7 
cells but their levels are not modified following serum removal. This result suggests that 
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mir-23 and mir-214 are specifically up-regulated in ND7 cells following their 
differentiation induced by serum removal. 
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Fig 3.13: Northern blot analysis of microRNAs expression in ND7 cells. Total RNA was extracted from 
ND7 cells grown with or without FCS and used for a northern blot analysis (see material and methods for 
an extended protocol). U6 was used to normalize RNA loading. (A), typical northern blot for the indicated 
microRNAs and (B), graphical representation of the effect of serum removal on the levels of the indicated 
microRNAs as evaluated by densitometry analysis of three independent northern blots. 
------------- 
 
The mRNA and protein levels of Dicer, one of the key enzymes involved in the 
production of mature microRNAs, were next evaluated in order to understand if it was 
regulated in ND7 cells following serum removal. As shown in figure 3.14, Dicer is 
expressed in ND7 cells and intriguingly both its mRNA and protein levels seem to be up-
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regulated following serum removal. Due to the key role played by Dicer in the production 
of microRNAs, this result prompted speculation regarding the fate of microRNAs in ND7 
cells. It would have been extremely interesting, for instance, to assess whether the 
reduction in serum levels in ND7 cells would be a trigger of a global increase of 
microRNAs but due to time constraints and in order to keep the focus of the experimental 
work on the regulation of Bnr-3b by microRNAs, the mechanisms and the effect of the 
manipulation of Dicer levels, will be investigated in future work. Nonetheless, the lack of 
mir-96 and mir-152 increase in ND7 cells growing without serum, seem to suggest that, 
although Dicer levels might increase, this is not necessarily associated to an increase in 
microRNA levels. 
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Fig 3.14: Dicer expression levels in ND7 cells. Total proteins were extracted from ND7 cells induced to 
differentiate via serum removal or kept in full serum and subjected to a western blot analysis with an anti-
Dicer antibody. The blots were normalized with p85. The graph on the left represents the average of at least 
three experiments. 
----------------- 
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3.8 Discussion 
  
The Brn-3b transcription factor, a POU IV-class protein, is modulated in retinal ganglion 
cells (RGCs) during development (Xiang et al. 1993; Xiang 1998). Furthermore its 
expression levels are reduced upon differentiation of the ND7 cell line (Smith et al. 
1996). Intriguingly, the 3’UTR, a region well-known to be a target for post-
transcriptional regulation (Kenealy et al. 2000; Andreassi et al. 2009), is highly 
conserved amongst Brn-3b in different species. By using different approaches, it is 
suggested that the 3’UTR of Brn-3b is directly involved in the degradation of a reporter 
chimaeric mRNA putatively via microRNAs binding specific sequences. This effect 
occurs in the neuronal ND7 and SHSY-5Y but not in the MCF-7 breast cancer cell line. 
Brn-3b is normally expressed in all these cell lines (Lee et al. 2005; Budhram-Mahadeo 
et al. 2008). Although very few cell lines have been used to draw any conclusions, as a 
working hypothesis the data presented so far seemed to suggest that the microRNA-
mediated degradation of Brn-3b could be a phenomenon that occurs only in neuronal 
cells. This working hypothesis will be analyzed and disproven in the next chapter when 
more data had become available.  
 The initial data concerning the fate of the GFP chimaeric mRNA harbouring the 
3’UTR of Brn-3b, had left open the question on whether the observed down-regulation 
was due to degradation of the mRNA or vicerversa simply a consequence of increased 
cell death due to some intrinsic toxicity of the peGFP::3b-3’UTR constructs compared to 
the control GFP. The latter hypothesis was excluded by showing that cells transfected 
with the peGFP::3b-3’UTR or control GFP vector alongside a vector encoding for a red 
fluorescent protein and induced to differentiate via serum removal showed a reduced 
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level of GFP in the presence of the 3’UTR of Brn-3b but no differences of red 
fluorescence across all samples. If increased cell death was the cause of the reduction in 
GFP levels in the presence of the 3’UTR of Brn-3b (fig.3.1 and fig.3.2), then a 
comparable reduction in red fluorescence would have been observed. Furthermore, the 
expression levels of neomycin, expressed from within the peGFP vector, do not decrease 
in cells transfected with peGFP::3b-3’UTR compared to cells transfected with control 
GFP vector suggesting that the construct is not associated to any increased cell death (fig 
3.1) following differentiation induced by serum removal.  
The experiment with actinomycin D aimed at evaluating the degradation rate of 
the chimaeric mRNA containing the 3’UTR of Brn-3b in comparison to control GFP, 
seems to indicate that the 3’UTR of Brn-3b mediates an increased rate of the reporter 
mRNA harbouring it compared to the control. This evidence is in accord with the 
proposed mechanism of action of microRNAs, whereby a perfect match between a 
microRNA and its target site leads to the degradation of the mRNA. As shown in table 
3.0, the mir-23 and mir-214 have perfect complementary matches on their target sites on 
the 3’UTR of Brn-3b.  
The individual mutagenesis of candidate microRNA binding sites in the 3’UTR of 
Brn-3b has shown that mir-23 and mir-214 but not mir-128 are likely to be involved in 
the down-regulation of Brn-3b upon serum removal in ND7 cells. Two other microRNAs, 
mir-96 and mir-152, both expressed in mouse (Hohjoh et al. 2007; Bak et al. 2008) did 
not show any modification of their expression levels following serum removal. This 
seems to suggest that the modulation of mir-23 and mir-214 levels could have a specific 
role regarding the differentiation of ND7 cells. It would be intriguing to perform a 
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microarray analysis on microRNAs extracted from ND7 cells induced to differentiate via 
serum removal compared to untreated ones and analyse the modification of microRNAs 
involved in cellular differentiation. Furthermore, the mRNA and protein levels of Dicer, 
one of the two enzymes involved in the production of mature microRNAs (Bernstein et 
al. 2001; Lee et al. 2003), are also up-regulated in ND7 cells subjected to differentiation. 
The up-regulation of Dicer levels could have a global effect on the levels of microRNAs 
and it would thus be intriguing to evaluate this aspect in future work. Furthermore, given 
the role played by Drosha in the microRNA pathway (Lee et al. 2003; Carmell et al. 
2004), it would be interesting to evaluate whether its expression is also subjected to a 
similar regulation as Dicer in ND7 cells induced to differentiate via serum removal.   
 
The ‘downstream’ mir-23 binding site on the 3’UTR of Brn-3b is part of a 
consensus sequence termed ‘K-box’ (cUGUGAUa) (Lai et al. 1998). This was originally 
identified in the 3’UTR of Notch pathway target genes such as the ones belonging to 
Enhancer of split complex (Lai et al. 1998; Lai 2002). The K-box present in the 3’UTR 
of E(spl)m8, one of the members of the Enhancer of split complex (Lai et al. 1998), is 
sufficient to mediate the post-transcriptional regulation of a reporter construct harbouring 
it (Lai et al. 1998). It has been reported that Notch pathway is involved in the 
differentiation of RGC during development (Silva et al. 2003), whereby the reduction of 
Notch expression increases retinal ganglion cell genesis (Silva et al. 2003). The down-
regulation of the Notch pathway (Nelson et al. 2006) leads to the up-regulation in RGCs 
of Brn-3b (Wang et al. 2001) and Math5 (Silva et al. 2003), another transcription factor 
involved in RGC differentiation. Due to presence of the K-box motif on the 3’UTR of 
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Brn-3b (Lai et al. 2005) it would be intriguing to speculate that the “downstream” mir-23 
putative site on the 3’UTR of Brn-3b is thus a target of Notch signaling pathway (Lai 
2002; Kawasaki H. 2005; Lai et al. 2005).  
 
The role of the 3’UTR of Brn-3b in the degradation of the chimaeric GFP mRNA 
has also been indirectly confirmed by evaluating its effect on the modulation of the 
endogenous Brn-3b transcription factor. In comparison to cells transfected with the GFP 
control vector, the endogenous Brn-3b mRNA is not down-regulated in cells transfected 
with the pGFP::3bUTR reporter construct. A possible explanation of this phenomenon 
concerns the “titration” of specific microRNAs involved in the down-regulation of Brn-
3b by the 3’UTR of the exogenous construct. This is also confirmed by the lack of any 
effect on the closely related Brn-3a transcription factor which is known to be up-
regulated in differentiating ND7 cells. Since the 3’UTR of Brn-3a and Brn-3b do not 
have any similarity, these data confirm the specificity of the observed effect as mediated 
by the 3’UTR of Brn-3b. This effect could also be used experimentally to block the 
down-regulation of Brn-3b or any other mRNAs which are modulated via their 3’UTR 
and control their levels in vitro at a post-transcriptional level.  
Although the mutagenesis of the microRNA binding sites on the 3’UTR of Brn-3b 
seems sufficient to alleviate serum starvation-induced down-regulation of GFP::3bUTR, 
these mutants display overall lower GFP levels compared to the ‘wild type’ GFP vector. 
The data presented in this thesis suggest that, as well as affecting the degradation of the 
GFP::3bUTR mRNA as mediated by microRNAs, the mutagenesis of the 3’UTR of Brn-
3b seems to be causing per se an increased degradation. This is especially evident in the 
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mir-23/mir-23 double mutant (Fig.3.11 E) or in the mir-23/mir-23/mir-214 triple mutant 
(Fig.3.11 F) in which the overall levels of GFP, instead of increasing due to the 
elimination of progressively more microRNA binding sites, are instead lower than their 
wild type counterpart. These data suggest that the down-regulation of the different mutant 
GFP::3bUTR constructs is a process which possibly involves two separate mechanisms. 
One, mediated by microRNAs, seems to be involved in the specific down-regulation of 
the GFP::3bUTR mRNA as triggered by serum removal; the other instead seems to be 
causing a microRNA- and differentiation stimuli-independent degradation of the 
chimaeric mRNA. Although at the present time the mechanism involved in the latter 
phenomenon is not clear, it is possible to speculate that, as described previously, the 
chimaeric mRNA harbouring a mutated 3’UTR has an altered secondary structure and is 
therefore degraded (Monde et al. 2000; Puga et al. 2005).  
MicroRNAs can potentially bind several target sequences (Burgler et al. 2005; 
Rusinov et al. 2005). Based on data available at the moment of writing this thesis and 
retrieved from a public available database at http://targetscan.org/, mir-23 and mir-214 
can theoretically bind 672 and 348 target different mRNAs respectively. Intriguingly, 
beside Brn-3b, only 34 mRNAs of both lists contain target sequences putatively bound by 
both mir-23 and mir-214 (data not shown). Mir-96 and mir-152 (the control microRNAs 
used in figure 3.12), can putatively target 715 and 417 different mRNAs respectively. 
The number of mRNAs targeted by both microRNAs is 17. Although these in-silico data 
provide little information regarding the possible physiological effect of such joint 
regulation, it is possible that future experiments and advancements in computing will 
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help scientists to elucidate whether the multiple binding of different microRNAs on one 
target has a specific role in the regulation of mRNAs. 
  The analysis of microRNA expression levels has shown that mir-23, mir-214 and 
mir-128 are expressed in ND7 cells and that mir-23 and mir-214 are up-regulated in ND7 
cells subjected to serum removal. In order to further confirm their specific role on the 
modulation of Brn-3b mRNA, it would be intriguing to reduce or silence the expression 
of endogenous mir-23 and mir-214 by specific siRNA and assess whether this reduction 
has any effect on the levels of endogenous Brn-3b in ND7 cells subjected to 
differentiation stimuli. 
The next chapter will focus on analysing how the 3’UTR of Brn-3b is regulated in 
the RGC-5 retinal ganglion cell line which constitutes a more physiological system for 
Brn-3b.  
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4.0  Regulation of Brn-3b 3’UTR in RGC-5 cells 
To test whether the 3’UTR of Brn-3b is subjected to post-transcriptional 
regulation in the RGC-5 cell line, the GFP::3b-3’UTR reporter construct was used and 
the levels of GFP measured by a western blot analysis. RGC-5 and, as a control, ND7 
cells, were transfected with the aforementioned construct or a GFP vector as control. It 
has been previously reported in this thesis that the GFP::3b-3’UTR mRNA is down-
regulated upon serum removal in ND7 cells, a treatment known to induce differentiation 
of ND7 cells and an upregulation of mir-23 and mir-214 expression. In order to achieve a 
similar response, transfected RGC-5 cells were induced to differentiate using 
staurosporine (SS) or depolarize using KCl rather than with serum removal which has no 
effect on this cell line (Harvey et al. 2007). In RGC-5 cells staurosporine induces the 
expression of Thy-1, a typical RGC differentiation marker (Lieven et al. 2007). KCl 
induces calcium influx in RGC-5 cells which induces the redistribution of protein 
complexes in this cell line (Selamat et al. 2009). This treatment could thus have an effect 
on the activity of the proteins involved in the miRNA silencing pathway. As a control, 
transfected cells were left in full serum.  
Although the evidences described in chapter 3 concerning the regulation of the 
GFP::3b-3’UTR, were based on few cell lines only, the experiments seemed to suggest a 
working hypothesis by which the GFP::3b-3’UTR construct could be down-regulated in 
neuronal cells only. Surprisingly, the GFP reporter construct harbouring the 3’UTR of 
Brn-3b is not down-regulated in RGC-5 cells maintained in full serum. Furthermore, 
neither treatment induces any further down-regulation of the GFP levels (figure 4.0, panel 
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A). In comparison, and as described previously in this thesis, the same construct is down-
regulated in ND7 cells induced to differentiate via serum removal (figure.4.0, panel B).  
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GFP::3’UTR GFP::3b-3’UTR
FCS        KCl SS FCS       KCl SS
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Fig. 4.0: Western blot analysis of GFP levels in RGC-5. RGC-5 cells were transfected with the indicated 
construct and subsequently treated as reported above and subjected to a western blot analysis with an anti-
GFP antibody. The experiment was normalized with anti-neomycin antibody for loading differences. 
SS=Staurosporine, KCl=potassium chloride, FCS=foetal calf serum 
----------------- 
 
 
 
4.1 MicroRNA  expression  analysis in RGC-5 cells 
To understand whether the lack of GFP::3b-3’UTR downregulation in RGC-5 
cells was due to the absence of specific microRNA targeting its 3’UTR,  the expression 
levels of mir-23 and mir-214 were analysed in RGC-5 cells. As reported in section 3.5, 
these two microRNAs, which target and degrade Brn-3b mRNA, are upregulated 
following serum removal in the ND7 neuroblastoma cell line. To understand whether a 
similar modulation occurs in RGC-5 cells, these were treated with staurosporine, KCl or 
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left untreated and total RNA was extracted and subjected to a northern blot analysis. As 
shown in figure 4.1, although both the 75 and 22 nucleotide long precursor and mature 
form of mir-23 are expressed at detectable levels in RGC-5 cells, mir-214 is not detected. 
Furthermore, in contrast to their upregulation in ND7 cells induced to differentiate via 
serum removal, neither treatment seems to have any effect on the modulation of mir-23 
expression levels in RGC-5 cells.  
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Fig. 4.1: Northern blot analysis of miRNA expression in RGC-5 and ND7 cells. Total RNA was 
extracted from RGC-5 (A) or ND7 (B) treated as described. RNA was run on polyacrylamide gel and 
probed with mir-23 or mir-214 probes. Blots were normalized with U6. The 75 nt. and 22 nt. long mature 
microRNAs are indicated by arrows. The data represent a typical northern blot which were repeated three 
times. 
----------- 
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4.2  Effect of mir-23 and mir-214 on Brn-3b levels in RGC-5 and ND7 cells 
To test whether the lack of GFP::3b-3’UTR downregulation was due to the 
absence of these microRNAs and for the direct role exerted by mir-23 and mir-214 on the 
stability of the 3’UTR of Brn-3b, RGC-5 cells were transfected with the GFP::3b-3’UTR 
reporter construct or a GFP empty vector together with synthetic mir-23, mir-214, mir-23 
plus mir-214 or a control microRNA. After two days, cells were harvested and subjected 
to a western blot analysis. As shown in figure 4.2, GFP levels were reduced in RGC-5 
cells only upon the co-transfection of the two microRNAs suggesting a co-operative 
effect.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  132Chapter4: Alternative regulation of Brn-3b in the RGC-5 cell line  
 
 
 
GFP GFP::3b 3’UTR GFP::3b-3’UTR TM
GFP
Neo
+
+             +               
+      +   
+
+            +
+     +
+
+             +
+     +
GFP levels in RGC-5
0
20
40
60
80
100
120
140
UTR Trip.Mut
R
e
l
a
t
i
v
e
 
v
a
l
u
e
s
 
(
G
F
P
=
1
0
0
)
C-
mir23
mir214
mir23+214
C-
Mir-23 
Mir-214 
***
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.2: Effect of microRNAs on the GFP levels in RGC-5 cells. RGC-5 cells were co-transfected with 
the indicated constructs and microRNAs. Extracted proteins were subjected to a western blot analysis. The 
graph represents the average of at least three experiments and the error bars indicate standard error. 
***=P<0.001 
------------------ 
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Conversely, as shown in figure 4.3, the same experiment performed in ND7 cells 
shows that mir-23 and mir-214 mediate the degradation of the reporter construct 
harbouring the 3’UTR of Brn-3b both individually and in combination. This, once more, 
suggests that the chimaeric mRNA is subjected to a differential modulation depending on 
the cell line in which it is expressed. 
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Fig 4.3: Effect of microRNAs on the GFP levels in ND7 cells. RGC-5 cells were co-transfected with the 
indicated constructs and microRNAs. Proteins were extracted and subjected to a western blot analysis. The 
graph represents the average of at least three experiments and the error bars indicate standard error. 
***=P<0.001 
-------------- 
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4.3  Effect of mir-23 and mir-214 on endogenous Brn-3a and Brn-3b expression 
levels. 
To confirm the reported findings at a more physiological level, the above 
experiment was repeated without the presence of the GFP reporter construct and the 
levels of the endogenous Brn-3b mRNA were measured via realtime RT-PCR. As shown 
in figure 4.4, the levels of Brn-3b, but not of the closely related Brn-3a transcription 
factor, are markedly reduced upon the co-transfection of mir-23 and mir-214. This 
suggests a direct effect of the microRNAs on the 3’UTR of endogenous Brn-3b. 
Furthermore, endogenous Brn-3b mRNA levels are also reduced upon the transfection of 
mir-214 but not of mir-23. This is likely due to the endogenous expression of mir-23 in 
RGC-5 cells which, together with mir-214, triggers Brn-3b degradation. This could also 
explain why such an effect is not observable on the chimaeric construct, which by being 
vastly in excess in RGC-5 cells transfected with the peGFP::3b-3’UTR construct, is not 
degraded by the endogenous levels of mir-23 combined with the exogenously transfected 
mir-214.  
As a control, a northern blot analysis was performed to test whether the result was 
due to differential microRNAs transfection efficiency but found no differences in the 
levels of the exogenously transfected mir-23 and mir-214 (data not shown). 
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Fig 4.4: Endogenous levels of Brn-3a and Brn-3b mRNA in RGC-5. Total RNA was extracted from 
RGC-5 cells transfected with the indicated microRNAs, subjected to a cDNA synthesis and used for a 
realtime RT-PCR reaction to detect the levels of endogenous Brn-3a and Brn-3b mRNAs. The graph 
represents the average of three experiments. 
------------------- 
 
 
4.4  Effect of Brn-3b reduction on RGC-5 and ND7 cell survival  
As reported before, the deletion of Brn-3b causes RGC death during development 
(Gan et al. 1996; Erkman et al. 2000; Wang et al. 2000). The data presented in this thesis 
seems to indicate that the mRNA of Brn-3b is degraded by specific microRNAs in the 
ND7 but not in the RGC-5 cell line. In order to understand whether this is due to the pro-
survival role exerted by Brn-3b in the RGC derived cell line, Brn-3b expression was 
suppressed and RGC-5 cell viability assessed.  
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Initially, RGC-5 cells were transfected with mir-23, mir-214, mir-23 plus mir-214 
or control miRNA and cell viability was measured by propidium iodide uptake. This 
compound enters the membrane of dead or dying cells and upon binding DNA its 
fluorescence increases up to 30 fold compared to the non-bound form. As shown in figure 
4.5, mir-214 and mir-23 plus mir-214 induce cell death in RGC-5 cells compared to 
control.  
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Fig. 4.5: Propidium iodide uptake in RGC-5 cells. RGC-5 cells were transfected with the indicated 
microRNAs and after two days incubated with propidium iodide. Red nuclei were observed under 
fluorescent microscope. 
--------------- 
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In view of the fact that microRNAs can bind several target mRNAs, the cell death 
assay was repeated with shRNAmir specifically targeting three sites on the coding 
sequence of Brn-3b. Furthermore, since Brn-3b is not essential for its survival, the ND7 
cell line was used as a control. The shRNAmir were transfected in RGC-5 and ND7 cells 
and the effect on cell survival assessed by propidium iodide uptake measured via flow 
cytometry analysis. As shown in figure 4.6, increased amounts of shRNA produce an 
increased amount of cell death in the RGC-5 but not in the ND7 cell line. This suggests 
that, as well as in primary RGC, Brn-3b plays an essential role in RGC-5 survival but not 
in the ND7 cell line. 
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Fig.4.6: RGC-5 and ND7 cell death assay. RGC-5 and ND7 cells were transfected with increased 
amounts of shRNAmir and their death assessed by propidium iodide uptake as measured via flow 
cytometry analysis.  The data represent cell survival and the graph is the mean of at last four independent 
experiments. Error bars indicate standard error. 
---------------- 
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4.5 Discussion 
The Brn-3b transcription factor is essential for RGC survival as demonstrated by 
the loss of up to 70% of RGC in mice lacking the gene (Gan et al. 1999; Erkman et al. 
2000; Wang et al. 2000). In chapter 3 of this thesis it has been described how Brn-3b 
seems to be subjected to down-regulation by two microRNAs (mir-23 and mir-214) in the 
ND7 and SHSY-5Y neuronal cell line but not in the MCF-7 cell line. In this chapter this 
analysis was extended and the regulation of Brn-3b by microRNAs was evaluated in an 
immortalized rat retinal ganglion cell line (RGC-5). 
Contrary to previous findings in the ND7 and SHSY-5Y cell line, Brn-3b does not 
seem to be down-regulated in RGC-5 cells following differentiation. Furthermore, 
although mir-23 is expressed in RGC-5 cells, differentiating or depolarizing agents such 
as staurosporine and KCl do not modulate its levels and mir-214 is not even detectable. 
Due to the presence of a positive control in the northern blot, it is unlikely that the lack of 
mir-214 expression in RGC-5 is due to a technical issue and therefore the result seems to 
indicate the existence of a differential regulation of mir-214 in the RGC-5 compared to 
the ND7 cell line. This differential expression would probably not be of much 
significance in itself as different cell lines have different gene and microRNA expression 
profiles but intriguingly, a similar microRNA expression profile, whereby mir-23 is 
expressed and mir-214 is un-detectable, occurs in primary rat retinas (Arora et al. 2007; 
Hackler et al. 2010). This suggests that the pattern observed in RGC-5 might reflect a 
physiological phenomenon. Hackler and colleagues (Hackler et al. 2010) have recently 
reported that while mir-23 is expressed during mouse retinal development and its 
expression increases at the adult stage, mir-214 is not expressed at any developmental 
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stages (Hackler et al. 2010). It has been reported in chapter 3 that Brn-3b is not down-
regulated in the MCF-7 cell line. Intriguingly, it has been previously reported  that Brn-
3b is essential for MCF-7 cell proliferation and invasiveness (Dennis et al. 2001). The 
reduction of Brn-3b levels via anti-sense leads to a drastic decline of MCF-7 cell growth. 
Paralleling the microRNA expression profile in the rat retina, mir-23 is expressed in the 
MCF-7 cell line at low levels while mir-214 is not detectable (Volinia et al. 2006). 
Furthermore, Kovalchuk and colleagues (Kovalchuk et al. 2008) have shown that while 
mir-214 is virtually absent, mir-23 is highly expressed in wild type MCF-7 cells 
(Kovalchuk et al. 2008). Both classes of microRNAs are modulated by the treatment of 
MCF-7 cells with doxorubicin with a slight increase of mir-214 levels and a slight 
decrease of mir-23 levels (Kovalchuk et al. 2008).  
The regulation of mRNAs by microRNAs is very likely not as straightforward as 
one microRNA one target mRNA. Several studies (Gaidatzis et al. 2007; Alexiou et al. 
2009; Ghildiyal et al. 2009; Orom et al. 2010) offer a much more complicated reality in 
which the distribution of the number of target sites per miRNA is highly nonuniform. 
This ranges from an apparent lack of targets for seven miRNAs to 268 targets for let-7b 
(John et al. 2004) , with an average of 7.1 mRNA targets per miRNA (John et al. 2004; 
John et al. 2006; Ambros et al. 2007). Furthermore it has been also reported (Hon et al. 
2007) that the spacing between microRNA target sites and the length of the 3’UTR 
affects the way the latter is downregulated (Hon et al. 2007; Saetrom et al. 2007). These 
data suggest that the regulation of mRNAs by microRNAs is of high complexity and that 
the apparent necessity of both mir-23 and mir-214 to regulate Brn-3b mRNA in RGC-5 
cells is very likely just one aspect of Brn-3b regulation.    
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In the RGC-5 cell line, the modulation of the GFP::3b-3’UTR mRNA and of the 
endogenous Brn-3b mRNA seems to occur only when both mir-23 and mir-214 are 
exogenously transfected. In particular, the decreased expression of endogenous Brn3b 
mRNA upon the transfection of the mir-214 but not of the mir-23 microRNA seems to 
support the hypothesis that both microRNAs are important for Brn-3b degradation. As a 
working hypothesis it would be intriguing to speculate that endogenous levels of mir-23 
act in concert with the transfected mir-214 to down-regulate Brn-3b. In contrast, the 
transfection of mir-23 does not induce a similar phenomenon and this is possibly due to 
the lack of mir-214. Since this phenomenon is not due to a differential transfection 
efficiency or degradation of the two microRNAs as measured by a northern blot analysis, 
these data suggest that in this cell line, and perhaps in MCF-7 cells, both mir-23 and mir-
214 are required for the downregulation of Brn-3b mRNA. Furthermore, the lack of any 
downregulation on the GFP::3b-3’UTR construct harbouring the triple mutation which 
disrupts both the mir-23 and mir-214 binding sites suggests that the reduction of Brn-3b 
levels is not mediated by, fore instance, the reduction of a protein protecting Brn-3b 
mRNA but is instead due these microRNAs acting directly on the 3’UTR of Brn-3b.  
At the present time it is not known whether the degradation of the 3’UTR of Brn-
3b occurs following the binding of both mir-23 and mir-214 or to an indirect effect 
associated to the over-expression of mir-23 and mir-214 in RGC-5 cells.  An mRNA 
targeted by several microRNAs could undergo, for instance, to a modification of its 
secondary and tertiary structure (Hofacker 2007; Zhao et al. 2007; Rabani et al. 2008) 
and this could potentially reduce or enhance its chances of being degraded.  
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Furthermore, since the transfection of exogenous microRNAs might “flood” the 
RNAi machinery of RGC-5 cells, it would be intriguing to evaluate the effect of mir-23 
and mir-214 on Brn-3b following the modulation of their endogenous levels by acting on 
their promoters.  Conversely, silencing the expression of endogenous mir-23 and mir-214 
via specific siRNA could allow the understanding of their specific role on the degradation 
of Brn-3b mRNA. As mentioned above, although mir-23 and mir-214 are involved in 
Brn-3b regulation, it is expected that other, not yet identified microRNAs, might be 
involved in its regulation.  
 
Given the evidence provided in this chapter, it could be speculated that, possibly 
due to its essential role, the Brn-3b transcription factor could be physiologically protected 
from degradation by microRNAs in the RGC-5 and MCF-7 cell lines in which plays a 
pro-survival and pro-growth role, compared to the ND7 and SHSY-5Y cell lines in 
which, although expressed (Smith et al. 1997; Lee et al. 2005), does not play any 
essential role. 
The next chapter will present preliminary evidence regarding the effect of 
manipulating Dicer levels in RGC-5 and primary retinal ganglion cells.  
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5.0   Analysis of the 3’UTR of chicken Brn-3b 
The results presented in chapter 3 and 4 prompted questions regarding Brn-3b 
regulation in primary RGCs. Furthermore, given the function of Dicer and generally of 
PTGR in neuronal development it became interesting to understand what role, if any, it 
had in RGC development and survival.  
In order to study the role played by Brn-3b and its regulation by microRNAs in 
primary RGC, the chick embryo was chosen as model system because of the abundance 
of RGCs at different embryonic stages (Prada et al. 1991; Butowt et al. 2000; James et al. 
2003)and its easy manipulation.  
 
The Ensembl DNA database (ensemble.org) was used to identify the 3’UTR of 
chicken Brn-3b (cBrn-3b). This search showed that, despite the evolutionary distance 
between avians and mammals, this region in the chicken shows a relatively high degree 
of homology with the murine 3’UTR of Brn-3b (figure 5.0).  
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Fig. 5.0: Homology of the 3’UTR of murine and avian Brn-3b. The murine (mus) mir-23 binding sites 
on the 3’UTR of Brn-3b are highlighted by blue-boxes (“upstream” and “downstream” respectively), the 
avian mir-23 binding site on the 3’UTR of cBrn-3b (gallus) by a yellow box while the murine mir-214 
binding site is labelled with a red box. The asterisks denote nucleotide identity. Continued on the next page.  
---------------- 
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Fig..5.0 (continued): Homology of the 3’UTR of murine and avian Brn-3b.  The purple box represents 
the non–conserved mir-1777 binding site on the 3’UTR of the avian but not of murine Brn-3b. 
-------------------- 
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Although none of the murine-equivalent mir-23 binding sites are present on the 
3’UTR of cBrn-3b (figure 5.0 blue boxes), the chick mir-23 has a binding site close to the 
position of the mouse mir-23 ‘downstream’ site (figure 5.0 yellow box) and this region is 
highly conserved between the murine and chick sequence (table 5.0).  
The mir-214 microRNA is partially conserved on the 3’UTR of cBrn-3b but its most 
important part, the seven nucleotide ‘seed’ towards the 3’ end of the consensus sequence, 
is not present on the chick sequence. Intriguingly, a new microRNA, mir-1777, can 
putatively bind the 3’UTR of cBrn-3b but not the mouse sequence. Although no data are 
available yet as to its expression, it would be interesting to assess whether it plays any 
role in the modulation of cBrn-3b. 
 
 3’ GGAAAUCCCUGGC
 
 
 
AAUGUGA
******* 
******* 
AAUGUGA
******* 
UUACACU
 5’  Chick mir-23 
    * ***  ***           
 5’ CTTTTCTGCAT--TTACACT 3’  Chick Brn-3b 
       *** ** *          
 5' AACAAUUCCGGUA  3'  Mouse Brn-3b 
       *** ** *          
 3' CCUUUAGGGACCG  5'  Mouse mir-23 
Mir-23 binding site conservation 
on the 3’UTR of chick and mouse Brn-3b
 
CUUUUC  TGCAU-- UUAC A CU  
 
 
 
 
Table 5.0: Conservation of mir-23 binding site on the 3’UTR of murine and chick Brn-3b. 
---------------- 
 
 
The in silico results concerning the potential regulation of the 3’UTR of cBrn-3b 
by chick microRNAs has shown i) that the previously described murine mir-23 binding 
sites are not conserved on the 3’UTR of cBrn-3b, ii) a new potential mir-23 binding site 
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is present on the 3’UTR of cBrn-3b iii) mir-214 is not conserved on the 3’UTR of cBrn-
3b and iv) a different microRNA, mir-1777, putatively targets cBrn-3b.  
 
 
5.1  Evaluation of microRNA activity in primary RGC 
As reported previously, Brn-3b has been found to be expressed in primary chick 
RGCs (Lindeberg et al. 1997). Due to the uncertain findings concerning its regulation by 
microRNAs and the lack of any evidence concerning the PTGR of Brn-3b in primary 
RGCs, the first question to be addressed was to evaluate whether the machinery involved 
in post-transcriptional gene regulation was operative in this system. For this purpose the 
chick system was used to assess the regulation of the murine peGFP::3b-3’UTR construct 
by microRNAs. 
Primary chick RGCs were obtained from the trypsinization of E6 retinas. 
Following their dissociation, cells were plated on PLL/laminin coated coverslips and the 
following day transfected with the peGFP::3b-3’UTR vector on its own or alongside the 
mir-23 and mir-214 or a control microRNA to test for potential toxicity. As shown in 
figure 5.1, the mir-23 and mir-214 microRNA mediated the degradation of the reporter 
construct in primary chick RGCs as exemplified by the loss of GFP signal in transfected 
RGCs while the control did not have any effect. This result suggests that the machinery 
responsible for microRNA-mediated degradation of the reporter construct is expressed 
and is functioning in primary RGCs.  
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+c-microRNA
100 μm
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.1: Regulation of the peGFP::3b-3’UTR reporter construct by microRNAs in primary RGC. E6 
cells derived from dissociated retina were  transfected with the indicated constructs and microRNAs. The 
levels of GFP have been evaluated by fluorescent microscopy. 
---------------- 
 
Given the data reported above concerning the existence of PTGR in chick retinal 
cells, the amplification, subcloning and study of the 3’UTR of cBrn-3b would have been 
the natural evolution from the results presented in this thesis so far. However, in order to 
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avoid the simple mechanical replication of the experimental approach reported in chapter 
3 and 4 of this thesis, it seemed more interesting to start to assess whether PTGR plays a 
more general role in RGC differentiation and survival and postpone the analysis of cBrn-
3b regulation for a later date. For this purpose, due to its key role in PTGR, Dicer levels 
were experimentally manipulated in RGC-5 and primary RGCs and its sub-cellular 
localization and effect on specific RGC markers evaluated. 
 
 
5.2   Expression of Dicer in RGC-5 cells 
In section 3.5 it has been reported that the levels of Dicer are modified in ND7 
cells induced to differentiate via serum removal. Although it has not been investigated 
yet, the modulation of Dicer levels might thus affect cellular differentiation. Before 
evaluating the potential role played by Dicer in the survival and/or differentiation of 
primary RGCs, its endogenous levels were firstly measured in RGC-5 cells treated with 
KCl and staurosporine or grown in full serum. As mentioned previously, (section 4.0) 
staurosporine and KCl are known to respectively affect the differentiation of RGC-5 cells 
and the intracellular relocation of protein complexes. Contrary to the increased levels of 
Dicer observed in ND7 cells following differentiation induced by serum removal (figure 
3.12, page 98), the differentiation of RGC-5 cells following the treatment with 
staurosporine induces a reduction of Dicer levels compared to untreated cells (fig 5.2) 
while KCl has no effect. 
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Fig. 5.2: Dicer mRNA levels in RGC-5. Dicer expression was measured via realtime RT-PCR following 
treatment of RGC-5 cells with the following compounds: KCl=potassium chloride; SS=Staurosporine or 
FCS=grown in full serum. The experiment was repeated at least three times and the error bars indicate 
standard error. 
---------------- 
 
 
In order to confirm and expand the data concerning the regulation of Dicer to the 
protein level, its intracellular localization was evaluated via an immunofluorescence 
analysis of RGC-5 cells subjected to the aforementioned treatments. As shown in figure 
5.3, Dicer can be identified throughout RGC-5 cell bodies and neurite projections and its 
expression is slightly reduced in SS-treated cells compared to untreated cells. This 
experiment confirmed the data obtained via realtime RT-PCR and presented in figure 5.2 
whereby SS induces a small down-regulation of Dicer mRNA expression in RGC-5 cells. 
Furthermore, the treatment with KCl seems to be inducing a relocation of Dicer. As 
shown in figure 5.3 (middle panel of the left column), its expression is more pronounced 
in what seems to be the peri-nuclear region compared to untreated or staurosporine-
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treated cells (see inset in each panel).  At this moment is still not clear whether this 
relocation has any effect on the function of Dicer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SS
KCl
Dicer Field
FCS
50 μm 50 μm
50 μm
50 μm 50 μm
 
 
Fig. 5.3: Localization of Dicer in RGC-5 cells. RGC-5 cells were treated with SS, KCl or left untreated 
and subjected to an immunofluorescence analysis using an anti-Dicer antibody (left column) or visualized 
via optic microscopy (right column). The magnification in the inset is to show the subcellular localization 
of Dicer. 
----------- 
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5.3  Modulation of Dicer expression levels in RGC-5 cells 
To investigate whether Dicer has any role in RGC-5 cell survival and 
differentiation, its levels were initially increased in this cell line via an expression vector 
encoding Dicer or conversely reduced via a specific siRNA and its protein and mRNA 
levels were evaluated via western blot or real-time PCR analysis respectively (figure 5.4). 
Interestingly, the mRNA levels of Dicer in RGC-5 cells transfected with a Dicer 
expression vector are more significantly increased than Dicer protein. This might indicate 
a high turnover of Dicer protein, a low translation rate of its mRNA or a combination of 
both which might have a direct impact in cell physiology. Conversely, Dicer levels were 
successfully reduced both at the mRNA and protein level following the transfection with 
a Dicer specific siRNA. 
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Fig. 5.4: Expression levels of Dicer in RGC-5 cells. RGC-5 cells were transfected with the indicated 
constructs or siRNA and its expression levels evaluated after two days via realtime RT-PCR. The error bars 
indicate standard error. 
-------------- 
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Once more, in order to visually confirm the result, the above experiment was 
repeated and RGC-5 cells were subjected to an immunofluorescence analysis with an 
anti-Dicer antibody. As shown in figure 5.5, the expression of Dicer is noticeably 
increased following its over-expression while the transfection with a Dicer specific 
siRNA drastically reduces its amount. Conversely a control siRNA does not have any 
effect on the levels of endogenous Dicer as they appear to be similar to the untreated 
sample. Although cells lacking Dicer would have been the right control to evaluate the 
specificity of the anti-Dicer antibody, this is indicated by the differential amount of signal 
in the Dicer over-expressing cells compared to the ones in which Dicer has been silenced.  
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Fig. 5.5: Immunofluorescence analysis of Dicer expression in RGC-5 cells. RGC-5 cells were 
transfected with a Dicer over-expression vector, a specific siRNA or a control siRNA and subjected to an 
immunofluorescence analysis with an anti-dicer antibody. Field=light microscopy; Dicer=Dcr antibody; 
DAPI= staining of nuclei. 
------------------ 
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5.4  MAP2C expression is affected by the modulation of Dicer’s levels 
After having successfully modulated Dicer levels in RGC-5 cells, it was next 
evaluated whether these changes affected the expression of a neuronal differentiation 
marker such as the microtubule associated protein, MAP2C.  
One of the hallmarks of neuronal differentiation is the extension of a network of 
neurites which require the formation and remodelling of the cytoskeleton for their 
elongation. MAP2C plays an essential role by stabilizing microtubules involved in the 
formation of the cytoskeleton (Lieven et al. 2007). This protein is a marker of primary 
RGCs and RGC-5 cell differentiation (Lieven et al. 2007) and is expressed during 
neuronal development (Garner et al. 1988; Lieven et al. 2007).  
RGC-5 cells were thus transfected with a Dicer expression construct or specific 
siRNA as described previously and the levels of MAP2C analysed via realtime RT-PCR. 
Intriguingly, the modulation of Dicer levels has an effect on the expression of MAP2C in 
RGC-5 cells whereby an increase in Dicer levels produces a corresponding increase in 
the expression of MAP2C. Similarly, decreased Dicer levels produce a reduction in 
MAP2C levels. No differences were found following the transfection of a control siRNA 
suggesting specificity of the effect. 
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 Fig. 5.6: MAP2C levels in RGC-5 cells. Cells were transfected with the indicated constructs and siRNA 
and after few days total RNA was subjected to realtime RT-PCR with primers specific for MAP2C and its 
values normalized with GAPDH. The error bars indicate standard error. 
---------------- 
 
 
5.5   Cultivation of primary embryonic retinal strips  
Following the identification of Dicer in RGC-5 cells and its effect on the 
expression of the RGC differentiation marker MAP2C, the next step was to evaluate 
whether Dicer is similarly expressed and the manipulation of its levels in primary RGCs 
has a similar effect to the one observed in RGC-5 cells.  
Primary E7 chick retinal strips were prepared as described in section 2.7 of this 
thesis and grown on PLL/laminin coated-coverslips as exemplified in figure 5.7.  
 
 
  158Chapter5: Preliminary evaluation of the role of Dicer in primary chick RGCs  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
coverslip
Retinal strip
100 μ m
 
 
Fig. 5.7: Neurite outgrowth from primary E7 RGCs. Microphotograph of a typical neurite outgrowth 
from RGCs of an explanted E7retinal strip on PLL/Laminin coated coverslips. Refer to section 2.6 of the 
material and methods for a detailed description of the technique. 
--------------- 
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Embryonic stage 7 (E7) was chosen for several reasons. Firstly, peak production 
of chick RGCs occurs around E7, secondly their axons are fully developed and by the end 
of E7 reach and innervate the tectum (superior colliculum in mammals) and lastly E7 
chick embryos are relatively easy to manipulate.  
Primary retinal strips were firstly subjected to immunofluorescence analysis using 
an anti-actin antibody (fig 5.8). This showed that the neurite arborisation structure of 
primary retinal strips had been preserved during their manipulation and that actin could 
be detected as expected throughout cell bodies and their neurites.  
 
 
Anti-Actin
10 μ m
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.8: Immunofluorescence analysis of E7 RGCs with anti-actin antibody. Retinal strips were fixed 
and permeabilized as described in the material and method section, probed with anti-actin antibody and 
photographed under fluorescent light. 
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5.6  Expression of Dicer at different embryonic stages 
Next, the expression of Dicer was evaluated at different embryonic stages in the 
chick retinal strips. As shown in figure 5.9, Dicer is expressed at all tested embryonic 
stages. As a control, the bottom panel shows an immunofluorescence assay performed 
without primary antibody.  
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Fig. 5.9: Expression of Dicer at different chick embryonic stages. Retinal strips from embryonic stages 
E7 and E8 have been treated as described previously. The C- control consists of an immunofluorescence on 
E7 retinal strip performed without the primary antibody. 
-------------- 
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Intriguingly, as reported previously in mice (Hengst et al. 2006), Dicer can be found both 
in cell bodies and throughout almost the entire length of neurites. This suggests that the 
activity of Dicer in the production of mature microRNAs might be required close to the 
synaptic terminal where mRNAs and ribosomes have already been identified(Steward et 
al. 1982) . Furthermore, and as also measured via realtime RT-PCR later in paragraph 5.7 
(Fig. 5.10), the expression levels of Dicer seem to remain constant from E6 to E8. At this 
moment it is still not known whether its expression levels vary throughout chick RGC 
development. 
 
 
5.7 RGCs  differentiation  markers during development. 
Before assessing the role Dicer might play in neurite extension and general RGC 
differentiation, the mRNA expression levels of the differentiation markers of primary 
RGCs were evaluated at different embryological stages. E6, E7 and E8 retinas were 
grown on coverslips as described previously and the levels of MAP2C, cATH5 and Brn-
3b measured via realtime RT-PCR. While the role of Brn-3b in RGC development has 
been reported previously in this thesis, cATH5 is a basic helix-loop-helix transcription 
factor essential for RGC development (Ma et al. 2004). As shown in figure 5.10 the 
levels of MAP2C increase during embryonic development. This is expected considering 
the role of MAP2C in the establishment of the neurite network. 
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Fig. 5.10: Expression levels in primary RGCs. E6, E7 and E8 primary retinas were dissociated and 
grown on coverslips. The levels of Brn-3b, Dicer, cATH5 and MAP2C were evaluated by realtime RT-
PCR and normalized with GAPDH. Error bars indicate standard error. 
---------------- 
 
 
Intriguingly, the levels of Brn-3b, cATH5 and Dicer mRNA were not increased during 
this time-span. This confirms previously published data which describes the beginning of 
decline of cATH5 expression by E7.5 (Liu et al. 2001) and of Brn-3b by E15.5 in the 
mouse (E8.5 in the chick) (Pan et al. 2005). The expression levels of Dicer mRNA seem 
virtually unchanged in the observed time-frame.  
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5.8  Effect of manipulation of Dicer levels on RGCs differentiation markers  
  Next, in order to evaluate whether Dicer played any role in modulating the 
expression levels of MAP2C as demonstrated in the RGC-5 cell line, its expression was 
artificially elevated in primary RGCs via an over-expression vector. After having 
confirmed that Dicer mRNA levels were actually increased in this experiment, the 
mRNA levels of Brn-3b, MAP2C and cATH5 were also measured via realtime RT-PCR. 
As shown in figure 5.11, the levels of MAP2C are increased following the over-
expression of Dicer paralleling the findings in the RGC-5 cell line. Intriguingly the levels 
of Brn-3b are also increased while the expression of cATH5 is reduced in Dicer over-
expressing cells. 
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Fig. 5.11: MAP2C levels in primary RGCs. Dissociated E7 retinas were transfected with a Dicer 
overexpression vector and MAP2C RNA levels evaluated via realtime RT-PCR and normalized with 
GAPDH. Error bars indicate standard error. 
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This result shows that Dicer, via an unknown mechanism, seems to be involved in RGC 
differentiation as measured by the variation in the expression levels of RGC- 
differentiation markers following its increased expression. 
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5.9 Discussion 
Subsequent to the analysis of the regulation of the 3’UTR of murine Brn-3b in 
several cell lines, a similar evaluation was attempted in regard of the 3’UTR of the chick 
Brn-3b. The analysis of this sequence showed that, despite a relatively high homology 
between the murine and chick 3’UTRs, the microRNA binding sites are poorly 
conserved. In particular the first 300 nucleotides of murine 3’UTR of Brn-3b, where the 
mir-23 ‘upstream’ binding site is localized, are not present in the chick. Intriguingly, 
although the chick mir-23 is different from its murine counterpart, the 3’UTR of the 
cBrn-3b has a mir-23 binding site which is situated not far from the murine mir-23 
‘downstream’ site. Whether this site has any physiological relevance in the regulation of 
Brn-3b in RGCs, remains to be established. With regard to the other microRNAs 
involved in the regulation of the 3’UTR of Brn-3b, mir-214, it is only moderately 
conserved and the region encompassing the “seed” is not present in the chick 3’UTR. In 
contrast, a different putative microRNA binding site (mir-1777) was identified. Future 
work will establish whether this site has any physiological function.  
Overall the analysis of microRNAs in the chick genome is still in its early stages 
compared to their identification and analysis in mammals (Sevignani et al. 2006; Glazov 
et al. 2008). This might also explain why the 3’UTR of the chick Brn-3b seems to be 
targeted by fewer microRNAs than the 3’UTR of murine Brn-3b. Alternatively it could 
be possible that the regulation by microRNAs increased in complexity during evolution 
(Xie et al. 2004; Grun et al. 2005; Chapman et al. 2007) and hence more microRNAs are 
produced in mammals compared to avian species (Lee et al. 2007). 
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In order to test whether primary RGCs contain the machinery involved in PTGR, 
these cells were transfected with the construct harboring the 3’UTR of murine Brn-3b 
along with various microRNAs. The 3’UTR of murine Brn-3b was degraded by murine 
mir-23 and mir-214 suggesting that PTGR is active and functioning in primary chick 
RGCs.  
Due to the presence of Dicer in synaptic terminals (Jin et al. 2004; Siomi et al. 
2004; Giraldez et al. 2005; Hengst et al. 2006) it was also assessed whether the 
manipulation of its levels had any role in the differentiation of RGCs. Firstly a time-
course analysis of Dicer expression was performed in E6, E7 and E8 primary RGCs. This 
showed that, while the levels of Dicer seem to remain constant in this time-frame, the 
expression of MAP2C increases while the levels of cATH5 and Brn-3b slightly decrease.  
This result is in agreement with previous findings which show a reduction of Brn-3b an 
of cATH5 levels during RGC development (Liu et al. 2001; Pan et al. 2005). 
In order to further evaluate whether Dicer plays any role in RGC differentiation, 
its levels were artificially manipulated in RGC-5 cells and in primary E7 RGCs. The 
over-expression of Dicer in both the RGC-5 cell line and in primary RGCs led to 
increased levels of MAP2C. Conversely, the reduction of Dicer levels via siRNA led to 
reduced amount of MAP2C in RGC-5 cells. The elevated levels of MAP2C, a protein 
involved in the stabilization of the cytoskeleton and neurite outgrowth (Lieven et al. 
2007), suggest that Dicer might actually have a role in neuronal differentiation as also 
suggested previously (De Pietri Tonelli et al. 2008; Kawase-Koga et al. 2009). This is 
also suggested by its effect on two transcription factors, Brn-3b and cATH5, both 
involved in the development of RGCs whereby the over-expression of Dicer in E7 RGCs 
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is associated with increased expression of Brn-3b and with decreased cATH5 levels. 
These results indicate that, directly or indirectly, Dicer may be involved in RGC 
differentiation. A possible explanation of this result is that the modification of Dicer 
levels affects the production of microRNAs modulating the expression of specific 
mRNAs involved in differentiation. Whilst mir-23 and mir-214 are involved in the 
degradation of Brn-3b, the over-expression of Dicer might, for instance, increase the 
production of microRNAs which target inhibitors of Brn-3b transcription and of other 
mRNAs involved in RGC differentiation. An opposite scenario, whereas microRNA 
target cATH5 activators, might instead be at the basis of cATH5 down-regulation in 
Dicer over-expressing cells. Besides the modulation of MAP2C, Brn-3b and cATH5, is 
likely that the modulation of Dicer levels indirectly affects the expression of several other 
mRNAs involved in RGC development. Although at the present time it is not clear how 
the manipulation of Dicer levels might affect the expression of the analyzed mRNAs, it 
would be very interesting to perform a microRNA and mRNA profiling of differentiating 
RGCs and of RGCs over-expressing Dicer.  
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The regulation of transcription via the modification of DNA packaging (Gatti et 
al. 1992; Dernburg et al. 1996; Richards et al. 2002; Coulthard et al. 2003; Richards 
2008) and via the intervention of specific proteins such as transcription factors (Lee et al. 
2000; Latchman 2002) are all mechanisms aimed at insuring that the genetic material is 
transcribed into RNA only when needed for specific cellular functions. Messenger RNAs 
are also subjected to a control of their turnover and/or translation via several mechanisms 
(Kruys et al. 1988; Andrei et al. 2005; Barreau et al. 2005). Furthermore proteins can be 
subjected to post-translational modification which alters their conformation and activity 
(Lamph et al. 1990; Chou et al. 1995; Han et al. 1997; Niklinski et al. 2000) and/or 
differential degradation which modifies their intracellular abundance according to 
cellular needs (Marquardt et al. 1992; Roth et al. 2008). 
The role played by post transcriptional gene regulation in the modulation of the 
expression of the Brn-3b transcription factor in several neuronal cell lines, was explored 
in this thesis as an example of another mechanism involved in controlling gene 
expression. Brn-3b is expressed and plays an essential role in the survival of retinal 
ganglion cells (Gan et al. 1996; Erkman et al. 2000; Wang et al. 2000; DeCarvalho et al. 
2004; Qiu et al. 2008; Badea et al. 2009).  
The analysis of the 3’UTR of this transcription factor had evidenced its high 
degree of conservation amongst different species thus suggesting it might play a still 
unidentified role in the regulation of its mRNA. It was thus interesting to assess whether, 
beside its transcriptional regulation, Brn-3b could be subjected to post-transcriptional 
gene regulation. Initial experiments showed that in cis regulatory sequences are likely to 
be playing a role in the modulation of a reporter construct harboring it in the ND7 
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neuroblastoma cell line. In particular the differentiation of this cell line via serum 
removal induces an even stronger degradation of the reporter construct containing the 
3’UTR of Brn-3b. This result parallels the modulation of endogenous Brn-3b in ND7 
cells whereby the differentiation of this cell line triggers an increase of the closely related 
Brn-3a transcription factor and a reduction of Brn-3b (Budhram-Mahadeo et al. 1995; 
Smith et al. 1997). Intriguingly a reduction of the levels of a reporter construct harboring 
the 3’UTR of Brn-3b was observed in the other neuronal SHSY-5Y tested cell line but 
not in the breast-cancer derived MCF-7 cell line. This result was interpreted as a working 
hypothesis that the regulation of the 3’UTR of Brn-3b could be a neuron-only 
phenomenon. Subsequent analysis proved this hypothesis to be incorrect. 
The analysis of the 3’UTR of Brn-3b showed that it contained several putative 
microRNA binding sites. These were individually mutagenised to assess for their specific 
role in the degradation of the reporter construct. Two microRNAs, mir-23 and mir-214 
were shown to be putatively involved in the degradation of Brn-3b. 
MicroRNAs are short RNA molecules that, by binding to target sequences 
generally situated in the 3’UTR of mRNAs (Lai 2002; Bartel 2004; Rajewsky et al. 2004; 
Yang et al. 2005), induce their degradation or inhibition of translation (Belostotsky 2004; 
Cullen 2004; Filipowicz et al. 2005; Jabri 2005; Liu et al. 2005; Rehwinkel et al. 2005). 
MicroRNAs thus play an essential role in post-transcriptional gene regulation. They are 
synthesized from within the genome of virtually every organism (Finnegan et al. 2003; 
Allen et al. 2004; Altuvia et al. 2005; Onishi et al. 2005; Smalheiser et al. 2005; Ying et 
al. 2005; Zhang 2005) and after a process of maturation which occurs in the nucleus and 
in the cytoplasm of cells, they acquire their mature and active form (Lee et al. 2002; Cai 
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et al. 2004; Denli et al. 2004; Murchison et al. 2004; Saito et al. 2005). Following their 
quasi-serendipitous discovery, the number of identified microRNAs and of their targets 
has been constantly increasing (Smith 2005; Wang et al. 2005; Corcoran et al. 2009). 
This, alongside their common evolutionary conservation (Ohler et al. 2004; Altuvia et al. 
2005; Zhang et al. 2006), has set microRNAs as potential key players in several aspects 
of cellular physiology and pathology. 
The identification of two microRNAs directly involved in the regulation of the 
Brn-3b transcription factor triggered further investigation by analyzing their role in 
retinal ganglion cells where Brn-3b plays an essential role. This study, presented in 
chapter 4 of this thesis, brought interesting results and speculations. The reporter 
construct containing the 3’UTR of Brn-3b did not seem to be regulated in the RGC-5 
immortalized retinal ganglion cell line as in the other neuronal cell lines. This led to the 
analysis of the expression levels of the mir-23 and mir-214 in RGC-5 cells. It had been 
previously shown that both microRNAs are expressed in ND7 cells and that their 
expression is modulated following differentiation stimuli applied to the cells. Contrary to 
previous findings in ND7 cells, mir-214 was not detectable in the RGC-5 cell line and 
mir-23, although expressed at detectable levels, was not upregulated following RGC-5-
specific differentiation stimuli. Furthermore, the degradation of the GFP::3b-3’UTR 
reporter construct mRNA and of endogenous Brn-3b mRNA, seemed to occur only when 
mir-23 and mir-214 are simultaneously transfected in RGC-5 cells. 
This result disproved the working hypothesis that the regulation of Brn-3b was a 
neuron-only phenomenon and prompted instead a new hypothesis. Could it be possible 
that, due to the pro-survival role played by Brn-3b in retinal ganglion cells its mRNA is 
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protected from microRNA-mediated degradation in the immortalized RGC-5 cell line? If 
that is the case, what is the microRNA expression profile in the primary RGCs? Is Brn-3b 
mRNA protected from microRNA-mediated degradation during development? The 
experiments presented in this thesis suggest that Brn-3b might be differentially subjected 
to microRNA-mediated degradation in different cell lines. This seems to be accomplished 
by the lack of expression of one of the two microRNAs (mir-214) involved in its 
regulation and by the observation that Brn-3b is down-regulated in RGC-5 cells, and 
presumably in primary RGCs as well, only when both mir-23 and mir-214 are transfected 
in RGC-5 cells. Intriguingly a similar microRNA expression profile, whereby mir-23 is 
expressed and mir-214 is not detectable, occurs in primary RGCs (Arora et al. 2007; 
Hackler et al. 2010) where Brn-3b is essential for their survival (Gan et al. 1996; Erkman 
et al. 2000) and in breast cancers and a the breast-cancer derived MCF-7 cell line 
(Volinia et al. 2006; Kovalchuk et al. 2008), in which Brn-3b has been shown to have a 
role in cell proliferation  and invasiveness (Dennis et al. 2001).  
  The last chapter of the results initially assessed whether the phenomenon of 
PTGR plays a role in the differentiation of retinal ganglion cells. This was investigated 
by manipulating the expression of Dicer and by analyzing its effect on the levels of 
several RGC markers such as MAP2C, involved in neurite outgrowth (Lieven et al. 
2007), and of Brn-3b and cATH5, two transcription factors involved in RGC 
development (Liu et al. 2001; Ma et al. 2004). These experiments drew a correlation 
between the expression of Dicer and the levels of RGC markers. Via a still unknown 
mechanism, increased Dicer levels are correspondingly followed by an increase in 
MAP2C and Brn-3b levels and a concomitantly decrease of cATH5 levels. This could be 
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due to a modification in the production of specific microRNAs targeting these RGC 
markers. Due to the focus of this thesis on the post-transcriptional regulation of Brn-3b, 
the effect of manipulating Dicer levels on RGC markers has not been followed any 
further. In order to analyze this aspect, RGC-5 cells could be transfected with a Dicer 
over-expression vector or conversely with a vector encoding for specific shRNA which 
suppress its expression and subsequently perform a profiling of the microRNA 
population resulting from this manipulation. The identified microRNAs could be then 
matched to their putative targets via an in silico analysis which could suggest whether 
any of the microRNAs target cATH5 and other RGC markers 
The data presented in this thesis indicate that Brn-3b, via sequences contained in 
its 3’UTR seems to be subjected to regulation by specific microRNAs in some but not all 
the cell lines tested. As a working hypothesis, due to its essential role in the survival of 
some cell lines, Brn-3b might be protected from degradation by silencing the expression 
of mir-214 and by allowing the degradation of Brn-3b only when both mir-23 and mir-
214 are expressed. Although at the present moment no other microRNAs targeting Brn-
3b have been identified, their existence cannot be totally excluded. Very often the 
understanding of biological phenomena triggers more questions than the answers it 
provides, and thus several issues concerning the regulation of Brn-3b in RGCs remain yet 
to be addressed.   
Firstly it would be interesting to understand whether Brn-3b plays a direct role in 
the transcriptional regulation of mir-214 and/or mir-23 promoter. This would open an 
intriguing scenario whereby Brn-3b regulates the expression of a microRNA that has a 
causative role in its degradation. This could be performed by subcloning the mir-23 and 
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mir-214 promoters upstream of a luciferase reporter gene, transfect the resulting construct 
in different cell lines and evaluating whether Brn-3b has any role in their regulation. 
Secondly, it would be interesting to subclone the 3’UTR of chick Brn-3b and 
evaluate whether it is subjected to a similar regulation by microRNAs in primary RGCs. 
Although murine mir-23 and mir-214 do not have a conserved binding site on the chick 
3’UTR of Brn-3b, it is possible that other yet to be identified microRNAs, still modulate 
the expression of Brn-3b in RGCs. This should be associated to an evaluation of mir-23 
and mir-214 expression during chick development. 
Since Dicer knock out mice die at very early stages of development (Bernstein et 
al. 2003) it would be intriguing to explore whether, besides being an essential enzyme in 
the production of mature microRNAs, Dicer is involved in other still undisclosed 
essential functions. In order to assess this aspect in RGC development it will be important 
to separate the role that Dicer has in the production of microRNAs from any other 
essential function it may have in neuronal differentiation. This could be accomplished by 
silencing Dicer function in RGCs and by co-injecting the same neurons with microRNAs 
extracted from developing RGCs. If Dicer is only essential to produce microRNAs and 
these molecules play a direct role in the differentiation of RGCs, neurons transfected with 
microRNAs extracted from differentiating RGCs, should be complemented for the deficit 
of Dicer and will be able to grow axonal projections as the wild type does. If Dicer also 
plays an undisclosed essential role in neuronal differentiation, the phenotype will not be 
rescued and neurons will not be able to differentiate and will die. 
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Lastly, I would like to report an anecdote related to the approach I would like to 
have in regard of natural phenomena in my scientific career. 
 
When I was studying medicine I was taught that stomach ulcers were caused, 
among other reasons, by abuse of coffee, cigarettes and by stress. As a student, I had 
always wondered what “stress” was and why, in the medical environment, it was so often 
used to explain so different diseases and states of morbidity.  
Eventually, Dr Barry J. Marshall and Dr J. Robin Warren discovered that the 
“stress” causing stomach ulcer was actually a bacterium, Helicobacter pilori (Marshall et 
al. 1984). Thanks to their unorthodox and incredibly open-minded view they broke a 
dogma and gave a real explanation to the cause of stomach ulcer, at least until their 
discovery will be superseded/incorporated by new knowledge.  
The history of science is full of examples like these but somehow they get 
forgotten, new dogmas arise and new people break them. We just have to remember that 
there are no such things as absolute truths, especially in science, and we have to draw on 
our absolute ignorance if we want to be able to invent new wheels. 
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